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Echocardiography is the most important non-invasive diagnostic tool for the clinical 
management of cardiac patients1. Measurement of left ventricular volume and func-
tion are the most common clinical referral questions to the echocardiography labo-
ratory because of its value in clinical decision-making, assessment of therapeu-
tic effects and determination of prognosis. Therefore, an accurate, fast and easy 
measurement of left ventricular volume and function is important. Two-dimensional 
echocardiography remains the most widely used method, but the advantages of 
three-dimensional echocardiography over two-dimensional echocardiography are 
increasingly recognised. Using two-dimensional echocardiography, only a limited 
number of cross-sections of the heart are available for analysis, while three-dimen-
sional echocardiography allows reconstruction or real-time acquisition of a single 
dataset encompassing the complete heart. From this dataset an indefinite number 
of cross-sections and viewing planes can be analyzed, avoiding the geometric as-
sumptions of left ventricular shape and the foreshortened image acquisition of the 
left ventricular cavity.
Over the years, several methods for acquisition of three-dimensional echocardio-
graphic data have been used (Table). In the 1990’s, dynamic three-dimensional 
echocardiographic images were created from a number of individual two-dimen-
sional cross-sections of the heart, which were acquired using either an external 
(e.g. freehand scanning device) or internal reference system (e.g. a rotational sys-
tem, in which the transducer is rotated stepwise or continuously around its central 
axis). All recorded cross-sections were then reconstructed into a volume dataset. 
Disadvantages were long acquisition and reconstruction times, motion artefacts 
(from patient breathing and transducer movement by examiner), and large gaps 
between image planes resulting in interpolation errors. Researchers at the Eras-
mus University developed a fast-rotating ultrasound transducer, which enables the 
acquisition of a full three-dimensional dataset of the heart in 10 seconds. Unlike 
Table. Approaches for three-dimensional echocardiography
A. Reconstruction techniques
External reference system / non-systematic image acquisition
•	 Mechanical	arm8, 9
•	 Acoustic	(spark	gap)	locator10
•	 Optical	or	electromagnetic	sensor11, 12
Internal reference system / systematic image acquisition
•	 Linear	transducer	motion13
•	 Fan-like	transducer	motion14
•	 Stepwise15, 16 or continuous rotational transducer motion17, 18
B. Real-time volumetric techniques2
Adapted from: Three-dimensional echocardiography of the heart and coronary arteries (Editor: JRTC 
Roelandt)
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other mechanical acquisition systems, which can only collect images over a limited 
number of rotations, this transducer acquires images over as many rotations as 
required. The size of the transducer is slightly larger than a standard transducer for 
two-dimensional echocardiography. Major advantages of this system are a short 
acquisition time and availability of all two-dimensional echocardiographic imaging 
techniques, such as second harmonic imaging.
A further development was real-time three-dimensional echocardiography, which 
is based on the matrix-transducer technology and first introduced by von Ramm et 
al. at Dukes ( it is Duke and not Dukes) University2. This method is based on a two-
dimensional grid of miniature ultrasound elements, which acquire a three-dimen-
sional pyramidal dataset in real-time, without the need for off-line reconstruction. 
These systems are currently the standard for three-dimensional echocardiographic 
examinations. The impressive evolution of dynamic three-dimensional echocar-
diography in the past 17 years is illustrated by the number of world-wide PubMed 
publications on this topic (Figure). A increase of its applications can be expected 
with further technical improvements. Currently, software developments for data 
analysis increase the clinical applicability, including (semi-)automatic analysis of 
the left ventricular endocardial contour.
The aim of the first part of the thesis was to evaluate the feasibility and clinical 
applicability of the fast-rotating ultrasound transducer. For determination of left 
ventricular function, the fast-rotating transducer may be an excellent tool for rapid 
evaluation, without the necessity of an expensive high-end ultrasound system with 
multiple and complex applications.
 
 
Fig 1.1 
Figure 1. Annual number of publications in PubMed on three-dimensional echocardiography.
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Chapter two focuses on the technical details of the fast-rotating ultrasound 
transducer.
Chapter three describes a validation study using the fast-rotating ultrasound 
transducer, for analysis of left ventricular function with magnetic resonance imag-
ing as the reference technique.
In chapter four, we evaluate the clinical applicability of the fast-rotating ultra-
sound transducer in patients undergoing hemodialysis. These patients have rapid 
changes in volume load of the heart and three-dimensional echocardiography may 
potentially improve accuracy for serial measurements of left ventricular perfor-
mance, compared to two-dimensional echocardiography.
Cardiac resynchronization therapy is an additional treatment for selected pa-
tients with severe heart failure and ventricular dyssynchrony. When used in combi-
nation with optimal medical therapy, it has shown to reduce symptoms and improve 
cardiac function by restoring the mechanical sequence of ventricular activation and 
contraction. In chapter five, the feasibility of the fast-rotating transducer is evalu-
ated for the determination of dyssynchrony in heart failure patient, including deter-
mination of the best pacing site for resynchronization therapy.
Part two of the thesis concerns the analysis of left ventricular function using three-
dimensional echocardiography.
Numerous studies3, 4 have focused on the advantages and improved accuracy of 
three-dimensional echocardiography over two-dimensional imaging for measure-
ment of left ventricular volume and function by obviating geometric assumptions.
In chapter six, an overview of methods for acquisition of three-dimensional 
echocardiographic images is shown, including earlier studies on left ventricular 
volume and function assessment with three-dimensional echocardiography.
Several online and off-line analytic software programs for left ventricular vol-
ume quantification by real-time three-dimensional echocardiography are available, 
which use a wide spectrum of endocardial contour tracing algorithms, ranging from 
manual to fully automated algorithms. Chapter seven shows a comparison in ac-
curacy between two different computer algorithms for calculation of left ventricular 
volume and function. The first algorithm determines a geometric model for the left 
ventricle through manual definition of the mitral annulus, aortic valve and apex, after 
which semi-automated border detection is performed in a limited number of cross-
sections. In contrast, the second more recent algorithm performs semi-automated 
contour detection in the complete dynamic three-dimensional dataset (‘full volume 
reconstruction’). Thus, significantly more data is used to determine the endocardial 
cavity contour for left ventricular reconstruction.
Ultrasound contrast, consisting of gasfilled microbubbles, is used for improve-
ment of endocardial border definition by enhancement of ultrasound backscatter of 
the bloodpool compared to the surrounding myocardium. A higher accuracy for as-
sessment of left ventricular function has been shown in two-dimensional echocar-
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diography, particularly in patients with a suboptimal acoustic window. In chapter 
eight we evaluate whether the use of contrast enhancement improves accuracy of 
left ventricular function analysis by real-time three-dimensional echocardiography.
In part three of the thesis, the current status of three-dimensional stress echocar-
diography is described. Two-dimensional dobutamine stress echocardiography is 
a well-established method for the diagnosis and of prognostic value in patients 
with suspected coronary artery disease5. Chapter nine and ten present an overview 
of diagnostic dobutamine stress echocardiography studies and a methodological 
analysis to explain the wide range in diagnostic variability of dobutamine stress 
echocardiography.
In several recent publications the advantages of real-time three-dimensional 
echocardiography6, 7 are described. The faster acquisition time and low operator 
dependency improve the diagnostic accuracy. The results of these studies are 
described in a review article on real-time three-dimensional dobutamine stress 
echocardiography in chapter 11.
However, some critical remarks are appropriate, particularly with respect to the 
current technical limitations of three-dimensional echocardiography. These are de-
scribed in chapter 12. Finally, we performed two studies to assess the value of 
ultrasound contrast during real-time three-dimensional stress echocardiography. 
The study presented in chapter 13 was performed to examine the role of ultrasound 
contrast for the improvement of segmental image quality and inter-observer agree-
ment of wall motion analysis during real-time three-dimensional stress echocar-
diography. In chapter 14, we evaluate the diagnostic accuracy of contrast enhanced 
real-time three-dimensional stress echocardiography for the diagnosis of coronary 
artery disease in comparison with coronary arteriography findings as a reference.
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Abstract
Although the advantages of three-dimensional (3-D) echocardiography have been 
acknowledged, its application for routine diagnosis is still very limited. This is mainly 
due to the relatively long acquisition time. Only recently has this problem been 
addressed with the introduction of new real-time 3-D echo systems. This paper 
describes the design, characteristics, and capabilities of an alternative concept for 
rapid 3-D echocardiographic recordings. The presented fast-rotating ultrasound 
(FRU)-transducer is based on a 64-element phased array that rotates with a maxi-
mum speed of 8 Hz (480 rpm). The large bandwidth of the FRU-transducer makes 
it highly suitable for tissue and contrast harmonic imaging. The transducer presents 
itself as a conventional phased-array transducer; therefore, it is easily implemented 
on existing 2-D echo systems, without additional interfacing. The capabilities of the 
FRU-transducer are illustrated with in-vitro volume measurements, harmonic imag-
ing in combination with a contrast agent, and a preliminary clinical study.
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Introduction
Over the last 20 years the application of threedimensional (3-D) echocadiography 
has been explored extensively. The reconstruction of unconventional 2-D views 
from a 3-D dataset has been seen as a welcome addition to the possibilities of 
echocardiography1. Also, the examination of volume-rendered 3-D recordings, the 
socalled surgical view, has proven very useful for the preparation of surgical inter-
ventions 2. In addition, many studies have validated the increased accuracy ob-
tained with the quantification of cardiac structures from 3-D data as compared to 
2-D data3.
In spite of its advantages, 3-D echocardiography is still mainly used for research 
purposes. Most 3-D echocardiographic techniques developed in the past are based 
on the stepwise displacement of a phased array4–6.With these techniques, only one 
position is covered during a cardiac cycle. The subsequent cycle then is used to 
move to the next location. This relatively slow process prolongs the acquisition time 
beyond the feasible duration of a single breath hold, which in turn calls for respira-
tory and electrocardiogram (ECG) gating. For a densely sampled 3-D recording, 
the process described above requires an acquisition time of several minutes. The 
recordings often suffer from motion artefacts as a result of the lengthy acquisition 
time. Although the acquisition of a 3-D dataset does not consume more time than 
alternative techniques, such as magnetic resonance imaging (MRI), it is still con-
sidered a drawback. As long as standard 2-D examinations are performed in the 
same amount of time as a single 3-D recording, it will not likely be widely accepted 
in daily clinical practice.
Real-time 3-D echocardiography solves the problem of lengthy acquisition 
times; however, first-generation realtime 3-D echo systems suffered from insuf-
ficient image quality7. The recently introduced second-generation systems from 
Philips (Eindhoven, The Netherlands) and General Electric (Milwaukee, WI) possess 
an improved image quality. These commercially available systems have resulted in 
the increased use of 3-D echocardiography for routine diagnosis8.
State-of-the-art 2-D echo systems cover two spatial dimensions and time with 
sufficient spatial and temporal resolution. Therefore, the key to fast acquisition of a 
3-D dataset is an effective coverage of the third spatial dimension. With stepwise, 
displaced phased arrays, more frames are discarded during motion and gating than 
used for the actual 3-D dataset. However, a phased array moved in a continu-
ous, uniform motion would be able to make use of the full frame rate. This paper 
describes the design, characteristics, and capabilities of a continuous, rotating, 
phased-array transducer intended for rapid 3-D echocardiographic recordings.
Boudewijn Krenning BW.indd   17 12-10-2007   15:18:56
Chapter 2 
18
Materials and Methods
In the first part of this paper, the transducer’s design and its consequences for the 
acquisition morphology will be described. The rotation speed of the transducer is 
not stored with the echo data but is extracted from it. The technique to recover the 
rotation speed from the data is explained in a subsequent section. The process 
needed for the reconstruction and quantification of a scanned volume will be dis-
cussed. The optimization of the rotation speed for the clinical setting is described.
The Fast-Rotating Ultrasound Transducer
The fast-rotating ultrasound (FRU)-transducer consists of three major parts: a high 
precision drive, a slip-ring device, and a phased array. Fig. 1 shows the latest pro-
totype of the transducer9. Key features of the transducer are its wide bandwidth, 
allowing harmonic imaging, and its ergonomic design (width: 53 mm, height: 33 
mm, length: 147 mm, and weight: 350 g).
The drive of the transducer consists of a direct current (DC) motor, a gear, an 
encoder, and a controller (see Fig. 1). The DC motor, gear, and chain wheel trans-
 
 
 
 
Figure 
2.1 
Figure 
2.2 
Figure. 1. The latest prototype of the fast-rotating ultrasound (FRU)-transducer. The upper panel 
shows the construction of the transducer with some key components annotated. The lower panel 
shows the transducer with its housing. Note the LEDs on the housing, which are used to indicate 
whether the phased array is located in one of its two fixed positions (0° and 90°).
Boudewijn Krenning BW.indd   18 12-10-2007   15:18:57
Harmonic 3D echocardiography with a fast rotating ultrasound transducer
19
mission combination produce a maximum torque of 85 mNm, which is well above 
the torque required to drive the slipring and the array. The encoder and controller 
provide a feedback regulation for a highly constant rotation speed, which can be 
controlled manually. For the acquisition of a 3-D dataset, the rotation speed is set 
between 4 and 8 Hz (240 and 480 rpm). In addition, the array can be positioned 
at two fixed stationary and perpendicular angles (0° and 90°) that are indicated 
with LED’s on the housing of the transducer (see Fig. 1). Using a footswitch, these 
positions can be alternated for alignment of the transducer prior to the acquisition 
of a 3-D dataset (e.g., by checking the four and two chamber views before a left 
ventricular acquisition).
The slip-ring device is custom made (Kaydon, Reading, Berkshire, UK) and con-
tains 82 contacts, of which 64 are used for the array elements and 16 as distributed 
signal ground. No measurable noise generation from the slip-ring device could be 
detected within the frequency range used for imaging.
 
 
 
 
Figure 
2.1 
Figure 
2.2 
Figure. 2. Panel A shows a normalized fundamental (dashed line) and harmonic (solid line) beam 
profiles in lateral direction for an excitation frequency of 1.8 MHz, a pulse length of 2.5 cycles, and a 
nonderated mechanical index (MI) of 1.7 MI. Panel B shows the transmit sensitivity of the transducer.
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The transducer’s array, custom made by Delft Instruments, Delft, The Nether-
lands, contains 64 elements with a pitch of 0.21 mm and is tapered into an octago-
nal shape, approximating a circle with a radius of 7 mm. It has a fractional band-
width of 86% with a center frequency of 3.2 MHz (see Fig. 2(A)). The fixed focus of 
the acoustic lens in the elevation direction is set at 60 mm. Fig. 2(B) gives the lateral 
transmit beam profiles at the focal distance for an excitation frequency of 1.8 MHz 
and a pulse length of 2.5 cycles. At −6 dB a fundamental beam width of 3.86 mm 
and a harmonic beam width of 2.62 mm were found. The side lobe levels of both 
the fundamental and harmonic profile were equal to −18.1 dB.
The transducer is connected to a General Electric/ VingMed (Horten, Norway) 
Vivid 5 system like a conventional phased array, but it could be used with any scan-
ner as no additional interfacing is required.
Morphology of the Acquisition
The typical acquisition time for a full 3-D dataset is approximately 10 seconds, 
which allows for a dataset to be recorded within a single breath hold. With a stan-
dard frame rate of about 100 frames per second (fps), a typical dataset consists 
of approximately 1000 harmonic B-mode images. The frames are first stored in 
the scanner and later transferred to a computer for processing. The ECG signal is 
stored with the frames. No ECG gating is used, and exclusion of irregular cardiac 
cycles is carried out after the acquisition.
The continuous rotation of the array results in nonuniformly sampled 4-D data-
sets (three spatial dimensions and time). First, the individual frames of the recording 
have a curved morphology in space, as shown in Fig. 3(A). Second, the frames will 
sample the volume in an interleaved manner. This is most clearly illustrated in the 
spherical coordinate system, which is the native coordinate system of the acquisi-
tion (see Fig. 3(B)). In the spherical coordinate system, the frames are divided into 
halves by the imaging (or rotation) axis of the transducer. By definition, this is a 
consequence of the limited range of the elevation angle (−1/2π to 1/2π rad), which 
represents the steering angle of the individual ultrasonic beams in the spherical 
domain. When a frame is acquired from right to left, the steering angle from the 
right half of the frame will run down. However, for the beams of the left half, the 
steering angle will run up. This results in inclined and intersecting rows of ultrasonic 
beams from the two frame halves (see Fig. 3(D)). The intersecting nature of the 
frame halves also can be observed in the cartesian coordinate system, but less 
clearly due to the curvature of the frames (see Fig. 3(C)).
From Fig. 3(C), it also can be seen that the sample density increases toward the 
rotation axis. The uniformity of the sampling could be improved by optimizing the 
scanning in the 2-D sector. In the cartesian coordinate system, which is used for 
visualization, there is no uniform sampling along any axis (see Fig. 3(C)). For volume 
rendered reviewing of recorded datasets, the data, therefore, are interpolated with 
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the use of a uniform cartesian grid. Reconstruction can, of course, be performed 
only with the availability of an accurately determined rotation speed.
Determination of the Rotation Speed
To avoid additional interfacing between the echo system and the transducer, the ro-
tation speed is extracted from the recorded harmonic B-mode data in two steps. A 
first estimate of the rotation speed is obtained by correlating all frames of the data-
set with an arbitrary reference frame from the same dataset. The correlation value 
is calculated as the sum of absolute difference between the frames. An example of 
the resulting correlation signal is shown in Fig. 4(A). The correlation result reveals a 
periodic signal with a periodicity related to the rotation speed. Fourier analysis of 
the correlation signal gives the first estimate of the rotation speed.
The accuracy of the first estimate of the rotation speed is limited to approxi-
mately 10 MHz due to noise and the interference of cardiac motion. To improve this 
 
 
 
Figure 
2.3 
Figure 
2.4 
Figure. 3. Panel A shows a typical 2-D image recorded with the FRU-transducer from a cavity 
phantom in perspective. The consecutive frames repeat the same image, but each time rotated 60◦ 
clockwise. The sequence gives a good appreciation of the curved shape of the frame. The first part 
of panel B shows a curved frame and its relation to the spherical and cartesian coordinate system. 
The second part depicts the conical shape of the volume sampled by the FRU-transducer and the 
position of a C-plane. In addition, panel B shows how a frame is divided by the imaging axis into a 
left and a right half, indicated with L and R. Panel C shows the position of the ultrasonic beams from 
a number of frames in the cartesian coordinate system. Beams from the left half of the frames are 
indicated with an open dot and those from the right half with a closed dot (see also panel B). Panel D 
shows the more orderly position of the same beams in the spherical coordinate system.
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accuracy, the rotation speed is corrected in a second step. Enddiastolic C-planes 
are reconstructed from each recorded cardiac cycle. The C-plane of the first car-
diac cycle is used as a reference for correlation with the C-planes of subsequent 
cycles. By maximizing the correlation between the planes, by rotating them around 
the rotation axis, the angular correction for each C-plane can be found. Fig. 4(B) 
gives an example of the result from a C-plane correlation.
The correlation result of the C-planes shows a linear increase of the angular er-
ror due to the insufficient accuracy of the first rotation speed estimation. Using the 
regression of the C-plane correlation, the accuracy of the rotation speed can be 
increased an order of a magnitude beyond the first estimate. Typically, the residual 
angular error after the second order rotation speed estimation is not larger than a 
 
 
 
Figure 
2.3 
Figure 
2.4 
Figure. 4. Panel A shows an example of a normalized frame-to-frame correlation signal r with the 
reference frame indicated by the cross on the x-axis. The value at the reference frame is a linear 
interpolation of the values of its neighboring frames and, therefore, is not equal to 1. Approximately 
50 rotations are shown for a recording that was made with a frame rate of 106.1 fps. An example 
of the second order rotation speed estimation is shown in panel B. The regression (solid line) of 
the angular errors Δ◦ calculated (solid dots) resulted in a rotation speed correction of 5.3 MHz. The 
residual angular error after correction of the rotation speed also is shown (open dots). Panel C shows 
two reconstructed long axis images of the left ventricular acquisition in question. For the image 
on the right, the second order rotation speed correction was used, but the left image did not use 
the second order correction. The circled area of the image on the left clearly shows the artefacts 
resulting from inaccuracies in the rotation speed used.
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few degrees (see Fig. 4(B)), which is only a fraction of the optimal angular resolution 
(see also Appendix A). Fig. 4(C) gives an example of the artefacts resulting from in-
accuracies in the first estimate of the rotation speed. As can be seen from Fig. 4(C), 
the artefacts are resolved when the second order estimate is used.
Reconstruction
Following the determination of an accurate rotation speed, 4-D datasets can be 
constructed from the recorded frames. Datasets constructed from an acquisition of 
one cardiac cycle result in a sparse sampling of the time-volume space. To obtain 
a denser sampling of the time-volume space, a number of cardiac cycles are fused, 
which is also referred to as multibeat fusion.
Although the multibeat fusion results in a densely sampled 4-D dataset of the 
scanned volume, the dataset still has a nonuniform structure. A suitable interpola-
tion technique is used to resample the data into a uniformly spaced cartesian grid.
Fig. 5 gives an example of the above techniques. The improved image quality 
obtained with the use of multibeat fusion is clearly depicted in Fig. 5.
Optimization of the Rotation Speed
For successful reconstruction, the acquired frames should be distributed adequately 
over the rotation angle. This distribution depends, in the first place, on the rotation 
speed and the frame rate. With the use of multibeat fusion, the distribution also is 
dependent on the heart rate and the number of cardiac segments (i.e., the number 
 
 
 
 
 
 
 
Figure 
2.5 
Figure 
2.6 
Figure. 5. In panel A the time intervals of four corresponding cardiac segments are indicated 
when each cardiac cycle is divided into 12 segments of equal width. If only segment a is used for 
reconstruction, a sparse sampling of the volume is obtained. Panel B depicts both the sampling 
of the rotation angle and the reconstruction of the corresponding C-plane for this case (z is the 
axial direction of the transducer; see also Figure. 3). The individual frames recorded within the 
time interval of the segment are indicated with solid lines. Panel C shows the same results when 
all four segments are used. The denser sampling of the volume and the improved resolution of 
reconstructed images clearly can be appreciated.
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of time intervals in which the cardiac cycle is subdivided, typically 16). For a record-
ing of a stationary volume with an arbitrary rotation speed, the minimum sampling 
interval of the rotation angle is the angle between two consecutive frames. For a 
cardiac recording, even this minimal resolution is not assured. It is not even unlikely 
that the frames from the cardiac segments used will end up in the same quadrant 
of the rotation angle. To prevent this from happening, an optimized rotation speed 
needs to be used for a given frame rate, heart rate, and number of cardiac seg-
ments. Appendix A gives the details of the calculation of such an optimized rota-
tion speed. The calculation is based on the use of a candidate rotation frequency 
in which the continuity of the frame distribution over the rotation angle is assured. 
By correcting this candidate rotation speed toward an equiangular distribution, an 
optimized rotation speed is obtained. Table I gives a number of examples of the 
calculation for some randomly selected clinical settings.
Table 1. Randomly Selected Examples of the Rotation Frequency Calculations.
heart rate 
[bpm]
fFrame
 [Hz]
fCandidate
[Hz]
NRotation fRotation
 [Hz]
Resolution 
(°)
deviation 
(%)
47 98.7 6.6894 3 6.6920 8.18 6.4
51 98.7 7.2417 3 7.2402 8.78 3.2
64 93.4 5.6266 3 5.6252 7.20 4.1
73 104.8 6.4677 3 6.4644 7.35 7.0
81 104.8 5.7412 3 5.7394 6.54 4.6
89 104.8 6.2554 3 6.2572 7.20 2.9
97 106.1 5.1319 3 5.1319 5.81 2.0
104 106.1 7.4427 4 7.4427 6.32 1.8
120 93.4 6.3683 3 6.3683 8.18 1.4
142 104.8 7.6666 4 7.6634 6.55 3.5
Heart rates are from a wide range, commonly used frame rates and an intended reconstruction with 
16 cardiac segments. The angular position of the first ultrasonic beam from each frame is defined as 
the angular position of the frame itself. The deviation then is specified as the standard deviation of 
the difference between the maximum resolution and the achieved inter-frame resolution. The mean 
difference between the maximum resolution and the achieved resolution always will be zero with a 
given number of frames and, therefore, is not included.
Quantification
Quantification tools are based on manual or semiautomatic tracing of an anatomi-
cal feature in a stack of 2-D images. This is necessary due to the fact that currently 
there are no fully automatic quantification algorithms available. In addition, com-
puters are equipped with 2-D monitors that essentially can be used only to view 
two spatial dimensions plus time. Therefore, the recorded 4-D dataset needs to be 
resliced in order to obtain the 2-D image set required by the selected quantification 
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tool. In the case of left ventricular (LV) volume measurement this could mean a set 
of long and/or short axis images.
Results
The capabilities of the FRU-transducer are illustrated in three examples: in-vitro 
volume measurements, harmonic imaging in combination with contrast, and a pre-
liminary clinical study.
In-Vitro Evaluation
Two geometrical agar units were made with cavities in the shape of a sphere and 
a beam. Each unit consisted of two halves. From the units, five different phantoms 
were constructed: a sphere, a beam, half a sphere, half a beam and a mixed com-
bination of half a sphere and half a beam (or “mushroom”). Another agar phantom 
was made that had a LV shape.
Recordings of the phantoms were made with a rotation speed of 6 Hz (360 rpm) 
and a frame rate of 67.5 fps. One to two seconds of each recording were used to 
reconstruct the phantoms. After reconstruction, the phantom cavities were extracted 
with an advanced threshold-based method. For this method, depth dependent bi-
modal histogram thresholding, a closing procedure with a diamond structuring ele-
ment of size three and volume extraction using a connectivity of six were used10. The 
extracted volumes were compared with the actual volume of the phantom cavity.
The result of one of the agar phantom reconstructions is depicted in Fig. 6. The 
reconstructions of the six different phantoms showed an average volume error of 
approximately 1% (see Table II).
Table 2. Results of the In-Vitro Volume Measurement Evaluation.
phantom
volume (ml)
deviation (%)
actual reconstructed
sphere 135.5 136.9 1.0
beam 133 131.5 1.1
½ sphere 68.5 67.6 1.3
½ beam 63 62.5 0.7
‘mushroom’ 131.5 132 0.4
LV 131 128.7 1.8
Contrast Harmonic Imaging
A commercially available tissue mimicking flow phantom (Model 524, ATS Labo-
ratories Inc., Bridgeport, CT) was used to explore the harmonic capabilities of the 
FRUtransducer in combination with the use of contrast agents. Backscatter power 
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spectra from a tissue and a contrast region of interest (ROI) were calculated from 
recorded radio frequency data. The spectra and the extracted contrast to tissue 
ratio from these spectra were used to determine the efficacy of harmonic imaging 
over fundamental imaging11.
The contrast to tissue ratio (CTR) was defined as the ratio of the scattered power 
caused by the contrast to that of the tissue. The contrast and tissue ROI were se-
lected as shown in Fig. 7(A). Optison contrast agent (Amersham Health, Princeton, 
NJ) was used at a dilution of 1 over 2000 in Isoton II (Beckman Coulter, Fullerton, 
CA) and was flowing at a constant rate of 90 ml/minute through the phantom. The 
ROI’s were insonified with a pulse comprising a derated peak negative pressure of 
150 kPa, a transmit frequency of 1.74 MHz, and a pulse length of 2.5 cycles. With 
these settings, an increase of more than 8 dB in the CTR was found at the second 
harmonic compared to the fundamental frequency (see Figs. 7(B) and (C)).
 
 
 
 
 
 
 
Figure 
2.5 
Figure 
2.6 
Figure. 6. Rendered reconstruction of the LV-shaped agar phantom.
 
 
 
 
 
 
Figure 
2.7 
Figure 
2.8 
Figure. 7. In panel A, a B-mode image from the tissue-mimicking phantom with contrast in the 
flow area is shown. The gray and white solid lines indicate the ROI used for the power spectra 
calculations. The power spectra obtained from the tissue (dashed line) and contrast (solid line) region 
at a transmission frequency of 1.74 MHz are depicted in panel B. The difference of these power 
spectra, defined as the CTR, is shown in panel C.
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Clinical Recordings
Fig. 8 shows a rendered patient recording of the left ventricle. The image shows the 
LV cavity, the mitral valve, and the aortic outlet tract. In addition, two reconstructed 
2-D images of the LV short and long axis are shown.
From another patient, the LV volume and ejection fraction was determined. Quan-
tification of the recorded echo data was performed with 4-D LV analysis software 
from TomTec (Munich, Germany) featuring a semiautomated border detection algo-
rithm. End diastolic and end systolic volumes were determined using seven slices 
per volume with equiangular intervals. Fig. 9 shows the analysis result. An end-dia-
stolic and end-systolic surface rendering of the endocardial border is shown along 
with the obtained time-volume curve. From the time-volume curve, an end-diastolic 
volume of 131 ml, an end-systolic volume of 66 ml, and an ejection fraction of 50% 
were extracted. An MRI recording of the same patient on the same day resulted in 
an end-diastolic volume of 131 ml, an end-systolic volume of 62 ml, and an ejection 
fraction of 53%.
 
 
 
 
 
 
Figure 
2.7 
Figure 
2.8 
Figure. 8. The upper panel depicts a volume-rendered reconstruction of a left ventricular patient 
recording. The two lower panels show a reconstructed long and short axis image, respectively. The 
shaded regions in the lower panels annotate the cut away areas of the volumerendered image in 
the upper panel. LV, left ventrical; MV, mitral valve; LVOT, left ventricular outflow tract; SC, sinus 
coronaries.
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Discussion
A novel transducer design, based on the continuous rotation of a phased array, for 
rapid 3-D echo has been presented. The short acquisition time, of approximately 
10 seconds, makes it highly suitable for echocardiographic application and avoids 
the need for respiratory gating. In addition, its wide bandwidth allows for tissue and 
contrast harmonic imaging.
Although the need for fast 3-D echocardiography has been widely recognized, 
only one other research group has reported on a similar concept as presented 
 
 
 
 
 
Figure 
2.9 
Figure. 9. The upper panel shows an end-diastolic and end-systolic surface rendered tracing result 
from a patient recording. The corresponding time-volume curve is shown in the lower panel. From 
the time-volume curve, the end-diastolic volume (131 ml), the endsystolic volume (66 ml), and the 
ejection fraction (50%) are derived.
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here12-14. Their transducer uses a fast-rotating array that is oscillating within its rota-
tion angle range of 720◦. Although its rotation speed matches that of the FRU-trans-
ducer, the oscillatory motion results in an even more complex sampling of the time-
volume space. Studies in which this transducer has been used have been limited to 
fundamental imaging, so no record exists on its harmonic imaging capabilities.
Another concept for fast 3-D echocardiography is the use of matrix array 
transducers, which are currently available with the Philips Sonos 7500 scanner 
(Eindhoven, The Netherlands) and its x4 xMATRIX transducer as well as the Gen-
eral Electric Vivid 7 scanner (Milwaukee,WI) with its 3 V transducer. At the cur-
rent state-of-the-art, it is very difficult for matrix transducers to both deal with the 
complex technology involved and also match the image quality of contemporary, 
phased-array transducers. Although it has been reported that second generation 
matrix array transducers show a big improvement of image quality compared to 
its predecessors8,15, this relatively young technique still provides suboptimal image 
quality, especially when it comes to harmonic imaging16,17. In addition, advanced 
2-D imaging techniques, such as contrast superharmonic imaging18, can be imple-
mented with the FRU-transducer in a straightforward manner and extended for 
use in 3-D applications. With the use of multibeat fusion, an acquisition with the 
FRU-transducer requires 10 seconds maximally. In principal, the matrix approach 
has the advantage of real-time acquisition and display; but in clinical practice, the 
field-of-view of real-time scanning is too limited. For a so-called full-volume record-
ing with the Philips scanner, the acquisition is extended to four cardiac cycles, after 
which the data can be viewed and analyzed offline. In this respect, there is no dif-
ference between our approach and matrix-array transducers. Ultimately, the FRU-
transducer also provides a cost-effective alternative to matrix-array transducers.
Although the results show feasibility of the clinical application of the FRU-trans-
ducer, a full evaluation of its clinical capabilities will be conducted in the near future. 
This will include the determination of the LV function compared with other tech-
niques such as MRI and the use of contrast agents for improved 3-D assessment 
of the heart.
With the availability of fast 3-D echocardiographic acquisition, quantification of 
the recorded data has become the most time-consuming element in the diagnostic 
use of 3-D datasets. This is mainly due to the lack of tracing algorithms that do not 
need an expert to initialize the algorithm and review the tracing result. Improved 
image quality and border delineation will be a welcome contribution toward fully 
automatic quantification tools. The unique harmonic capabilities of the presented 
transducer could be beneficial for this purpose. Therefore, future efforts will be 
aimed at the use of tissue and contrast harmonic images from the FRU-transducer 
for such algorithms.
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Conclusions
A continuous rotating array transducer has been presented suitable for fast acquisi-
tion of 3-D datasets within a clinical setting without the use of respiratory or ECG 
gating.
Its harmonic capabilities provide unique possibilities for tissue and contrast har-
monic 3-D imaging, which could be beneficial for quantification algorithms. The 
concept is easily integrated in state-of-the-art, 2-D echo systems due to its innova-
tive and cost-effective design.
Appendix A
The sampling of the rotation angle in a fused cardiac cycle, when using multibeat 
fusion is determined by four parameters: the rotation speed fRotation, the heart rate, 
the frame rate fFrame, and the segmentation of the cardiac cycle. To determine an 
optimized rotation speed, we first look for a rotation speed from which the frames 
of corresponding and consecutive segments fill up the rotation angle as taken from 
a continuous sequence of frames. For a given heart rate, frame rate, and number 
of segments, we can calculate the average number of frames within each cardiac 
cycle NF/C and the average number of frames within each segment NF/S. With n be-
ing the number of complete rotations covered within the time between two corre-
sponding and consecutive cardiac segments, we can calculate candidate rotation 
speeds fCandidate for our solution with the following formula:
[ ] [ ]SFCF
Frame
Candidate NN
fn
f
// −
⋅=
 with 
84 ≤≤ Candidatef Hz and { },...3,2,1∈n
From the range of possible rotation speeds and the typical frame rate of approxi-
mately 100 fps, it appears that an adequate sampling of the rotation angle can 
be reached when a number of rotations are merged (see also Fig. 5). When, for 
instance, three rotations are merged, the first frame of the second rotation should 
start at exactly one-third or two-thirds of the angle between the first and the second 
frame of the set. If this is the case, the sequence will repeat itself after three full 
rotations, and the frames of the fourth rotation will be at the same angular position 
as those of the first rotation. The candidate rotation speeds usually will not meet 
the above requirement but can be corrected to approximate it. With a given num-
ber of merged rotations NRotation, which is limited by the duration of the recording, 
we can calculate the number of frames per rotation of the preferred rotation speed 
N’F/R from the number of frames per rotation of the candidate rotation speed NF/R 
as follows:
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To avoid that the frame sequence will repeat itself before the number of rotations to 
merge m has to agree to the following additional requirement when NRotation is larger 
than 1:
RotationNjmi ⋅≠⋅  with { },...3,2,1, ∈ji  and RotationNi <
By selecting the preferred number of frames per rotation that deviates the least 
from the number of frames per rotation of the candidate rotation speed, we then 
can calculate the rotation speed:
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With this solution, it is assured that the frames of the first and the last segments 
used will assume their ideal angular position. By using the rotation speed resulting 
from the candidate needing the smallest correction, the frames from intermediate 
segments only will deviate minimally from their ideal position (see Table I).
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Abstract
Measurement of left ventricular (LV) volume and function are the most common 
clinical referral questions to the echocardiography laboratory. A fast, practical and 
accurate method would offer important advantages to obtain this important infor-
mation.
Objective
To validate a new practical method for rapid measurement of LV volume and func-
tion.
Design
We developed a continuous fast-rotating transducer, with second-harmonic capa-
bilities, for three-dimensional echocardiography (3DE). 15 cardiac patients under-
went both 3DE and magnetic resonance imaging (MRI, reference method) on the 
same day. 3DE image acquisition was performed during a 10s breath-hold with a 
frame rate of 100 frames/s and a rotational speed of 6 rotations/s. The individual 
images were postprocessed with Matlab software using multi-beat data fusion. 
Subsequently, with these images 12 datasets per cardiac cycle were reconstruct-
ed each comprising 7 equidistant cross-sectional images for analysis in the new 
TomTec 4DLV analysis software, which uses a semi-automated border detection 
(ABD) algorithm. The ABD requires an average analysis time of 15 min. per patient.
Results
A strong correlation was found between LV end-diastolic volume (r = 0.99; y = 0.95x 
– 1.14 ml; SEE = 6.5 ml), LV end-systolic volume (r = 0.96; y = 0.89x + 7.91 ml; SEE 
= 7.0 ml) and LV ejection fraction (r = 0.93; y = 0.69x + 13.36; SEE = 2.4 %). Inter- 
and intra-observer agreement for all measurements was good.
Conclusion
The fast-rotating transducer with new ABD software is a dedicated tool for rapid 
and accurate analysis of LV volume and function.
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Introduction
Left ventricular (LV) volumes and function have major diagnostic and prognostic 
importance in patients with heart disease1,2 and are the most common referral 
questions to the echocardiography laboratory. A fast, practical and accurate meth-
od is a prerequisite to obtain this important information for patient management. 
Three-dimensional echocardiography (3DE) allows accurate calculation of left ven-
tricular ejection fraction without geometric assumptions of its shape.3-6 Recent 
transducer and software developments may now allow fast acquisition and semi-
automated analysis, enabling the routine clinical application of three-dimensional 
echocardiography.7,8
This study was performed to assess both the feasibility and accuracy of a new 
continuous fast-rotating phased-array transducer for left ventricular volume and 
ejection fraction calculation using commercially available quantification software. 
MRI was used as the reference method.
Material and methods
Study patients
Seventeen male patients (mean age 52 years, range 29 – 74 years) with a history 
of myocardial infarction and various degrees of wall motion abnormalities were 
included. All 15 patients were in sinus rhythm. Two patients suffered from ischemic 
cardiomyopathy. None of the patients had to be excluded because of insufficient 
image quality. However, two patients were excluded because of incomplete visual-
ization of the LV in the echocardiographic window due to LV dilatation. The mean 
heart rate (SD) during echocardiographic examination was 57 (13) bpm. Both stud-
ies were completed in each subject within 4 hours, and MRI was performed before 
3DE examination. All patients gave informed consent.
Three-dimensional echocardiography
Instrumentation
We used a new third generation prototype transthoracic, fast-rotating 64-element 
array transducer with a center frequency of 3 MHz. Besides decreased transducer 
size and technical improvements, this transducer features the capability of sec-
ond harmonic imaging (Figure 1). The transducer continuously rotates around its 
central axis with a maximum rotation speed of 480 rotations per minute and is 
connected to a commercially available ultrasound system (GE Vingmed Vivid 5, 
Horton, Norway).9,10 Interfaces are present for motor control, image synchronisation 
and data processing. Unlike other mechanical 3D-acquisition systems, which can 
only collect images over a limited number of rotations, this transducer acquires im-
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ages over as many rotations as required.5,7,11-15 A slip-ring, consisting of a static and 
rotating part, maintains electrical contact between the rotating array and the static 
part of the transducer. Therefore, any cable twisting and subsequent need for rota-
tion inversion is not present. Because this transducer is capable of using standard 
2D-ultrasound capabilities, a high frame rate at a wide sector angle of 90° can be 
chosen, which is necessary to capture the full LV in most patients. The size of the 
transducer is nearly the same as a standard 2D transducer. The typical frame rate 
for a 3D acquisition is approximately 100 frames/s..
Image acquisition
Patients are studied in the left lateral decubitus position with the transducer in the 
apical position and the image plane rotating around the LV long axis. The depth 
settings are adjusted to visualize the entire LV and part of the left atrium. Gain 
and power settings are optimised for endocardial border visualization. The image 
acquisition is made during a single end-expiratory breath hold of approximately 
10 s., in second harmonic imaging mode (transmit frequency: 2 MHz). The ECG is 
simultaneously recorded for the 3D reconstruction process.
Figure 1: Image of the most recent prototype of the continuous fast-rotating transducer used in 
this study. Below, a 2D phantom image displayed in perspective from different angles. As shown, 
continuous rotation results in a curved shape of the original images.
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Imaging processing and analysis
Image data are transferred via a network connection to a dedicated PC for process-
ing and analysis. With custom designed software, based on MatLab (The Math-
Works Inc., Natick MA, USA), the original 2D images are post-processed (Figure 
2A). Using the ECG, the echo data are located in their correct spatial and temporal 
position.16,17 To obtain an adequate density of the spatial and temporal sampling 
multi-beat data fusion is employed.16,17 Twelve 3D-datasets were reconstructed by 
A
B
C
Figure 2: (A) An original image of the apical long 
axis view showing the image quality during fast 
rotation. (B) Endocardial surface rendered image 
of the endocardial border. (C) Volume-Time 
Curve; dots show measured data points.
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dividing the cardiac cycle in 12 equidistant time-intervals, irrespective of its length. 
Due to the continuous rotation of the transducer-array, the original 2D imaging 
planes have a curved shape and are not suited for automated contour analysis with 
currently available software. Therefore, seven equidistant cross-sectional images 
are re-sampled from the 12 datasets and used for further contour analysis. This 
resulted in a rotational interval of 27° between the cross-sectional images.17
Subsequently, all re-sampled cross-sectional images are imported into the 
TomTec© 4D LV-analysis software (TomTec© Imaging Systems, Munich, Germany). 
Their orientation in 3D space is determined by manually marking the mitral valve, 
aortic root and apex. An elliptical model is then placed over one of the images of 
each of the 7 cross-sectional positions. Contrast and gain settings can be adjusted 
for optimal endocardial border visualization. After this, the software automatically 
performs endocardial border detection in all images of each cross-sectional posi-
tion in the 12 datasets. A spatio-temporal spline model is used to generate smooth 
contours for both the temporal and spatial domain. Two investigators verified and 
corrected the results from the automated border detection independently. This was 
done blinded to MRI results. The first investigator analyzed the 3DE images twice, 
blinded for the results of the first analysis.
The analysis program displays a reconstruction of the LV as a dynamic surface 
rendered image, in which LV wall motion is shown in three dimensions (Figure 2B). 
From an automatically plotted time-volume curve (Figure 2C), LV end-diastolic 
(LVEDV) and end-systolic volume (LVESV) were determined by the maximal and 
minimal volume and ejection fraction (LVEF) was calculated.
Magnetic Resonance Imaging and analysis
All patients are studied in a supine position, with a 4-channel quadrature body 
phased array coil placed over the thorax, in a 1.5T whole body MR imaging system 
(General Electric, Milwaukee WI, USA; Signa CV/i, with an amplitude of 40 mTm-1 
and a slew rate of 150 Tm-1s-1). For quantitative analysis approximately 10 to 12 
cine short-axis series (slice thickness 8 mm, gap 2 mm) covering the heart from 
base to apex where acquired using a breath-hold cardiac triggered steady state 
free precession sequence (FIESTA) with a TR and TE of 3.5 and 1.3 ms respectively 
and a flip angle of 45 degrees. Additional imaging parameters were: Field of View of 
340 x 255 mm, a matrix of 160x128 and a temporal resolution of 28 ms. The whole 
protocol could be performed within 30 minutes.
Quantitative analysis was performed using standardized software (MassPlus, 
General Electric, Milwaukee WI, USA). With this software endocardial contours 
were semi-automatic traced on all end-diastolic and systolic images to calculate 
the LV volumes and EF using Simpson’s rule. Review of the automated tracing was 
performed by an investigator, blinded to the 3DE data.
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Statistical analysis
Data are presented as mean (SD). A linear regression analysis was performed for 
the comparison of results obtained by 3DE and MRI. The first measurement of the 
first observer was used for comparison with MRI. The 3DE measurements from two 
independent observers were compared mutually to assess inter-observer variabil-
ity. To assess intra-observer variability, the two blinded measurements by the first 
observer were compared. In addition, the limits of agreement were calculated for 
all comparisons and expressed as the mean ± 2 times SD18. To determine whether 
there is a statistically significant difference between the populations of each com-
parison, a paired t-test was performed. Data were tested for normality with the 
Kolmogorow-Smirnov test with Lilliefors significance correction. A probability level 
of p< 0.05 was considered significant.
Results
LVEDV measurements for MRI ranged from 127 to 241 ml and from 122 to 239 ml 
for 3DE. LVESV measurements from MRI ranged from 58 to 144 ml and from 60 
to 144 ml for 3DE. The mean (SD) for LVEDV measurements were 186 (41) ml and 
177 (40) ml (P < 0.001), for MRI and 3DE respectively. The mean (SD) for LVESV 
measurements were 99 (28) ml and 96 (25) ml (P = NS), for MRI and 3DE respec-
tively. The Kolmogorow-Smirnov tests for normality were not significant, indicating 
a normal distribution of data. The time for data analysis averaged 15 (5) min. per 
patient.
Comparison between 3DE and MRI
Results of the regression analysis and the limits of agreement calculation for LVEDV, 
LVESV and LVEF are shown in Figure 3. A strong correlation was observed between 
MRI and 3DE for both LVEDV (r = 0.99; y = 0.95x – 1.14 ml; SEE = 6.5 ml) and LVESV 
measurements (r = 0.96; y = 0.89x + 7.91 ml; SEE = 7.0 ml). The limits of agreement 
analysis demonstrated a mean difference of -9.7 ± 13.1 ml for LVEDV and -3.0 ± 
14.7 ml for LVESV. A good correlation was also observed for calculated LVEF (r = 
0.93; y = 0.69x + 13.36; SEE = 2.4 %), with a mean difference of -1.7 ± 7.2%.
Intra-observer variability
The two independent measurements from the first observer show an excellent cor-
relation for LVEDV (r = 1.00; y = 0.97x + 4.3 ml; SEE = 3.2 ml), LVESV (r = 1.00; y = 
1.00x – 0.2 ml; SEE = 2.3 ml) and LVEF (r = 0.99; y = 1.04x – 2.4%; SEE = 1.2%). 
The limits of agreement analysis demonstrated a mean difference of -1.4 ± 6.6 ml 
for LVEDV, -0.1 ± 4.4 ml for LVESV and -0.3 ± 2.4% for LVEF. No significant differ-
ence was present between the two measurements.
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Figure 
3.3 
Figure 3: Relation between 3DE and MRI measurements of LVEDV, LVESV and LVEF.
The left panels show the regression line between the two methods. Dashed lines delimit 95% 
confidence interval. The right panels show plots of the difference between MRI and 3DE, as a 
function of the average calculated volumes. Solid and dashed lines represent mean ± 2 SDs of 
the difference, respectively. (LVEDV = left ventricular end-diastolic volume, LVEF = left ventricular 
ejection fraction, LVESV = left ventricular end-systolic volume).
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Figure 
3.4 
Figure 4: Interobserver variability for 3DE measurements of LVEDV, LVESV and LVEF. The left panels 
show the regression line between measurements obtained by two different observers. Dashed 
lines delimit 95% confidence interval. The right panels show plots of the differences between both 
measurements by two observers as a function of the average measurement. Solid and dashed 
lines represent mean ± 2 SDs of the difference, respectively. (LVEDV = left ventricular end-diastolic 
volume, LVEF = left ventricular ejection fraction, LVESV = left ventricular end-systolic volume).
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Inter-observer variability
The linear regression and limits of agreement calculation for LVEDV, LVESV and 
LVEF from the 3D echocardiographic data by two independent observers are shown 
in Figure 4. These results show a good correlation and only a small mean differ-
ence for LVEDV (r = 0.99; y = 0.98x + 3.53; SEE = 6.0 ml) and LVESV (r = 0.99; y = 
1.00x + 0.97; SEE = 4.5 ml). The results of the linear regression analysis for LVEF 
was acceptable (r = 0.93; y = 0.91x + 3.24; SEE = 2.4 %). The limits of agreement 
analysis demonstrated a mean difference of -0.1 ± 11.7 ml for LVEDV, 1.3 ± 8.7 ml 
for LVESV and -0.7 ± 4.8% for LVEF. No significant difference was present between 
the two observers.
Discussion
This study demonstrates that 3DE with a continuous fast-rotating ultrasound trans-
ducer and TomTec© 4DLV analysis software provides an accurate method for deter-
mination of LV volume and function. This technique allows the acquisition on data 
during 10s of suspended respiration, which makes it clinically feasible. We found a 
strong overall correlation between MRI and 3DE in a group of patients with a wide 
range of LV volumes who underwent MRI and 3DE examination on the same day. 
Further, analysis of inter- and intra-observer variability also showed a good correla-
tion.
The MRI measurements for LVEDV in our study were higher then those of 3DE. 
However, almost all 3DE studies tend to underestimate LV volumes when compared 
to MRI19. One explanation for this underestimation may be a difference in tracing 
method. TomTec© 4DLV software requires long-axis images for endocardial bor-
der detection, while the MRI software uses short-axis cross-sections with a disk-
summation method to obtain a LV volume. Using the latter method, a part of the 
aortic root or left atrium can be included in the volume of the reconstructed disk in 
the most basal cross-section. This error can theoretically be reduced by increasing 
the number of disks (and subsequent decrease of slice thickness), resulting in an 
increased review time.
Second, the endocardial contour tracing may have an important influence on vol-
ume determination20. MRI tracings were performed excluding the trabeculae, while 
3DE tracings are performed on the endocardial border, mostly including tarbeculae. 
During diastole, individual trabeculae are difficult to visualize due to their small size. 
In systole, however, the trabeculae form a compact layer, clearly distinguishable 
from the blood-pool. This may explain differences in LVEDV.
In this study, we used 7 equidistant long-axis cross-sections for endocardial 
border detection, resulting in a good agreement compared to MRI. Several studies 
calculated the optimal rotational interval for LV volumes mostly based on endo-
cardial border tracing of short axis slices of the LV or intersecting long and short 
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axis images.21,22 Tanabe et al. showed that as few as 4-6 axial slices can accurately 
quantify LV volumes using a similar apical rotational technique in non-beating ca-
nine heart specimens with irregular shapes.4 Because currently available software 
most often uses long axis border tracing, further studies are needed to determine 
the optimal rotational interval for this tracing method in normal and remodelled or 
asymmetric human ventricles with a low error in volume calculation. Also, the meth-
od described should be compared with available methods used in daily echocardio-
graphic practice, such as acoustic quantification23,24 and new electronic real-time 
(matrix) ultrasound systems.8,25-28 Theoretically, major advantages of our system are 
the availability of all conventional 2D echocardiography features (such as harmonic 
imaging and Doppler capabilities and 90 degree sector angle imaging) and the 
compatibility with multiple commercially available ultrasound systems. Also, new 
echocardiographic techniques, such as super-harmonic imaging, may be easier to 
implement in our transducer.29
LV volume and function analysis is the most frequent referral question for echocar-
diography. A recent meta-analysis showed that 2DE can only provide a moderately 
accurate assessment of LV systolic function.30 In literature, a 95%-confidence in-
terval for LVEF<±10% is suggested to be important in patients with borderline LV 
dysfunction (LVEF 30-50%) for adequate diagnosis and risk stratification. 3DE can 
serve as an additional imaging technology for more accurate LVEF assessment in 
these patients. A routine 2D examination can then be completed with a fast 3D LV 
function analysis.
Conclusion: The results of this study demonstrate that the fast-rotating transducer 
in combination with TomTec© 4DLV analysis software provides a dedicated tool for 
accurate measurement of LV volume and function.
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Abstract
The effects of hemodialysis (HD) on left ventricular (LV) function have been studied 
by various echocardiographic techniques (M-mode, 2D-echocardiography). These 
studies are hampered by a low accuracy of measurements because of geometric 
assumptions regarding LV shape. Three-dimensional echocardiography (3DE) over-
comes this limitation.
Methods
We tested the feasibility of 3DE assessment of LV function during HD. Conventional 
biplane Simpson rule (BSR) and single plane area length method (SPM) for LV func-
tion analysis were used as a reference.
Results
12 HD patients were studied and in 10 (83%) a total of 80 3D datasets were acquired. 
In three patients, one dataset (4%) was of insufficient quality and excluded from 
analysis. Correlation between SPM, BSR and 3DE for calculation of end-diastolic 
(EDV, r = 0.89 and r = 0.92, respectively), end-systolic volume (ESV, r = 0.92 and r = 
0.93, respectively) and for ejection fraction (EF, r = 0.90 and r = 0.88, respectively) 
was moderate. Limits-of-agreement results for EDV and ESV were poor with confi-
dence intervals larger than 30 ml. Both 2DE methods underestimated end-diastolic 
and end-systolic volume, while overestimating ejection fraction.
Conclusion
3DE is feasible for image acquisition during HD, which opens the possibility for ac-
curate and reproducible measurement of LV function during HD. This may improve 
the assessment of the acute effect of HD on LV performance, and guide therapeutic 
strategies aimed at preventing intradialytic hypotension.
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Introduction
Intradialytic hypotension is an important complication of hemodialysis (HD). Al-
though its pathogenesis is not completely understood, it is clear that the decrease 
in blood volume due to ultrafiltration is the most important initiating factor. Hypoten-
sion results from a decreased product of stroke volume (SV), heart rate (HR) and 
systemic vascular resistance. The continuing volume withdrawal during HD is a he-
modynamic challenge which may lead to an inability to generate sufficient cardiac 
output (CO). However, there is a large inter- and intra-individual variability regard-
ing the incidence of intradialytic hypotension. Therefore, to better understand the 
interplay between progressive volume withdrawal and changes in LV performance 
during HD, studies have been conducted using various echocardiographic tech-
niques, including M-mode echocardiography1,2, two-dimensional echocardiogra-
phy (2DE)3,4 and Doppler-imaging5,7. Nevertheless, the acute effect of HD on cardiac 
function remains poorly understood, due to conflicting results. A number of factors 
influence cardiac function measurements, such as loading conditions7,8. Earlier LV 
performance studies may have been hampered by a low accuracy of measure-
ments. M-mode and 2D echocardiography are limited by geometric assumptions 
as to volume and function calculation. 3D echocardiography (3DE) overcomes this 
limitation, and has recently become a feasible method for rapid and accurate mea-
surement of LV function in a clinical rather than research setting9. In this study, we 
therefore evaluate the feasibility of 3DE assessment of LV function during HD. Also, 
we compared our 3D results with conventional two-dimensional methods for LV 
function analysis.
Methods
Patients
Twelve patients on chronic intermittent HD entered the study. Two patients were ex-
cluded because of insufficient 3D echocardiographic image quality. The remaining 
10 patients had a mean age of 56 ± 15 years. All patients were in sinus rhythm and 
were dialysed three times a week according to a standard dialysis program, which 
had been unchanged for three months or longer. No medication was discontinued 
for this study. Four patients had a history of cardiac disease (2 coronary interven-
tions, 1 myocardial infarction, 1 angina pectoris). The mean heart rate (SD) during 
echocardiographic examination was 68 ± 10 bpm. All patients gave informed verbal 
consent.
Hemodialysis
All dialysis treatments used Fresenius 4008 machines (Fresenius Medical Care, Bad 
Homburg, Germany), biocompatible membranes (Hemophane or Polysulphone) and 
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bicarbonate-buffered dialysate (Fresenius Medical Care SK-F213). The duration of 
the dialysis procedure was 4 h in all patients. During the first 30 minutes patients 
were connected to the dialysis machine with only blood flow (recirculation) but no 
HD or ultrafiltration (UF) taking place. The mean amount of fluid withdrawn was 
2617 ± 1088 ml.
Three-dimensional echocardiography
We used a new prototype transthoracic, fast-rotating 64-element array transducer 
with a center frequency of 3 MHz. Technical aspects have been described else-
where10. In short, this transducer features the capability of second harmonic imag-
ing and continuously rotates around its central axis with a maximum rotation speed 
of 480 rotations per minute. The transducer is connected to a commercially avail-
able ultrasound system (GE Vingmed Vivid 5, Horton, Norway). A validation study 
using cardiac magnetic resonance imaging as a reference showed a strong correla-
tion and good inter- and intra-observer agreement11.
Image acquisition
3DE was performed before HD, 5 minutes after patient connection to the HD sys-
tem, during recirculation without UF (after 30 minutes), every hour during HD with 
UF, and 15 minutes after HD. In total, 8 acquisitions were performed in each patient. 
Patients were studied in a partial left lateral decubitus position during HD. The 
transducer was placed in the apical position with the image plane rotating around 
the LV long axis. The depth settings were adjusted to visualize the entire LV and 
part of the left atrium. Gain and power settings were optimized for endocardial 
border visualization. The image acquisition was made, in second harmonic imag-
ing mode (transmit frequency: 2 MHz) during a single end-expiratory breath hold 
of approximately 10 seconds and the ECG was simultaneously recorded for the 3D 
reconstruction process.
Three-dimensional imaging processing and analysis
Imaging processing and analysis was performed as previously described11. Image 
data were transferred via a network connection to a dedicated PC for processing 
and analysis. With custom designed software, based on MatLab (The MathWorks 
Inc., Natick MA, USA), the original 2D images are post-processed into a 3D data-
sets. Subsequently, TomTec© 4D LV-analysis software (TomTec© Imaging Systems, 
Munich, Germany) was used for further analysis. Eight equidistant cross-sectional 
image planes were used for analysis. The orientation of these images in 3D space 
was determined by manually marking the mitral valve, aortic root and apex. Con-
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trast and gain settings were adjusted for optimal endocardial border visualization. 
Subsequently, the software automatically performed endocardial border detection 
in all images. One investigator verified the results from the automated border detec-
tion and corrected if necessary.
The analysis program displays a reconstruction of the LV as a dynamic surface 
rendered image, in which LV wall motion is shown in three dimensions (see Figure 
1). From an automatically plotted volume-time curve, LV end-diastolic (EDV) and 
end-systolic volume (ESV) was determined by the maximal and minimal volume and 
ejection fraction (EF) was calculated.
Two-dimensional image processing and analysis
From the 3D dataset, two perpendicular images were extracted representing the 
apical two-dimensional four- and two-chamber views. Manual endocardial bor-
 
 
 
Figure 
4.1 
Figure 1:
(A) The LV is divided into 8 equidistant cross-sectional images which are used for contour analysis. 
(B) An original image of an apical long axis view during fast rotation. (C) Reconstruction of the LV in 
end diastole, and (D) end systole.
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der delineation was performed with MatLab using custom designed software. Two 
common algorithms for 2DE ventricular volume calculation were used, as recom-
mended by the American Society of Echocardiography12: 1) The disc summation 
method or biplane Simpson rule (BSR), based on orthogonal planes from apical 
two- and four-chamber views. Volumes were computed using the formulation: (a 
and b represent diameters of discs, see Figure 2).
The single plane area length method by calculation of LV end-diastolic and end-
systolic volumes and ejection fractions from the four-chamber view. Volumes were 
computed using the formulation: (Figure 2).
Inter- and intraobserver variability
To assess inter-observer variability for 2DE, the first two acquisitions of each pa-
tient were independently analyzed by another observer blinded to previous results. 
For assessment of intra-observer variability, the first observer repeated analysis in 
Figure 2:
Top panel: Biplane Simpson Rule for calculating LV volume, based on orthogonal planes from 
apical 2- and 4-chamber view. Bottom panel: Single Plane Area Length method, based on a 
single apical view. (Reprinted from Reference 12, with permission from The American Society of 
Echocardiography).
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a random order. Both were blinded to 3DE results. Data on inter- and intra-observer 
variability for 3DE were available from a previous validation study11.
Statistical analysis
Results for EDV, ESV and EF are represented as mean and standard deviation (SD). 
Data was tested for normality with the Shapiro-Wilk test. A repeated measures 
ANOVA was used for analysis of differences within the variations. Post-hoc testing 
was performed with the paired t-test. Regression and limits of agreement analysis 
was performed for 3DE and 2DE measurements according to the method of Bland 
and Altman13. Results for inter- and intraobserver variations are represented as 
mean ± SD for the difference between the two measurements. A value of p < 0.05 
was considered to be significant.
Results
Successful image acquisition was achieved in 10/12 patients (83%). A total of 80 
3D datasets were acquired in these 10 patients. In three patients, one dataset (4%) 
was of insufficient quality and excluded from analysis. One patient suffered from 
symptomatic hypotension during HD, although no intervention was required. The 
time for data analysis averaged 15 ± 5 minutes per 3D-dataset.
The test for normality was not significant, indicating that the data did not signifi-
cantly deviate from the normal distribution. Repeated measures ANOVA showed a 
significant difference between the measurement methods (F=10.5; p<0.02) but no 
significant difference between the moment of measurement (F=0.57, p<0.78). Be-
cause a significant effect in time was not found, the data was averaged for further 
analysis.
Correlation between the 2DE methods and 3DE for EDV (r<0.92), ESV (r<0.93) 
and EF (r<0.90) was moderate (see Figure 3). However, the limits-of-agreement 
Table. Comparison of LV volume and function measurement by 3DE and 2DE methods
R
Regression 
equation
SEE
Mean diff 
± SD
T-test vs 3DE 
(P-value)
Single plane method EDV (ml) 0.89 y = 0.88x – 0.86 23.12 -16.2 ± 22.7 <0.05
ESV (ml) 0.92 y = 0.80x + 1.33 15.43 -15.3 ± 16.7 <0.02
EF (%) 0.90 y = 0.93x + 5.55 4.87 3.1 ± 4.6 NS
Biplane Simpson EDV (ml) 0.92 y = 0.85 – 3.04 18.91 -21.9 ± 19.4 <0.01
ESV (ml) 0.93 y = 0.82x – 1.57 14.20 -16.8 ± 15.4 <0.01
EF (%) 0.88 y = 0.92x + 4.60 5.27 1.7 ± 5.0 NS
Results of regression analysis and Bland-Altman analysis comparing LV volume and function with 
3D-echocardiography (3DE) and two 2D-echocardiography (2DE) methods (see text for details).
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Figure 
4.3 
Figure 3:
Relation between 3DE and 2DE measurements of EDV, ESV, and EF. The left panels show the 
regression analysis between the two methods. Dashed lines delimit 95% confidence interval. (, solid 
line = biplane Simpson method; o, dashed line = single plane area length method). The right panels 
show plots of the difference between 3DE and 2DE, as a function of the average calculated volumes. 
Solid and dashed lines represent mean ± 2 SDs of the difference, respectively. (EDV = left ventricular 
end-diastolic volume; EF = left ventricular ejection fraction; ESV = left ventricular end-systolic volume).
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between methods for EDV and ESV were poor with confidence intervals all larger 
than 30 ml (see Table). ANOVA analysis for EDV, ESV and EF showed significant dif-
ferences between the different measurement methods (F=8.4, p<0.005). Post-hoc 
testing showed that both 2DE methods significantly underestimated EDV and ESV 
compared to 3DE. Limits-of-agreement analysis for EF showed an overestimation 
for both 2DE methods. However, these differences were not significant compared 
to 3DE.
Inter- and intra-observer variability:
The limits of agreement analysis of 3DE data from measurements performed by the 
first observer showed a mean difference of -1.4 ± 6.6 ml for EDV, -0.1 ± 4.4 ml for 
ESV and -0.3 ± 2.4% for EF. For 2DE using SPM, the results were –1.2 ± 11.4 ml, 
-3.2 ± 16.0 ml and 1.6 ± 10.6%, respectively. For 2DE using BSR, the results were 
3.9 ± 13.9 ml, 1.7 ± 15.2 ml and 0 ± 10.5%, respectively.
The limits of agreement analysis demonstrated a mean difference of -0.1 ± 11.7 
ml for LVEDV, 1.3 ± 8.7 ml for LVESV and -0.7 ± 4.8% for LVEF, for 3DE data by two 
independent observers. For 2DE using SPM, the results were 0.3 ± 8.1 ml, -10.6 ± 
22.3 ml and 7.1 ± 14%, respectively. For 2DE using BSR, the results were –3.4 ± 
14.7 ml, -2.5 ± 16.4 ml and 1.0 ± 10.3%, respectively.
Discussion
This study demonstrates that image acquisition using 3D-echocardiography is fea-
sible for accurate evaluation of LV function in patients during HD. Previous studies 
showed that 3D echocardiography calculates LV volume with a precision compa-
rable to cardiac magnetic resonance imaging11,14,15. While both techniques are su-
perior to 2D echocardiography, magnetic resonance imaging is not feasible during 
HD. Tissue Doppler imaging (TDI), a newer Doppler technique advocated as less 
load-dependent16,17, can be used during HD18. TDI primarily yields information on 
myocardial contraction and relaxation, but is less used for assessment of overall LV 
performance, which is usually expressed using the well-known parameters SV and 
ejection fraction.
The large interval between the limits of agreement and the underestimation of LV 
volume by 2DE are in line with previous reports14,19. 2DE calculations of LV function 
using the disc-summation method is based on the assumption that a ventricle can 
be represented by a series of stacked elliptic discs of varying diameters. In patients 
with regional wall motion abnormalities and deformed ventricles, this assumption 
may be unjustified and result in an inaccurate and poor reproducibility of 2DE mea-
surements. Using 3DE, however, no assumption is made about the shape of the LV, 
and LV volume is calculated from a much greater set of data. Therefore, 2DE should 
be used with caution for LV function analysis when relatively small differences in 
Boudewijn Krenning BW.indd   57 12-10-2007   15:19:22
Chapter 4 
58
LV volume are expected, as during HD. When more image planes are used for LV 
volume calculation, as in 3DE, an increase in accuracy is observed. Previous stud-
ies suggested that at least four to eight image planes are necessary to accurately 
represent the ventricular volume20,21. Nosir et al. showed that a 1% change in LV 
volume can be observed with a 90% likelihood when 8 image planes are used22.
To our knowledge, this is the first study to use 3DE during HD. Only one study 
used 3DE in HD patients for LV function determination23. However, this study was 
not performed in the HD department. Accurately assessing the changes in LV vol-
umes during HD can result in a better insight into the development of dialysis hy-
potension. Especially the role of the so-called Bezold-Jarisch reflex, which leads 
to bradycardic hypotension believed to be triggered by a severely underfilled LV, is 
not well understood. Monitoring changes in LV filling may help predicting the onset 
of hypotension, and may guide therapeutic strategies such as ultrafiltration profil-
ing. Additionally, more reproducible assessment of LV volumes, function and mass 
helps cardiovascular risk stratification, which is important not only for managing the 
dialysis population but also for the work-up of renal transplant candidates among 
dialysis patients.
Our study is limited by the small number of patients. However, this study was not 
designed to determine the effect of a single HD session on LV performance. During 
image acquisition, a partial left lateral decubitus position and 10 sec breath-hold 
were required. This was well-tolerated by the HD patients in our study. 3DE relies 
on achieving good endocardial border definition which depends on various fac-
tors. As patients in the HD department cannot be positioned in the most optimal 
way as they are in the echocardiography department (because of interference with 
blood lines, absence of examination table), this could hamper optimal image qual-
ity. Although effort was required by patient and ultrasonographist, we could acquire 
sufficient image quality in 80% of patients. In only 3 patients, a single acquisition 
was of insufficient quality. Previous studies have shown an improvement in image 
quality24 and, subsequently, smaller limits of agreement in inter- and intraobserver 
variability when intravenous ultrasound contrast agents are used25,26. Further stud-
ies are necessary to evaluate the feasibility thereof in this patient population.
Conclusion
We conclude that successful image acquisition for 3D echocardiography is feasible 
for accurate and reproducible measurement of LV function during HD. This may 
improve the assessment of the acute effect of HD on cardiac function, and guide 
therapautic strategies aimed at preventing intradialytic hypotension.
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Abstract
Objective
To assess a new approach for guiding and hemodynamic optimization of resynchro-
nization therapy, using three-dimensional (3D) transthoracic echocardiography. 
Background
Resynchronization therapy for heart failure provides the greatest hemodynamic 
benefit when applied to the most delayed left ventricular (LV) site. Currently, the 
ideal LV pacing site is selected according to acute invasive hemodynamic assess-
ment and/or tissue Doppler imaging. 
Methods
A total of 16 patients with advanced heart failure and an implanted biventricular 
pacemaker were included in this study. Transthoracic apical LV images at equidis-
tant intervals were obtained using a prototype, fast-rotating second harmonic trans-
ducer to reconstruct 3D LV datasets during sinus rhythm (SR), right ventricular (RV) 
apical and biventricular pacing mode. A semi-automated contour analysis system 
(4D LV analysis, TomTec, Germany) was used for segmental wall motion analysis 
and identification of the most delayed contracting segment and calculation of global 
LV function. 
Results
Data acquisition duration was 10 s and analyzable 3D images were obtained in 12 
patients. Of these patients, data during SR were available in 9 and during biventric-
ular pacing in 11. The greatest contraction delay during SR was found in the anterior 
and antero-septal segments in five of nine patients. Biventricular pacing resulted in 
reduction of the contraction delay in seven of eight patients. The global LV function 
did not change significantly. 
Conclusion
3D echocardiography with appropriate analytic software allows detection of the 
most delayed LV contracting segment and can be used to select the optimal pacing 
site during resynchronization therapy.
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Introduction
Delayed intraventricular depolarization leads to dyssynchrony of ventricular con-
traction and worsens left ventricle (LV) dysfunction1-4. Resynchronization by simul-
taneous electrical stimulation of both ventricles significantly improves hemodynam-
ics, resulting in increased exercise tolerance and hence quality of life5-12. Reduction 
in morbidity and mortality awaits confirmation from ongoing large-scale studies5,13. 
Recent data indicate that biventricular pacing provides the greatest hemodynamic 
benefit when applied to the LV segment with the most delayed contraction14. Tissue 
Doppler imaging (TDI) is currently used to identify the most delayed contraction site 
before the implantation of a resynchronization device14-16. This method cannot be 
used online and the assessment of the hemodynamic effects requires additional 
studies. It has been demonstrated in previous studies that volume–time curves 
(VTCs) provide quantitative information on LV performance17,18. The aim of the pres-
ent study was to test the feasibility of 3D echocardiographic VTCs for determining 
the optimal pacing site. This allows simultaneous hemodynamic evaluation by mea-
suring global LV function.
Table I. Patient characteristics and results for contraction delay measurements
Patients age
NYHA 
class
Type of
CM
pacing
site
FCS
SR BiV RV
MDS
delay 
(ms)
MDS
delay
(ms)
MDS
delay
(ms)
1. 76 III 2 ant 16 9 64 1 69 9 61
2. 56 III 2 pcv 7 10 20 * * 3 50
3. 56 II 1 plcv 16 2 177 8 80 2 167
4. 71 II 2 lcv 11 7 200 4 143 8 137
5. 64 III 1 plcv 8† * * 11 130 8 230
6. 68 III 2 plcv 3† * * 6 261 6 198
7. 67 II 2 plcv 10† * * 3 53 9 45
8. 62 III 1 plcv 6 2 68 6 66 3 205
9. 63 III 1 plcv 12 7 256 3 128 14 240
10. 59 III 1 pcv 9 11 221 11 113 11 90
11. 61 III 1 plcv 6 9 140 5 88 8 248
12. 53 II 1 ant 12 1 182 11 108 2 228
ant = anterior, CM = cardiomyopathy (1 = dilated cardiomyopathy, 2 = ischemic cardiomyopathy), 
BiV= biventricular pacing, FCS = first contracting segment, lcv = lateral cardiac vein, MDS= most 
delayed segment, NYHA = New York Heart Association, pcv = posterior cardiac vein, plcv = postero-
lateral cardiac vein, RV= right ventricular pacing, SR= sinus rhythm, * = not applicable, † = during 
biventricular pacing
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Methods
Study patients
We studied 16 patients with severe heart failure and a permanent biventricular 
pacemaker. All patients gave informed consent. Patient characteristics are listed in 
Table 1. The diagnosis of dilated cardiomyopathy was established according to the 
classification of cardiomyopathy published previously19. Criteria for biventricular 
pacing were severe heart failure (NYHA II–IV) and dilated cardiomyopathy associat-
ed with complete left bundle branch block and a QRS duration of > 125 ms. The LV 
pacing lead was positioned in the coronary sinus and the right atrial and right ven-
tricular (RV) leads in standard locations. Three acquisitions for 3D reconstruction 
were performed as follows: The first acquisition was performed in the biventricular 
pacing mode and the second after the pacemaker was reprogrammed for RV pac-
ing. In patients with intact atrio-ventricular conduction and sinus rhythm (SR), the 
pacemaker was reprogrammed in order to perform acquisitions during SR. In every 
patient, the pacemaker was finally reset to the original settings. Acquisitions were 
performed 5 min after the pacing mode was switched. Data analysis was performed 
off-line for this feasibility study.
Image acquisition
We used a prototype transthoracic, fast-rotating ultrasound transducer for 3D 
echocardiographic image acquisition20 (Fig. 1), which is connected to a commer-
cially available ultrasound system (GE Vingmed Vivid FiVe, Horton, Norway). The 
64-element transducer array has a center frequency of 3 MHz and second harmonic 
capabilities21. It continuously rotates inside the transducer assembly at a maximum 
speed of 8 revolutions/s. The frame rate of the ultrasound system is 100 frames per 
second. The typical acquisition time is 10 s during a single end-expiratory breath 
 
 
 
figure 5.1 
 
 
 
 
figure 5.2 
 
 
Figure 1:
Latest prototype of the continuous fast-rotating transducer.
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hold. Patients were studied in the left lateral decubitus position with the transducer 
in the apical position and the image plane rotating around the LV long axis. The 
depth setting was adjusted to visualize the entire LV and part of the left atrium. Gain 
and power settings were optimized for endocardial border visualization. The ECG 
signal was simultaneously recorded for 3D reconstruction.
Image processing
Data are transferred via a network connection to a dedicated workstation for pro-
cessing and analysis. With self-developed software, using MatLab (The MathWorks, 
Natick, MA, USA), the original 2D images are post-processed by placing them in 
their correct spatial and temporal (ECG reference) position using multi beat data fu-
sion22. The cardiac cycle is divided in 12 equal intervals, which allows to create 12 
3D datasets. Due to the continuous rotation of the transducer array, the original 2D 
images have a curved shape. However, these are not suited for automated contour 
analysis with currently available software. Therefore, 20 equidistant plane cross-
sectional images (9° interval) are re-sampled from these 12 datasets and used for 
further analysis.
Image analysis
All the 20 cross-sectional images re-sampled from each of the 12 datasets are sub-
sequently imported into the TomTec® 4D LV-analysis software (TomTec® Imaging 
Systems, Germany) and displayed (Fig. 2). Their orientation in 3D space is deter-
 
 
 
figure 5.1 
 
 
 
 
figure 5.2 
 
 
Figure 2:
From each dynamic 3D data set, up to 20 cross-sectional images can be selected. The orientation of each 
cross-section is shown.
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mined by marking the mitral valve, aortic root and apex as landmarks. An elliptical 
model is placed over one of the images of each cross-sectional position. After this, 
the software automatically performs endocardial border detection in all images of 
each cross-sectional position in the 12 datasets. A spatio-temporal spline model is 
used to generate smooth contours for both the temporal and spatial domain. The 
long axis of the ventricle is calculated from the center of the mitral annulus to the 
most distant point in the ventricle, which is the apex.
Two experienced investigators verified and corrected the results from the auto-
mated border detection where necessary. This was done blinded, without knowl-
edge of the pacing mode for each analysis. The papillary muscles within the LV 
cavity are not taken into account for the definition of the contour. After completion 
of the endocardial border tracing, the program performs a dynamic surface ren-
dered endocardial reconstruction of the LV (Fig. 3A). For each pacing mode, a VTC 
is plotted from which global LV end-diastolic volume (LVEDV), end-systolic volume 
(LVESV) and ejection fraction (EF) are calculated applying Gaussian quadrature for-
mulas.
The LV endocardial surface is subdivided in 16 segments, which are colour cod-
ed for orientation (Fig. 3B). A segmental volume represents the pyramidal volume 
of a segment to the center of gravity (Fig. 4). The volume change of a segment over 
the cardiac cycle is plotted in a VTC (Fig. 5), in which time is defined as percent-
age of the total cardiac cycle. The end-systolic moment, at which a segment has 
completed maximal myocardial contraction, is represented by the nadir of the seg-
mental volume curve. This moment was extracted from the VTC for every segment 
in every pacing mode. The difference in time to maximal myocardial contraction 
between segments was used to assess regional mechanical delay and a measure 
 
figure 5.3 
 
 
 
 
 
 
figure 5.4 
 
 
 
 
 
Figure 3:
Three-dimensional reconstruction of the LV (A) and bulls-eye view according to which the 
endocardial surface is subdivided in 16 colour-coded segments (B).
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of segmental dyssynergy. From the VTC that represents segmental volume changes 
in SR, the first contracting segment and the most delayed segment were identi-
fied. The delay in contraction was calculated as the difference in time to maximal 
contraction between these segments and is expressed as percentage of the total 
cardiac cycle. Using the RR-interval, this was re-calculated in milliseconds. When 
a segment is hypo- or akinetic, which we defined as a segmental volume change 
during any part of the cardiac cycle of less then 20%, the segment is not included. 
 
figure 5.3 
 
 
 
 
 
 
figure 5.4 
 
 
 
 
 
Figure 4:
A segmental volume represents the 
pyramidal volume of a segment to the center 
of gravity. The long axis of the ventricle 
is calculated from the center of the mitral 
annulus to the apex.
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Figure 5.6: 
 
 
 
 
 
Figure 5:
Example of volume-time curves of four different segments. During sinus rhythm, each segment 
completes myocardial contraction at a different moment (indicated with an arrow for every segment), 
causing LV dyssynchrony. From the various delays, the largest delay is shown with a dotted line (A). 
During biventricular pacing, synchrony in segmental contraction is present (B).
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In both biventricular and RV pacing mode, the most delayed segment is determined 
and the delay between this segment and the first contracting segment calculated.
Statistical analysis
Data are presented as mean ± S.D.. 3D measurements of LV volume were calculated 
by the analysis software after completion of the endocardial border tracing. To as-
sess accuracy, analysis of VTCs was performed by two observers and analyzed by 
linear regression and a limits-of-agreement analysis, expressed as the mean differ-
ence and 2 S.D. of the difference between the measurements of the two observers. 
To determine whether the difference in the values between the two observers and 
between pacing modes was statistically significant, a paired t-test was performed. 
A probability level of p < 0.05 was considered significant.
Results
Of the 16 patients, four were excluded from analysis because of inadequate 
echocardiographic image quality for faithful automated analysis. In 3 of the re-
maining 12 patients, no spontaneous sinus rhythm was present and therefore only 
acquisitions in biventricular and RV pacing mode were performed. In one patient, 
we did not perform an acquisition in biventricular pacing mode because of LV lead 
displacement.
Global LV function
The mean ejection fraction of all patients before implantation, by equilibrium radio-
nuclide angiography, was 24 ± 7%. During sinus rhythm, the mean LVEDV, LVESV 
and LVEF derived from the VTC were 294 ± 85 ml, 230 ± 94 ml and 24 ± 12%, 
respectively. During RV pacing, these values were 291 ± 97 ml, 225 ± 81 ml and 
23 ± 6% and during biventricular pacing, 282 ± 94 ml, 226 ± 86 ml and 21 ± 6%, 
respectively. No significant difference was present between these values.
Dyssynchrony
The mean heart rate during SR was 69 ± 7 min-1, during biventricular pacing 73 ± 9 
min-1 and during RV pacing 74 ± 9 min-1. No significant difference was present be-
tween these values. In six of eight patients, heart rate was less during SR compared 
to biventricular pacing. Table 1 shows the most delayed segment for every pacing 
mode and the delay between the first contracting and most delayed segment. The 
mean delay was 147 ± 80 ms during SR, 103 ± 34 ms during biventricular pacing ( 
p < 0.01; SR vs. biventricular pacing) and 158 ± 78 ms during RV pacing (p < 0.01; 
RV vs. biventricular pacing). In five of nine patients, the anterior or antero-septal 
segment was most delayed during SR. Biventricular pacing resulted in reduction of 
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the contraction delay in seven patients, compared to SR. Also, in six patients, the 
contraction delay was less during biventricular pacing compared to RV pacing.
Interobserver agreement
Linear regression analysis indicated a good correlation (r = 0.96) between measure-
ments of delay in contraction between the first contracting segment and the most 
delayed site by two observers (Fig. 6). The standard error of estimate was 2.42%. 
The limits-of- agreement analysis demonstrated a small mean difference (0.03 ± 
2.50%) between measurements. A paired t-test indicated no significant mean dif-
ference between the two observers.
Discussion
This study shows that transthoracic dynamic 3D echocardiography performed with 
a fast-rotating transducer and combined with semi-automated contour analysis al-
lows to identify LV segments with dyssynchrony together with hemodynamic evalu-
ation. Our data indicate that this method is feasible for the selection of the optimal 
pacing site during resynchronization therapy.
Rationale for measuring mechanical delay in patients undergoing resynchronization 
device implantation
A delay in intraventricular conduction leads to dyssynchrony of ventricular con-
traction which can be corrected by biventricular pacing and subsequently improve 
 
figure 5.5 
 
 
A B 
 
 
 
Figure 5.6: 
 
 
 
 
 
Figure 6:
Regression analysis for measurement of delay between the two most delayed segments by two 
observers.
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hemodynamics and consequently exercise tolerance and quality of life in patients 
with severe heart failure. Large-scale trials are ongoing to study long-term effects 
including morbidity and mortality5,13,23. However, a substantial proportion of the pa-
tients does not show improvement. This may be partly related to methodological 
reasons. Indeed, a prolonged QRS complex cannot quantify the degree of dys-
synchrony. Clearly, biventricular pacing provides the most benefit when applied to 
the segment of the LV that is most delayed in contraction. Therefore pacing should 
be applied to this site but it should be noted that this site will not always be ap-
proachable during implantation. While longterm studies showed improvement of 
LVEF with biventricular pacing, this could not be observed in this study. Possibly, 
other regulating factors counterbalance the hemodynamic effect of changing pace-
maker programming.
The role of improved imaging techniques to guide and evaluate biventricular pac-
ing
Echocardiography has an important role in the evaluation of patients with me-
chanical dyssynchrony before biventricular pacemaker implantation24,25. Sogaard 
et al.26 previously used 3D echocardiography for hemodynamic assessment in pa-
tients before and after biventricular pacemaker implantation. Currently, TDI is most 
often used as a guiding tool for the implantation15,16 and is useful for identifying LV 
myocardial contraction dyssynchrony at discrete points in patients after ventricu-
lar resynchronization14. It is suggested that TDI analysis could serve in the future 
both as a tool for pre-implantation assessment and as a guide to select the most 
optimal pacing site. However, this approach requires a lengthy echo study and 
analysis before the implantation, while only the longitudinal function in the basal 
and mid-segments are studied. Also other diagnostic modalities, such as MRI18 and 
gated-SPECT 27, can be used to create volume–time curves and assess regional 
wall motion. However, MRI cannot be used after device implantation because of its 
magnetic properties. 3D echocardiography with appropriate software for segmen-
tal wall motion analysis allows to determine dyssynchrony between all segments. 
Obviously, expressing the delay is an issue and requires standardization in the near 
future. Currently, several parameters are used for describing intra- and interven-
tricular delays during the heart cycle. Using our method, the delay is expressed in 
relative units (as percentage of the total heart cycle). Actually, this method allows 
demonstration of shortening of the diastolic period when the heart rate increases. 
This may play a role in an adverse outcome of this patient population. This phe-
nomenon is clearly demonstrated in Fig. 5. In this particular example, the heart rate 
in sinus rhythm was lower than in a paced rhythm. This results in relatively longer 
diastolic period. As the heart rate increases, the systolic period shortens relatively 
less than the diastolic period, meaning that the systolic periods are almost identi-
cal in absolute units (ms), but the diastolic periods become different. Additionally, 
the position of the RV lead has a significant impact on the LV conduction pattern. 
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Therefore, the optimal technique should provide the information during the implan-
tation procedure and additional hemodynamic data. This is possible with a fastro-
tating ultrasound transducer and appropriate software for analysis.
Limitations of the study
We used prototype equipment for this proof-of-principle study requiring further 
refinements. The post-processing time to obtain a 3D dataset must be shortened 
to make this technique a practical guiding tool during the intervention. The semi-
automated border detection algorithms are userfriendly, but manual interaction 
remains often a necessity. Real-time 3D echocardiography using a matrix trans-
ducer is also appropriate for acquisition of 3D datasets and optimization of resyn-
chronization therapy, using the same border detection and analytic software. Most 
experience is with the system developed at Duke University28 (Volumetric Medical 
Imaging), which makes use of a sparse matrix phased array transducer to scan a 
60° x 60° pyramidal volume using parallel processing technology. More recently, 
Philips Medical Systems has introduced a matrix phased-array transducer with 
3000 transmit-receive elements. Development of new border detection algorithms 
along with technological improvements of 3D echocardiography should be able to 
improve the accuracy of semi-automated border tracing and eventually provide 
automatic, even on-line, data analysis in the future.
This was not a prospective study and the patients studied had already their re-
synchronization device in place. Therefore, we could only study the feasibility of the 
method and whether dyssynchrony in segmental contraction could be measured.
During image acquisition, a 10-s breath hold was required. We did not find this 
inconvenient in our patient population with advanced heart failure.
Conclusion
3D echocardiography is a feasible approach for determination of the most delayed 
LV site with the additional option to assess hemodynamic information, such as 
LVEDV, LVESV and EF. This preliminary data suggests that 3D echocardiography 
can be used for selection of the most optimal pacing site before and during resyn-
chronization device implantation. Further studies with prospective study design are 
required to validate this data against other techniques, e.g. TDI.
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Abstract
Accurate determination of LV volume, ejection fraction and segmental wall motion 
abnormalities is important for clinical decision-making and follow-up assessment. 
Currently, echocardiography is the most common used method to obtain this in-
formation. Three-dimensional echocardiography has shown to be an accurate and 
reproducible method for LV quantitation, mainly by avoiding the use of geometric 
assumptions. In this review, we describe various methods to acquire a 3D-dataset 
for LV volume and wall motion analysis, including their advantages and limitations. 
We provide an overview of studies comparing LV volume and function measure-
ment by various gated and realtime methods of acquisition compared to magnetic 
resonance imaging. New technical improvements, such as automated endocardial 
border detection and contrast enhancement, will make accurate on-line assess-
ment with little operator interaction possible in the near future.
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Review
Accurate quantification of left ventricular (LV) volume and function is important in 
clinical decision-making and follow-up assessment. Although various other tech-
niques including invasive angiography, radionuclide angiography and magnetic 
resonance imaging are used, echocardiography is currently the most commonly 
applied modality in the practice of cardiology.
M-mode echocardiography, a one dimensional ultrasound scanning of the cardiac 
structures, was developed in the early 1970s and immediately applied in practice 
for left ventricular function assessment because of its simple algorithm and non-
invasiveness. Ejection fraction was estimated as a percentage derived from the 
mid left ventricular diameters in end-systole and end-diastole and expressed as 
fractional shortening. However, serious problems were raised especially in patients 
with myocardial infarction and asymmetric ventricles.
Two-dimensional sectional echocardiography, with the ability of imaging of the 
heart in tomographic views, considerably improved the accuracy of left ventricu-
lar volume measurement. Of the different mathematical models, modified biplane 
Simpson’s rule provided more accurate data in both symmetric and asymmetric left 
ventricles.
Software-based algorithms for automatic endocardial border detection and on-
line calculation of left ventricular volume and ejection fraction have been developed. 
As a result, two-dimensional echocardiography has become a routine examination 
for left ventricular volume and function assessment but the assumptions about LV 
geometry remain a limitation.
In the past decade, three-dimensional echocardiography has emerged as a more 
accurate and reproducible approach to LV quantitation mainly by avoiding the use 
of geometric assumptions of the LV shape. Three methods have been proposed 
for the acquisition of temporal and positional image data: the use of positional lo-
cators (freehand scanning), rotational systems and real-time volumetric scanning. 
Reconstruction methods using positional locators and rotational scanning systems 
require additional intervention for respiratory gating (or breathhold) and off-line 
post-processing of data using specific software. This has limited current routine 
application in clinical practice. Real-time three-dimensional echocardiography has 
a great potential for immediate assessment of LV function in various clinical sce-
narios including stress echocardiography and during interventional procedures.
However, all methods need a stable cardiac rhythm and constant cardiac func-
tion during image acquisition.
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Freehand scanning (random imaging)
Different devices have been developed for locating the ultrasound transducer and 
the imaging planes through the ventricles1,2. These devices allow free movement of 
the transducer at one acoustic window or at different acoustic windows. An inter-
sectional line or an image plane (usually a longitudinal view of the left ventricle) is 
used to guide the position and orientation of other imaging planes. The endocardial 
border of the left ventricle on each cross-sectional view is manually traced. All the 
traced lines are connected according to their spatial order to form a three-dimen-
sional wire-frame image. The volume of the left ventricle is then calculated by the 
wedge summation method. Accurate results from this mode of reconstruction have 
been achieved in both symmetrical and aneurysmatic left ventricles. The limitation 
of this method is that the spaces between the sampled cross-sectional images 
are uneven and mistakes may result when interpolating big gaps between imaged 
planes. Furthermore, the reconstructed three-dimensional images are static and 
lack tissue depiction, which limits accurate endocardial border identification.
Gated sequential imaging
A. Linear acquisition
Parallel imaging can be performed by computer-controlled movement of the ultra-
sound transducer in a linear direction (Figure 1). Both a transthoracic and transoe-
sophageal approach were evaluated for this mode of data acquisition.
B. Fan-like scanning
A pyramidal dataset can be obtained by moving the ultrasound transducer in a 
fan-like arc at prescribed angles (Figure 1). This is accomplished by computer-
controlled motors adapted to the transthoracic or transoesophageal probe3.
C. Stepwise rotational scanning
In this approach, the transducer is rotated around its central axis, resulting in a 
conical volume dataset (Figure 1). Different algorithms have been developed for 
computercontrolled sequential image collection of the heart4. The endocardial con-
tours of a series of images obtained with a multiplane (omniplane) precordial trans-
ducer can be directly traced and used for volume calculation. In three-dimensional 
reconstruction, a series of images with rotational intervals between 2° and 16° is 
acquired and a voxel-based three-dimensional dataset is realised. With volume-
rendering and various shading techniques, the reconstructed image accurately 
portrays the tissue characteristics and depth of the cardiac anatomy. Paraplane 
methods provide multiple equidistant parallel short-axis planes (discs) allowing 
systematic cross-sectional review of the three-dimensional dataset. It has been 
shown that slices up to a thickness of 10 mm allow accurate volume determina-
tion5. By tracing the left ventricular endocardial border in each short-axis image, 
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the volume of each slice is calculated by the computer since the slice thickness 
is known. A summation of the volumes of all slices yields the total volume of the 
left ventricular cavity at end-diastole or end-systole4,5. Subtraction of end-systolic 
volume from end-diastolic volume results in stroke volume of the left ventricle. The 
percentage of stroke volume over end-diastolic volume represents left ventricular 
ejection fraction.
Other algorithms for volume calculation, such as TomTec 4DLV analysis software, 
are based on the analysis of longaxis views (Figure 2). This software is able to dis-
play a dynamic reconstruction of the LV after semi-automated border detection. 
Not only the sizes and shapes of the left ventricle, but also the regional wall motion 
of the myocardium can be analysed.
D. Continuous rotational scanning
Various acquisition methods based on continuous rotation with an internally rotat-
ing array are reported6–8. Some models require inversion of rotation because of 
cable twisting, thereby making the acquisition less efficient and the reconstruc-
 
 
 
Figure 
6.1 
Figure 1:
Different methods of data acquisition for transthoracic 3D-echocardiography. Continuous rotation 
results, unlike stepwise rotational scanning, in a curved shape of the original images. Real-time 
imaging provides a pyramidal dataset instantly.
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tion of datasets more complex. Fast continuous rotational scanning of the LV from 
an apical window can be performed with a newly developed transducer assembly 
using a standard second-harmonic phased-array transducer and ultrasound sys-
tem (VingMed Vivid 5) and allows acquisition of 16 volumetric datasets/ sec9. The 
typical acquisition time of 10s makes it possible to acquire all data during a single 
breath-hold. A slipring, consisting of a static and a rotating part, maintains electri-
cal contact between the rotating array and the static part of the transducer. The 
original images are transferred to a workstation for reconstruction of the datasets 
and semi-automated analysis of the LV endocardial contours10. This allows rapid 
calculation of LV volumes, ejection fraction and wall motion analysis. Such a special 
dedicated system offers advantages for follow-up studies, stress echocardiogra-
phy and during interventional procedures (e.g. resynchronisation therapy). Initial 
 
 
 
Figure 
6.2 
Figure 2:
End-diastolic (A) and End-systolic (C) reconstruction of the left ventricle after semi-automated border 
analysis of the long-axis views (B). Time volume curve from which ejection fraction can be derived 
(D).
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experience indicates that this near real-time approach is an alternative to real-time 
volumetric systems for global and regional wall motion analysis of the LV.
Real-time imaging
The ideal way of three-dimensional echocardiography is on-line acquisition of a 
three-dimensional dataset of the heart without the need for ECG and respiratory 
gating avoiding spatial motion artefacts. The first real-time 3D system has been 
developed by Von Ramm et al.11 at Duke University and most experience is with 
  Table 1
Volume and function measurement by reconstruction 3DE in comparison with magnetic resonance imaging
Author/ref.           Object                 N    r. SEE Mean Diff. ± SD
Gopal et al.12,14            LV-EDV  15 0.92 7 ml
                                    LV-ESV  -- 0.81 4 ml
Iwase et al.15                LV-EDV  30 0.93  -17 ± 23 ml
                                    LV-ESV  -- 0.96  -4 ± 18 ml
                                    LV-EF  -- 0.85  -2 ± 6%
Buck et al.16             LV-EDV  23 0.97 14.7 ml -10.7 ± 14.5 ml
                                    LV-ESV  -- 0.97 12.4 ml -3.4 ± 12.9 ml
                                    LV-EF  -- 0.74 5.6% -2.5 ± 6.7%
Altmann et al.18       LV-EDV  12 0.98 8.7 ml -14.2 ± 8.3 ml
                                    LV-ESV  -- 0.98 5.6 ml -3.4 ± 5.5 ml
                                    LV-EF  -- 0.85 5.3% -4.4 ± 5.3 %
Nosir et al.19             LV-EDV  46 0.98  -1.4 ± 13.5 ml
                                    LV-ESV  -- 0.98  -1.5 ± 10.5 ml
                                    LV-EF  -- 0.98  0.2 ± 2.5%
Kim et al.20 (patients)      LV-EDV  18   6.4 ± 20 ml
                                           LV-ESV  --   0.0 ± 13.3 ml
                                      LV-EF  --   1.4 ± 3.5 %
Kim et al.20 (volunteers)      LV-EDV  10   -3.1 ± 4.9 ml
                                      LV-ESV  --   -1.4 ± 2.2 ml
                                      LV-EF  --   0.5 ± 1.8 %
Poutanen et al.21 (children) LV-EDV  30 0.80  4.0 ± 19.6 ml
                                      LV-ESV  -- 0.88  0.4 ± 13.0 ml
                                      LV-EF  -- 0.20  1.7 ± 15.1%
Mannaerts et al.22              LV-EDV  17 0.74  -13.5 ± 13.5 %
                                      LV-ESV  -- 0.88  -17.7 ± 23.9 %
                                      LV-EF  -- 0.89  -1.8 ± 5.8 %
Krenning et al. (submitted) LV-EDV  15 0.98 13.4 ml -22.7 ± 13.6 ml
                                      LV-ESV  -- 0.99 8.7 ml -12.6 ± 9.9 ml
                                      LV-EF  -- 0.97  
3DE = three-dimensional echocardiography; N = number of subjects; LV = left ventricle; r = 
correlation coefficient; SEE = standard error or regression; Diff. = difference; SD = standard 
differentiation; EDV = end-diastolic volume; ESV = end-systolic volume; EF = ejection fraction.
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this system (Volumetric Medical Imaging). This system makes use of a sparse ma-
trix phased array transducer of 512 elements to scan a 60° × 60° pyramidal tissue 
volume using parallel processing technology which permits the reception of 16 
lines for each transmitted signal (16:1) at a rate of 17 volumes/sec with a depth of 
16 cm. Image display for analysis consists of 2 independent B-modes or 3 C-mode 
scans (these are cross-sections parallel to the transducer face which are displayed 
simultaneously in selected orientations. LV volumes are calculated with dedicated 
analytic software from either a series of parallel C-scans (short-axis views) or a se-
ries of rotated apical long-axis views. More recently, Philips Medical Systems has 
introduced its live 3D system using a matrix phased-array transducer with 3000 
transmit-receive elements. In this transducer, multiple recordings are automatically 
performed to cover the full left ventricle. This is especially useful in dilated ven-
tricles because of the limited sector angle. The multi-directional beam steering ca-
pability enables visualization of two views of the heart simultaneously. Experience 
is still limited, however, promising results have been reported.
Left ventricular volume measurement by three-dimensional echocardiography
Table 1 and Table 2 provide an overview of studies comparing left ventricular vol-
umes and function by reconstruction and real-time three-dimensional echocardiog-
raphy, respectively, in comparison with magnetic resonance imaging12–19. For the 
various 3D acquisition methods that have been used, a good correlation can be 
Table 2
Volume and function measurement by real-time 3DE in comparison with magnetic resonance imaging
Author/ref.    Object N r. SEE Mean Diff. ± SD
Shiota et al.23    LV-EDV 28 0.97 27 ml -43 ± 65 ml
       LV-ESV -- 0.94 29 ml -37 ± 67 ml
       LV-EF -- 0.98 0.04% 0.001 ± 0.04%
Qin et al.24 (controls)  LV-Vol 16 0.96  -13 ± 18 ml
Qin et al.24 (aneurysms)  LV-Vol 13 0.99  -28 ± 25 ml
Lee et al.25     LV-EDV 25 0.99 11.28 ml
       LV-ESV -- 0.99 10.21 ml
       LV-EF -- 0.92 0.06
Schmidt et al.26   LV-EDV 25 0.88
       LV-ESV -- 0.82
       LV-EF -- 0.72
       LV-Vol -- 0.91 28.0 ml -16 ± 36 ml
Zeidan et al.27    LV-EDV 15   -6 ± 11 ml
       LV-ESV --   -4 ± 9 ml
       LV-EF --   2 ± 5%
3DE = three-dimensional echocardiography; N = number of subjects; LV = left ventricle; r = correlation coefficient; 
SEE = standard error or regression; Diff. = difference; SD = standard differentiation; EDV = end-diastolic volume; 
ESV = end-systolic volume; EF = ejection fraction; Vol = volume
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observed. However, most three-dimensional echocardiography studies tend to un-
derestimate ESV and EDV. It should also be noted that large differences in study 
design were present, including number of patients, LV volumes, image quality and 
analysis methods. In recent studies, new semi-automated endocardial border de-
tection algorithms replace common methods to measure LV volume, as Simpson’s 
rule and algorithms based on manual border tracing.
Conclusion
Three-dimensional echocardiography is a non-invasive technique which can be per-
formed in many clinical scenarios. It is thus ideal for daily performance and for serial 
follow-up examinations of left ventricular volume and function.
Regardless of the many improved techniques in three-dimensional echocardiography, 
time consumption has been the major limitation hampering its routine employment for 
daily diagnostic echocardiography and for volume and function assessment. Faster 
data acquisition by reducing the number of cross-sections for reconstruction of the 
cavity, using a high-speed rotation transducer or a volumetric real-time three-dimen-
sional echocardiographic transducer is being investigated. Data processing and three-
dimensional image reconstruction has been accelerated and on-line processing and 
reconstruction is under investigation. Manual endocardial tracing needed for volume 
measurement is both laborious and prone for subjective errors. Development of various 
automatic border detection algorithms along with the improvement of ultrasound spa-
tial resolution and advances in other novel modalities such as harmonic, power-mode 
Doppler tissue imaging and development of intravenous ultrasound contrast agents 
that enhance the delineation of endocardium, should be able to avoid the need of 
manual border tracing and provide automatic, even on-line, volume measurement.
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Abstract
Aim of the study
We evaluated two different commercially available TomTec® real-time three-dimen-
sional echocardiographic (RT3DE) semi-automated border detection algorithms for 
left ventricular (LV) volume analysis in patients with cardiomyopathy and distorted 
LV geometry.
Methods
Fifty-three patients in sinus rhythm with various types of cardiomyopathy (mean age 
56 ± 11 years, 28 men), and adequate 2D image quality were included. The TomTec 
RT3DE multiplane interpolation (MI) and full volume reconstruction (FVR) methods 
were used for LV volume analysis. Magnetic resonance imaging (MRI) was used as 
the reference method.
Results
A strong correlation (R2 >0.95) was found for all LV volume and ejection fraction 
(EF) measurements by either RT3DE method. Analysis time was shorter with the 
FVR method (6 ± 2 vs. 15 ± 4 min, P <0.01) as compared to the MI method. Bland-
Altman analysis showed greater underestimation of end-diastolic volume (EDV) and 
end-systolic volume (ESV) by MI compared to FVR. For the MI method a bias of 
–24.0 ml (-15.0% of the mean) for EDV and –11.3 ml (-18.0% of the mean) for ESV 
was found. For FVR analysis these values were –9.9 ml (-6.0% of the mean) and –5.0 
ml (-9.0% of the mean), respectively. EF was similar for the MI and FVR method with 
a mean difference compared to MRI of 0.6 (1.0%) and 0.8 (1.3%), respectively.
Conclusion
In cardiomyopathic patients with distorted LV geometry and good 2D image quality, 
the TomTec® FVR method is faster and more accurate than the MI method in as-
sessment of LV volumes.
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Introduction
Accurate assessment of left ventricular (LV) volume and systolic function forms a 
routine part of daily echocardiographic practice.1 However, the geometric assump-
tions in motion-mode (1D) and two-dimensional (2D) echocardiography and the 
poor inter and intra-observer variability limit these techniques.2,3 The development 
of real-time three-dimensional echocardiography (RT3DE) with matrix transducer 
technology made a more reliable analysis of LV function feasible. The increasing 
accuracy and reproducibility of RT3DE for LV quantification has been shown in 
many studies.4-9 Several online and off-line software programs for LV volume quan-
tification by RT3DE are available. However, these programs use a wide spectrum of 
endocardial contour tracing algorithms, ranging from manual to fully automated al-
gorithms. In previous reports, semi-automated border detection software has been 
shown to be fast, accurate and less observer-dependent for RT3DE quantification 
of LV volumes and function.6 Patients with cardiomyopathy have a distorted LV 
geometry, which theoretically may preclude accurate LV quantification using semi-
automated border detection. The present study sought to assess the accuracy and 
inter-observer variability of two different TomTec® semi-automated border detec-
tion RT3DE analysis programs in patients with cardiomyopathic LVs.
Methods
Patient selection
Fifty-three patients (mean age 56 ± 11 years, 28 men), in sinus rhythm, with a car-
diomyopathy and adequate 2D image quality (no more than 2 LV segments not well 
visualized) were enrolled in the study. These patients represent in image quality 
terms the best half of our patients seen at the echo laboratory. All patients under-
went 3DE and cardiac magnetic resonance imaging (MRI) on the same day, to en-
sure comparable hemodynamic conditions between the examinations. The etiology 
of the cardiomyopathy was ischemic in 9 (17%), non-compaction in 11 (21%), hy-
pertrophic in 20 (38%), and idiopathic dilated in 13 (24%) patients. The institutional 
review board approved the study and all patients gave informed consent.
Transthoracic RT3DE image acquisition
RT3DE was performed using a Sonos 7500 equipped with a X4 matrix-array trans-
ducer or an IE33 ultrasound system equipped with a X3-1 transducer (Philips Medi-
cal Systems, Best, The Netherlands) with the patient in a left lateral decubitus posi-
tion. Image acquisition was performed from an apical window with the LV as region 
of interest. To encompass the complete LV into the 3D data set, a full volume of 93° 
× 84° scan was acquired in harmonic mode from 4 R-wave triggered subvolumes 
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(93° × 21°) during an end-expiratory breath-hold. The 3D dataset was stored on 
CD-ROM and transferred to an off-line analysis workstation.
Data analysis
All data were analysed by a single experienced observer (O.I.I.S.) using the 2 algo-
rithms on two separate occasions to assess intra-observer variability. The first 31 
patients were also analyzed by a second observer (A.N.) to assess inter-observer 
variability. All measurements were performed blinded to both the patient data and 
results of MRI. MRI data were analyzed by an independent third observer (S.K.) who 
was also blinded to the patient data and results of RT3DE.
Image analysis: Multiplane interpolation (MI) method
As seen in Figure 1, LV volume analysis using MI was performed off-line using 
commercially available software (4D LV-Analysis, version 1.2, TomTec®, Unter-
schleissheim, Germany). The algorithm has been described previously.6 In brief, 
the orientation of the 3D dataset is determined by manually marking 3 points in 
a 5-chamber view: the mitral annulus, aortic valve and apex. Subsequently, the 
data set is divided into 8 equidistant oblique sagittal (or long-axis) and coronal (or 
frontal) image planes.10 In each of the 8 planes, the 3 points are manually marked 
and end-diastolic and end-systolic still frames are manually defined. An ellipse is 
then automatically generated by the software and placed in the 8 end-diastolic and 
 
 
Figure 
7.1 
Figure 1
An ellipse is used for initiation of the semi-automatic algorithm in individual cross-sections.  After 
semi automated border detection, an interpolation algorithm is used for LV reconstruction.
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end-systolic planes. This ellipse serves for initiation of the semi-automatic algo-
rithm by which the software automatically defines the total endocardial border in 
all frames. A spatio-temporal spline interpolation model is then used to generate 
a LV model for both the temporal and spatial domain. The analysis program then 
displays a reconstruction of the LV as a dynamic surface rendered image in which 
LV wall motion is shown in 3D. At any stage it is possible to revise the ellipse and 
corresponding endocardial border tracing. LV ejection fraction (EF) is calculated by 
the software as (EDV − ESV) / EDV × 100%, where EDV = end-diastolic volume and 
ESV = end-systolic volume.
Image analysis: Full volume reconstruction (FVR) method
As seen in Figure 2, LV volume analysis using FVR was performed off-line using 
commercially available software (4D LV-Analysis, version 2.0, TomTec®, Unter-
schleissheim, Germany). The oblique coronal 4-chamber view and the 60° and 
 
Figure 2
The initial endocardial contour is expanded/rotated 360 degrees and adapted when additional 
contours are added. According to the initial balloons, the algorithm starts to detect the endocardial 
border continuously in the entire 4D dataset , e.g. like deforming the balloon in the LV until it best 
fits the walls in each frame. Adjustments can be made manually after this step and finally a LV 
reconstruction is created.
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120° incremental views are the (tri) planes used for primary analysis. To avoid fore-
shortening, the meeting points of the three oblique sagittal and coronal planes 
are adjusted to meet in the middle of the LV cavity. The end-diastolic and end-
systolic frames are identified automatically in this software version. Subsequently, 
the endocardial border in the three planes is manually traced (LV trabeculations 
and papillary muscles are included within the LV volume) in both the end-diastolic 
and end-systolic images for initialization of the algorithm. Based on these 6 initial 
contours, a spatio-temporal spline interpolation model (like a pulsating balloon) is 
created by rotational and temporal interpolation of these contours. According to the 
initial balloons, the algorithm starts to detect the endocardial border continuously in 
the entire 4D dataset (without large gaps due to interpolation as in the MI method), 
e.g. like deforming the balloon in the LV until it best fits the walls in each frame. The 
detection itself employs the same local boundary estimates as the MI method. Ad-
justments can be made manually after this step in approximately 30 single oblique 
sagittal and coronal planes. EF is calculated by the software as described in the 
previous section.
Magnetic resonance imaging
MRI images were acquired using a 1.5 Tesla scanner (GE Signa CV/i, Milwaukee, 
WI). Patients were positioned in the supine position, with a cardiac eight-element 
phased-array coil placed over the thorax). Repeated breath holds and electrocar-
diographic gating were applied to minimize the influence of cardiac and respira-
tory motion on data collection. Cine MRI was performed using a steady-state free-
precession technique (FIESTA). Imaging parameters were; repetition time, 3.5 ms; 
echotime, 1.3 ms; flip angle, 45°; field of view, 36-40 x 36-40 cm; matrix, 196x160; 
views per segment, 12, resulting in a temporal resolution of 42 ms. To cover the 
entire LV 10-12 consecutive slices of 8 mm in the short axis view were planned on 
the four chambers (gap 2 mm).
To quantify LV volumes, endocardial contours were detected automatically and 
corrected manually on short-axis cine-MRI images with a dedicated software pro-
gram using the centerline method (Mass; Medis, Leiden, the Netherlands). Papillary 
muscles were considered as part of the LV cavity.
Statistical analysis
All data are expressed as mean ± SD. For comparison between the MI and FVR 
method, and MRI and RT3DE data, linear regression analysis was performed and 
a Pearson correlation coefficient was calculated. For paired data, the Student’s t 
test was used. For agreement between the MI and FVR method, MRI and RT3DE 
data, the method of Bland and Altman was used.11 RT3DE inter- and intra-observer 
variability were calculated for individual patients as an absolute value of difference 
between the two readings and then mean value from all patients is expressed as a 
percentage of mean of the two readings. Statistical Package of the Social Science 
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(SPSS) software version 12.02 (SPSS Inc., Chicago, Illinois) was used for statistical 
analysis.
Results
The mean time for data analysis was 6 ± 2 minutes for the FVR method compared 
to 15 ± 5 minutes for the MI method (P <0.001).
Mean LV volumes and EF by the two different RT3DE algorithms and MRI are 
shown in Table 1. There was an excellent correlation between all values measured 
by MI, FVR and MRI analysis (Figures 3A to 3I). The lowest values for LV volumes 
were found by MI analysis; these values were significantly lower than the values 
found by FVR or MRI analysis. However, FVR still underestimated LV volumes as 
compared to MRI (Table 2). As seen in Figure 4, Bland-Altman analysis confirmed 
the greater underestimation of EDV and ESV by MI compared to FVR (when MRI 
was used as gold standard). As seen in Table 3, a bias of –24.0 ml (-15.0% of the 
mean) for EDV and –11.3 ml (-18.0% of the mean) for ESV was present with MI 
analysis compared to –9.9 ml (-6.0% of the mean) and –5.0 ml (-9.0% of the mean) 
with FVR analysis. As compared to MRI, RT3DE-derived values of EF were similar 
between the MI and FVR method with mean difference of 0.6 (1.0%) and 0.8 (1.3%), 
respectively.
Results of intra- and inter-observer variability for MI and FVR analysis are sum-
marized in Table 4.
Table 1. Left Ventricular Volumes and Ejection Fraction by Real-Time Three-Dimensional 
Echocardiography Using the Full Volume Reconstruction and the Multiplane Interpolation Method for 
Endocardial Contour Definition
EDV (range), ml ESV (range), ml EF (range), %
 Magnetic Resonance Imaging 175 ± 51 (74 to 328) 74 ± 51 (14 to 208) 61 ± 17 (15 to 86)
 Full Volume Reconstruction method 165 ± 50 (67 to 308) 69 ± 48 (15 to 194) 61 ± 18 (16 to 85)
 Multiplane Interpolation method 150 ± 48 (63 to 301) 63 ± 44 (16 to 182) 61 ± 18 (15 to 86)
Values are expressed in mean ± standard deviation (range), EDV = end-diastolic volume; ESV = end-
systolic volume; EF = ejection fraction;
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Table 2. Correlation and Comparison Between the Real-Time Three-Dimensional Echocardiographic 
Methods for Endocardial Contour Definition, and Magnetic Resonance Imaging
Linear Regression analysis Paired t-test
Regression 
Equation
R2 P Value SEE Mean Difference 
± SD
P Value versus 0
 Full Volume Reconstruction Method versus Multiplane Interpolation Method using RT3DE
EDV, ml Y = 1.0X + 9.0 0.98 P < 0.001 3.8 14.1 ± 8.4 <0.001
ESV, ml Y = 1.1X + 0.8 0.99 P < 0.001 1.1 6.4 ± 6.1 <0.001
EF, % Y = 1.0X - 0.1 0.96 P < 0.001 1.7 0.2 ± 3.3 NS
RT3DE Full Volume Reconstruction method versus MRI
EDV, ml Y = 0.98X – 5.7 0.99 P < 0.001 2.2 -9.9 ± 4.7 <0.001
ESV, ml Y = 0.94X – 0.5 0.99 P < 0.001 1.0 -5.0 ± 4.8 <0.001
EF, % Y = 0.97X + 2.3 0.98 P < 0.001 1.2 0.6 ± 2.4 NS
RT3DE Multiplane Interpolation method versus MRI
EDV, ml Y = 0.92X – 9.9 0.96 P < 0.001 4.3 -24.0 ± 9.7 <0.001
ESV, ml Y = 0.87X – 0.7 0.98 P < 0.001 1.5 -11.3 ± 8.6 <0.001
EF, % Y = 0.94X + 4.0 0.95 P < 0.001 2.0 0.8 ± 3.7 NS
Abbreviations as in Table 1. NS = not significant; RT3DE = real-time three-dimensional 
echocardiography; MRI = magnetic resonance imaging
Table 3. Bland-Altman Analysis and Agreement Between RT3DE Full Volume Reconstruction and 
Multiplane Interpolation Method and Magnetic Resonance Imaging
Mean Difference 95% Limits of Agreement
 Full Volume Reconstruction Method versus Multiplane Interpolation Method using RT3DE
EDV, ml 15.4 (9.0%) -3.1 to 33.9 (-2.0% to 20.0%)
ESV, ml 9.1 (10.0%) -6.8 to 24.9 (-7.0% to 26.0%)
EF, % -0.6 (-1.2%) -6.4 to 5.2 (-13.0% to 10.0%)
RT3DE Full Volume Reconstruction method Versus MRI
EDV, ml -9.9 (-6.0%) -19.1 to -0.9 (-11.0% to 1.0%)
ESV, ml -5.0 (-9.0%) -14.4 to -4.4 (-24.0% to 7.0%)
EF, % 0.6 (1.0%) -4.1 to 5.4 (-7.0% to 9.0%)
RT3DE Multiplane Interpolation method versus MRI
EDV, ml -24.0 (-15.0%) -43.0 to -5.0 (-26.0% to –3.0%)
ESV, ml -11.3 (-18.0%) -28.1 to -5.5 (-45.0% to –9.0%)
EF, % 0.8 (1.3%) -6.5 to 8.1 (-11.0% to 13.0%)
Values between brackets are percentage of the mean of the two measurements; abbreviations as in 
Tables 1 and 2.
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Table 4. Inter- and Intra-Observer Variability of Real-Time Three-Dimensional Echocardiography-
Derived Values of Left Ventricular End-Diastolic, End-Systolic and Ejection Fraction Using the 
TomTec Multiplane Interpolation and the Full Volume Reconstruction Method
Inter-observer Variability (%) Intra-observer Variability (%)
EDV
 Full Volume Reconstruction Method 6.4 ± 7.8 4.7 ± 3.2
 Multiplane Interpolation Method 8.2 ± 11.4 7.8 ± 8.5
ESV
 Full Volume Reconstruction Method 7.8 ± 9.7 6.1 ± 5.8
 Multiplane Interpolation Method 13.5 ± 14.2 9.1 ± 7.2
EF
 Full Volume Reconstruction Method 7.1 ± 6.9 6.6 ± 7.4
 Multiplane Interpolation Method 13.1 ± 7.9 11.1 ± 9.3
 Abbreviations as in Table 1
 Figure 3
Results of linear regression analysis of real-time three-dimensional echocardiographic values of left 
ventricular volumes and ejection fraction using the full volume reconstruction method (top) and the 
multiplane interpolation method (bottom) versus magnetic resonance imaging reference values.
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Discussion
The main finding of the present comparative study between two different TomTec® 
semi-automated border detection algorithms is that the newer FVR method (4D LV 
Analysis, version 2.0) more accurately estimates LV volumes in patients with car-
diomyopathic LVs. Because of the systematic underestimation of all LV volumes by 
both algorithms (compared to MRI), EF values were similar for both methods. LV 
volume and EF are important predictors of morbidity and mortality in a wide spec-
trum of cardiac patients.12,13
Recent advances in acquisition and software analysis has made accurate mea-
surements of LV volumes possible with RT3DE in large numbers of patients.4,6,14,15 
Currently, several off-line software programs are available for quantification of LV 
volumes. The method of endocardial border delineation used in the software algo-
rithm for analysis of a 3D dataset affects accuracy and reproducibility. This is of 
particular interest in patients with difficult and distorted LVs. In the present study, 
we compared side-by-side the accuracy and reproducibility of the recently devel-
oped FVR algorithm against the previously validated MI algorithm for LV volume 
quantification in patients with cardiomyopathy and substantially altered LV geom-
etry. The two analysis algorithms used in our study fundamentally differ. In the MI 
algorithm, the software determines a geometric model for the LV through manual 
definition of the mitral annulus, aortic valve and apex, and semi-automated border 
 
 
 Figure 
7.4 
Figure 4
Results of Bland-Altman analysis of real-time three-dimensional echocardiographic values of left 
ventricular volumes and ejection fraction using the full volume reconstruction method (top) and the 
multiplane interpolation method (bottom) versus magnetic resonance imaging reference values.
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detection in various LV oblique sagittal (or long-axis) and coronal (or frontal) image 
planes.6 This method is limited by boundary detection and contour revision in a 
limited number of cross-sections. In contrast, the newer FVR algorithm performs 
automated contour detection in the complete 4D dataset, which can be adjusted 
anywhere by the reviewer. Besides less (only 6 versus 16 planes) user interaction, 
faster processing time and better review options, significantly more data is used to 
estimate the endocardial contour for LV reconstruction. This study shows that this 
results in higher accuracy and reproducibility as seen from the lower biases and 
narrower limits of agreement.
Table 5. Comparison of Correlation, Agreement, and Variability Between Real-Time Three-
Dimensional Echocardiographic Studies of Left Ventricular Volumes and Function Quantification 
Using TomTec version 1.2 Software Program
Author Year Pts
MRI 
analysis
R2 Biases (units)
Inter-observer 
(%)
Intra-
observer (%)
LV-EDV (ml) Soliman 53 SAX 0.96 -24.0 ± 9.7 8.2 ± 11.4 7.8 ± 8.5
Jenkins 2006 110 SAX + LAX 0.75 -15.0 ± 28.0
Sugeng 2006 31 SAX + LAX 0.94 -5.0 ± 26.0 13.9 ± 2.0 11.2 ± 8.6
Nikitin 2006 64 SAX 0.96 7.0 ± 28.0 4.0 3.0
vd Bosch 2006 29 SAX 0.94 -2.9 ± 12.0
Kuhl 2004 24 SAX 0.97 -13.6 ± 18.9 0.9 ± 6.9 0.2 ± 6.6
LV-ESV (ml) Soliman 53 SAX 0.98 -11.3 ± 8.6 13.5 ± 14.2 9.1 ± 7.2
Jenkins 2006 110 SAX + LAX 0.84 -10.0 ± 22.0
Sugeng 2006 31 SAX + LAX 0.93 -6.0 ± 26.0 5.6 ± 3.9 14.2 ± 11.8
Nikitin 2006 64 SAX 0.96 3.0 ± 22.0 6.0 3.0
vd Bosch 2006 29 SAX 0.96 0.9 ± 10.0
Kuhl 2004 24 SAX 0.96 -12.8 ± 20.5 0.7 ± 9.6 -0.0 ± 3.8
LV-EF (%) Soliman 53 SAX 0.95 -0.8 ± 3.7 11.1 ± 9.3 13.1 ± 7.9
Jenkins 2006 110 SAX + LAX 0.78 1.0 ± 8.0
Sugeng 2006 31 SAX + LAX 0.93 0.3 ± 4.0 5.6 ± 3.4 10.5 ± 8.3
Nikitin 2006 64 SAX 0.89 -1.0 ± 10.0 4.0 4.0
vd Bosch 2006 29 SAX 0.89 -1.4 ± 7.2
Kuhl 2004 24 SAX 0.96 0.9 ± 4.4 -1.5 ± 7.0 -0.6 ± 4.1
Abbreviations as in Table 1
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Comparison to previous studies.
Our study is the first to report result for the new FVR method. Therefore, we can 
only compare the results of the old MI method (4D LV Analysis, version 1.2) with 
results published by others. As seen in Table 5, the biases described in our paper 
for ESV and EF are quite comparable to those described by others. Only the biases 
for EDV seem somewhat higher (but with a small standard deviation), most likely 
caused by the inclusion of patients with distorted LV geometry in our study.
Limitations.
MRI analysis uses short axis images with a disk summation method to obtain 
a LV volume. This analysis is not optimal near the apex because of partial-volume 
artifacts and has limitations in recognizing the mitral valve.16 Subsequently, a part of 
the aortic root or left atrium can be included in the volume of the reconstructed disk 
in the most basal cross-section. This may explain the difference between the mea-
sured volumes between RT3DE and MRI. This error can theoretically be reduced by 
increasing the number of disks (and subsequent decrease of slice thickness) result-
ing in increased review time. In the future incorporation of long-axis analysis can 
also improve assessment of LV volumes. However, the short-axis MRI method of 
analysis is still most widely used for LV volume assessment, both in clinical practice 
and research.6,14,17 and does not influence the head-to-head comparison between 
the two software programs. In should be noted that these results do not necessarily 
imply a higher accuracy for detection of wall motion abnormalities, which was not 
the aim of this study.
Conclusion
The newer TomTec® 4D LV Analysis software, version 2.0 that uses the FVR meth-
od provides superior assessment of LV volumes compared to the old 1.2 software 
version using the MI method.
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Abstract
Ultrasound contrast has shown to improve endocardial border definition. The pur-
pose of this study was to evaluate the value of contrast versus non contrast-enhanced 
real-time three-dimensional echocardiography (RT3DE) for the assessment of left ven-
tricular (LV) volumes and ejection fraction. Thirty-nine unselected patients underwent 
RT3DE with and without SonoVue contrast-enhancement and magnetic resonance 
imaging (MRI) on the same day. An image quality index was calculated by grading all 
16 individual LV segments as: 0 = not visible, 1 = poor, 2 = moderate, 3 = good, and 4 
= excellent. The 3D data sets were analyzed off-line using dedicated TomTec analysis 
software. By manual tracing LV end-systolic volume (LV-ESV), LV end-diastolic volume 
(LV-EDV) and ejection fraction (LV-EF) were calculated. After contrast-enhancement 
mean image quality index improved from 2.4 ± 1.0 to 3.0 ± 0.9 (P <0.001). Contrast-
enhanced RT3DE measurements showed better correlation with MRI (EDV: r = 0.97 
vs. 0.86; ESV: r = 0.96 vs. 0.94; EF: r = 0.94 vs. 0.81). The limits of agreement (Bland-
Altman analysis) showed a similar bias for RT3DE images with and without contrast 
but with smaller limits of agreement for contrast-enhanced RT3DE. Also, inter- and 
intraobserver variability decreased. In a subgroup, patients with poor-to-moderate im-
age quality showed an improvement in agreement after contrast (± 24.4% to ± 12.7%) 
to the same level as patient with moderate-to-good image quality without contrast (± 
10.4%). In conclusion, contrast-enhanced RT3DE is more accurate in assessment of 
LV function, evidenced by a better correlation and narrower limits of agreement com-
pared to MRI, and lower intra- and interobserver variability.
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Accurate assessment of left ventricular (LV) function is important for prognosis and 
treatment strategy in cardiac patients. Two-dimensional echocardiography (2DE) re-
mains the primary imaging modality for the assessment of cardiac function, besides 
other techniques such as magnetic resonance imaging1 (MRI) and radionuclide imag-
ing2. The use of these imaging modalities is limited by radiation exposure (for radio-
nuclide imaging), high costs and availability. However, echocardiographic images are 
sometimes of poor quality that limit LV function assessment. LV opacification with 
contrast agents has shown to improve image quality and in particular endocardial 
border delineation3,4. Improvement in accuracy has also been shown with real-time 
three-dimensional echocardiography (RT3DE), because of the absence of geomet-
ric assumptions regarding LV shape5. Recent advances in three-dimensional cardiac 
ultrasound imaging technology have made LV function assessment more clinically 
feasible. The purpose of this study was to evaluate a possible further improvement 
in accuracy and reproducibility by combing these two major improvements into con-
trast-enhanced RT3DE.
Methods
Thirty-nine consecutive patients (mean age 58 (15) years, range 24 – 79 years, 34 men) 
in sinus rhythm were prospectively studied with RT3DE and MRI on the same day. These 
patients were referred for routine evaluation of cardiac function after myocardial infarc-
tion (n = 28), cardiomyopathy (n = 10), and myocarditis (n = 1). No patient was excluded 
from the study because of echocardiographic image quality. The institutional review 
board approved the study and all patients gave informed consent.
RT3DE was performed using a Sonos 7500 equipped with a X4 matrix-array trans-
ducer (n = 18) or an IE33 ultrasound system equipped with a X3-1 transducer (n = 21) 
(Philips Medical Systems, Best, The Netherlands) with the patient in a left lateral de-
cubitus position. An apical full volume dataset was acquired in harmonic mode from 4 
R-wave triggered subvolumes during an end-expiratory breath-hold. After non-contrast 
enhanced image acquisition, imaging was repeated with intravenous infusion of Sono-
Vue contrast (Bracco, Milan, Italy). A start bolus injection of 0.5 mL was given, with ad-
ditional boluses of 0.25 ml when needed. Imaging was performed in harmonic mode at 
low mechanical index (0.3), and care was taken to record the images at a phase when 
contrast flow was relatively stable with absent or minimal swirling of contrast in the 
apex. Both 3D dataset was stored on CD-ROM and transferred to an off-line analysis 
workstation.
The 3D data sets were analyzed off-line using dedicated analysis software (Echo-
view© software 5.2, TomTec, Inc., Munich, Germany). In each data set end-systolic (be-
fore opening of the mitral valve) and end-diastolic (after closure of the mitral valve) frames 
were identified. Around a user-defined non-foreshortened LV long axis, the software 
generated eight uniformly spaced apical images 22.5° apart for each volume. These 8 
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long-axis end-diastolic and end-systolic images were manually traced with help of mid 
short-axis evaluations. LV trabeculations and papillary muscles were included within the 
traced area (LV volume). Subsequently, LV end-systolic volume (LV-ESV), LV end-dia-
stolic volume (LV-EDV) and ejection fraction (LV-EF) were calculated by the software.
Segmental image quality was evaluated by two observers (BJK, OIIS) by grading all 
16 individual LV segments6 as: 0 = not visible, 1 = poor, 2 = moderate, 3 = good, and 4 = 
excellent. Disagreement was solved by consensus or the evaluation by a third observer 
(AN). An image quality index was calculated for each acquisition by summation off all 
segmental scores divided by 16. Also, a separate image quality evaluation of the mid-
ventricular short-axis segments was done because these images are used for correction 
of manual tracings.
To assess intra- and interobserver variability for LV-EDV, LV-ESV and LV-EF measure-
ments, all datasets were re-analyzed by two observers (BJK, OIIS), who were blinded to 
the results of the previous analysis and the MRI measurements.
MRI images were acquired using a 1.5 Tesla scanner (GE Signa CV/i, Milwaukee, WI). 
Patients were positioned in the supine position, with a cardiac eight-element phased-ar-
ray coil placed over the thorax). Repeated breath holds and electrocardiographic gating 
Table 1. Comparison between Left Ventricular Volumes and Ejection Fraction by Real-Time Three-
Dimensional Echocardiography and Magnetic Resonance Imaging
Variable MRI RT3DE Contrast RT3DE
 End-diastolic volume (ml)
Mean ± SD 218 ± 70 198 ± 60* 200 ± 67*
Range 74 - 364 73 - 340 72 - 340
Correlation (R2, to MRI) 0.86 0.97
SEE 30.9 17.4
 End-systolic volume (ml)
Mean ± SD 125 ± 69 116 ± 58* 117 ± 65*
Range 26 - 329 23 - 303 18 - 301
Correlation (R2, to MRI) 0.94 0.96
SEE 19.9 12.5
 Ejection fraction (%)
Mean ± SD 45 ± 15 43 ± 13 44 ± 15
Range 10 - 81 11 - 78 11 - 83
Correlation (R2, to MRI) 0.81 0.94
SEE 7.7 5.1
MRI = Magnetic Resonance Imaging; RT3DE = Real-Time Three-Dimensional Echocardiography; 
*p < 0.01 vs MRI
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Figure 1:
Plots of the difference between RT3DE (left panels), contrast enhanced RT3DE (right panels) and 
MRI measurements of LV-EDV, LV-ESV and LV-EF, as a function of the average calculated volumes. 
Solid and dashed lines represent mean ± 2 SDs of the difference, respectively. (LVEDV = left 
ventricular end-diastolic volume, LVEF = left ventricular ejection fraction, LVESV = left ventricular 
end-systolic volume).
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were applied to minimize the influence of cardiac and respiratory motion on data collec-
tion. Cine MRI was performed using a steady-state free-precession technique (FIESTA). 
Imaging parameters were; repetition time, 3.5 ms; echotime, 1.3 ms; flip angle, 45°; field 
of view, 36-40 x 36-40 cm; matrix, 196x160; views per segment, 12, resulting in a tem-
poral resolution of 42 ms. To cover the entire LV 10-12 consecutive slices of 8 mm in the 
short axis view were planned on the four chambers (gap 2 mm).
To quantify LV volumes, endocardial contours were detected automatically and cor-
rected manually on short-axis cine-MRI images with a dedicated software program us-
ing the centerline method (Mass; Medis, Leiden, the Netherlands). Papillary muscles 
were considered as part of the LV cavity.
Data are presented as mean (SD). A linear regression analysis was performed for the 
comparison of results obtained by RT3DE and MRI. Limits of agreement were calculat-
ed according to the Bland-Altman method7. Similarly, inter- and intraobserver variability 
were calculated and expressed as the mean difference between the two measurements 
± 2SD. To determine whether there is a statistically significant difference between com-
parisons, a paired t-test was performed. A probability level of p< 0.05 was considered 
significant.
Results
The mean time for data analysis ranged from 5 to 20 minutes, depending on image 
quality. From the total number of 624 segments, 173 segments (28%) had an image 
quality score <2 without contrast-enhancement, this number decreased to 69 seg-
ments (11%) with contrast-enhancement. After contrast-enhancement mean image 
quality index improved from 2.4 ± 1.0 to 3.0 ± 0.9 (P <0.001). The most profound 
improvement was seen in the anterior segments (1.9 ± 1.4 to 2.6 ± 1.3). A similar 
improvement was found for the mid ventricular anterior and anteroseptal short-axis 
segments (from 1.7 ± 1.5 to 2.6 ± 1.2 after contrast-enhancement).
As seen in Table 1, mean LV-EDV, LV-ESV, and LV-EF values were not different 
between RT3DE images with and without contrast. Both techniques significantly 
underestimated LV-EDV and LV-ESV (but not LV-EF) compared to MRI. Better cor-
relations to MRI were found for LV-EDV, ESV and LV-EF with contrast-enhanced 
RT3DE (see also Table 1). As seen in Figure 1, the limits of agreement (Bland-
Altman analysis) showed a similar bias for RT3DE images with and without contrast 
but with smaller limits of agreement for contrast-enhanced RT3DE.
In a subgroup analysis of patients with poor-to-moderate image quality (image 
quality index ≤ 2, 14 patients), the 95% limits of agreements for LV-EF narrowed 
from ± 24.4% to ± 12.7% with contrast-enhanced RT3DE. For moderate-to-good 
image quality (image quality index ≥ 2.5, 16 patients), the 95% limits of agreements 
for LV-EF narrowed from ± 10.4% to ± 7.0% with contrast-enhanced RT3DE (See 
Figure 2).
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Interobserver variability for LV-EDV and LV-ESV was lower for contrast-enhanced 
RT3DE (-3.1 ± 20.0 ml and -0.8 ± 13.9 ml, respectively) compared to non-contrast-
enhanced RT3DE (5.6 ± 32.9 ml and 3.0 ± 25.7 ml, respectively). For EF, interob-
server variabilities were -0.5 ± 5.8% and 0.7 ± 9.2%, respectively. Intraobserver 
variability for LV-EDV and LV-ESV was lower for contrast-enhanced RT3DE (1.5 ± 
6.6 ml and 0.5 ± 7.3 ml, respectively) compared to non-contrast-enhanced RT3DE 
(-5.2 ± 21.4 ml and -3.1 ± 19.8 ml, respectively). For EF, intraobserver variabilities 
were 0.2 ± 3.2% and -0.2 ± 6.2%, respectively.
Discussion
2DE remains the most often used imaging modality to assess LV function, but is 
limited in accuracy because of geometric assumptions of LV shape and high in-
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Figure 2:
Subgroup analysis of LV-EF in patients with moderate-to-good (top panels) and poor-to-moderate 
image quality (bottom panels), with and without contrast enhancement. (abbreviations as in Figure 1)
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tra- and interobserver variability8. Improvement in accuracy was shown by 3DE, 
because of the absence of these geometric assumptions5. Despite technological 
improvements, image quality remains less compared to 2DE imaging. Reliable LV 
contour detection is only possible if the endocardial border is adequately visible 
during end-systole and end-diastole. Even in good quality echocardiograms, it is 
sometimes difficult to delineate the endocardium in still frames. In 2DE studies im-
provement in endocardial border detection with contrast-enhancement resulted in a 
significant decrease in intra- and interobserver variability for LV function analysis9,10. 
Others and us have shown the value of contrast-enhanced imaging during stress 
RT3DE11,12.
In the present study the improvement in endocardial border definition during 
contrast-enhanced RT3DE imaging is confirmed. The number of poor-to-moderate 
visible segments decreased with 60% after contrast enhancement, in particular 
the anterior and anteroseptal segments improved in quality. Also, identification of 
the LV contour improved in the mid-ventricular short-axis, which is important for 
accurate LV reconstruction. Contrast-enhanced imaging improved the accuracy by 
means of a higher correlation between RT3DE and MRI. Although the limits of agree-
ment analysis showed a higher agreement, a difference in bias was not observed. 
In a subgroup analysis, patients with poor-to-moderate image quality showed an 
improvement in agreement with contrast use to the same level as patients with 
moderate-to-good image quality studied without contrast. Also, an improvement in 
reproducibility was found, evidenced by narrower limits of agreement for inter- and 
intraobserver variability. In a first study, Caiani et al.13 did not find an improvement in 
accuracy after use of contrast, and suggested dual end-diastolic and end-systolic 
gating instead of continuous imaging to reduce bubble destruction and subsequent 
underestimation of LV volume14. We found a similar correlation and limits of agree-
ment using continuous infusion compared to the latter study, without use of dual 
triggering (see Table 2). We did not experience incomplete visualization of the LV 
due to bubble destruction while performing continuous acquisition. This may be 
explained by a different imaging protocol, as we used bolus injections of contrast 
agent rather than a continuous infusion. Possibly, bolus injections result in a higher 
LV contrast concentration that is less sensitive to (apical) bubble destruction, at the 
cost of a period of attenuation15. It should be noticed, however, that in our experi-
ence well timed bolus injections result in relatively stable LV contrast concentra-
tions during the recording phase. Also, differences in data analysis and baseline 
image quality may explain different results. However, in both studies patients were 
not selected for echo quality.
MRI analysis uses short-axis images with a disk summation method to obtain 
a LV volume. This analysis is not optimal near the apex because of partial-volume 
artifacts and has limitations in recognizing the mitral valve16. Subsequently, a part of 
the aortic root or left atrium can be included in the volume of the reconstructed disk 
in the most basal cross-section. This may partially explain the difference in volumes 
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between RT3DE and MRI. This error can theoretically be reduced by increasing the 
number of disks (and subsequent decrease of slice thickness) resulting in increased 
review time, or incorporation of long-axis analysis17-19. Of note, our main goal was to 
compare head-to-head the two different RT3DE imaging techniques (with a similar 
gold standard). To prevent possible error caused by an automated algorithm we 
used a manual tracing algorithm. Current developments in automated analysis of 
contrast-enhanced images may improve analysis time and agreement.
Table 2. Comparison of Correlation, Agreement, and Variability Between Real-Time Three-
Dimensional Echocardiographic Studies of Left Ventricular Volumes and Function Quantification 
Using Contrast Enhancement.
Author Year Pts R2 SEE Bias (%) SD (%)
EDV (ml) Caiani13 continuous imaging 2005 14 0.58 31 -34 38
Caiani14 dual triggering 2005 20 0.90 21 -14 (9%) 20 (13%)
Caiani14 continuous imaging 2005 20 0.79 27 -23 (17%) 30 (21%)
Krenning continuous imaging 2007 39 0.97 17 -16 (8%) 18 (9%)
ESV (ml) Caiani13 continuous imaging 2005 14 0.72 23 -19 26
Caiani14 dual triggering 2005 20 0.92 14 -5 (6%) 17 (19%)
Caiani14 continuous imaging 2005 20 0.86 18 -15 (19%) 20 (25%)
Krenning continuous imaging 2007 39 0.92 13 -7 (6%) 13 (11%)
EF Caiani13 continuous imaging 2005 14 0.50 12 -1 9
Caiani14 dual triggering 2005 20 0.59 11 -4 (10%) 11 (26%)
Caiani14 continuous imaging 2005 20 0.58 10 0 (0%) 11 (23%)
Krenning continuous imaging 2007 39 0.88 5 -1 (3%) 5 (11%)
EDV = end-diastolic volume; ESV = end-systolic volume; EF = ejection fraction,
RT-3DE = Real-time three-dimensional echocardiography, R2= Correlation Coefficient,
Ref = Reference technique, pts = patients, SEE = Standard error of estimate, SD = Standard 
deviation
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Abstract
Background
Dobutamine stress echocardiography (DSE) is an accepted test for the diagnosis of 
coronary artery disease (CAD), despite its wide diagnostic accuracy.
Aim
Which factors cause test variability of DSE for the diagnosis of CAD.
Methods
In a retrospective analysis of 46 studies in 5,353 patients, the potential causes of di-
agnostic variability were systematically analyzed, including patient selection, defini-
tion of CAD, chest pain characteristics, confounding factors for DSE (left ventricular 
hypertrophy, left bundle branch block, female gender), work-up bias (present when 
patient’s chance to undergo coronary angiography is influenced by the result of 
DSE), review bias (present when DSE is interpreted in relation to CAG), DSE proto-
col and definition of a positive DSE.
Results
Diagnostic variability was related to definition of a positive test, but not related to 
the definition of CAD or DSE protocol. However, only three of eight methodological 
standards for research design found general compliance. Differences in the selec-
tion of the study population (quality of echocardiographic window, angina pecto-
ris), handling of confounding factors and analysis of disease in individual coronary 
arteries were observed. Lack of data on analysis of relevant chest pain syndromes 
and handling of nondiagnostic test results hampered further evaluation of these 
standards.
Conclusion
Methodologic problems may explain the wide range in diagnostic variability of DSE. 
An improvement of clinical relevance of DSE testing is possible by stronger adher-
ence to common and new methodologic standards.
Boudewijn Krenning BW.indd   114 12-10-2007   15:19:49
Methodological analysis of DSE studies
115
Dobutamine stress echocardiography (DSE) is currently a routine and safe test for 
the diagnosis of coronary artery disease (CAD)1. However, reported studies show 
a wide range of diagnostic sensitivity and specificity1. To explain this wide range, 
we conducted a methodological review of the reported studies in which patients 
underwent both DSE and coronary arteriography. In analogy to a previous meth-
odological review2 on exercise testing, we assessed the common causes of diag-
nostic variability (differences in definition of CAD, the DSE protocol and definition 
of abnormal DSE). We also used modified methodological criteria for assessing 
diagnostic accuracy.
Methods
Data sources and data extraction
A MEDLINE search was performed for diagnostic DSE studies in English language 
between January 1990 and December 2000 that included patients who underwent 
both DSE and coronary arteriography. The search terms were ‘dobutamine stress’ 
and ‘coronary artery disease’. We also carefully reviewed all references of the se-
lected articles for additional studies.
Selection criteria
Criteria for the studies to be enrolled in the present analysis were (1) patients, or 
a subgroup of patients who underwent both DSE and coronary arteriography, (2) 
data containing calculations of sensitivity and specificity or information that could 
be used to derive this information. Excluded were studies, which included selected 
patient populations. In particular patients studied in DSE studies using contrast im-
aging were excluded because these patients were selected by poor image quality, 
obviously resulting in low diagnostic sensitivity for conventional DSE. Also excluded 
were studies including solely patients with left bundle branch block, hypertension, 
left ventricular hypertrophy or renal transplant recipients. When multiple articles by 
the same author were identified, only the largest study was included in the present 
analysis, unless it was clear that different patients were studied.
Data collection
Two investigators (BJK, MLG) independently screened the 44 articles3-46 that met 
the inclusion criteria for abstracted variables and the methodological standards 
described below. Variables abstracted from each report included identifying infor-
mation (first author, year of publication) and clinical characteristics (number of pa-
tients, mean age, percentage of male patients). In addition, we recorded the num-
ber of patients without and with CAD and the number of patients with true positive 
and true negative DSE results.
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According to the previously reported common reasons for the wide range of di-
agnostic accuracy2, we noted the definition of significant CAD (≥50 or ≥70% reduc-
tion in luminal diameter), DSE protocol and definition of positive DSE.
Definition of CAD
When 70% reduction in luminal diameter on a coronary angiogram is used as crite-
rion for significant CAD, the chance of false negative test results is smaller as com-
Table I Methodological standards
standard 1 adequate selection and identification of patients
A adequate selection of patients, information on age and gender available
B β-blockers stopped prior to DSE
standard 2 adequate analysis of disease in individual coronary arteries
A extent of CAD (1,2,3 vessel CAD or single/multi vessel disease) reported
B location of CAD (at least for single-vessel CAD) reported
C diagnostic accuracy for extent of CAD available
D diagnostic accuracy for location of CAD available
E identification of multi-vessel CAD by multi-region wall motion abnormalities
F
hemodynamic response at ischemic threshold for sub-groups (eg. 1,2,3 vessel CAD) 
reported
Standard 3 adequate analysis of relevant chest pain syndromes
A information on number of patients with typical angina pectoris
B diagnostic accuracy in patients with typical angina pectoris available
Standard 4 avoidance of a limited challenge group
A
inclusion of patients with possible confounding factors (left ventricular hypertrophy, 
left bundle branch block, female gender)
B inclusion of patients with poor thoracic echocardiographic window
standard 5 avoidance of work-up bias
absence of work-up bias (present when patient’s chance to undergo coronary 
angiography is influenced by the result of DSE)
standard 6 avoidance of diagnostic review bias
A DSE interpretation performed blinded to results of coronary angiography
B coronary angiographic interpretation performed blinded to results DSE
standard 7 adequate analysis for non-diagnostic DSE tests
A number of patients with non-diagnostic test result reported
B number of patients achieving target heart rate reported
C average maximum heart rate at peak infusion reported
standard 8 use of state-of-the-art protocol
addition of atropine to dobutamine if target heart rate was not achieved
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pared to a 50% reduction. This would cause sensitivity to increase and specificity 
to decrease.
DSE protocol
Also, addition of atropine to dobutamine and withdrawal of β-blockers has shown 
to increase diagnostic accuracy10, 30, 31, 37, 47. Therefore, the DSE protocol can influ-
ence the correlation to angiographic findings.
Definition of positive DSE
Different definitions of abnormal DSE could cause differences in diagnostic accura-
cy. Studies, in which either at rest or during stress inducible wall motion abnormal-
ity is considered indicative of CAD, sensitivity is likely to be higher than in studies in 
which dobutamine stress-induced wall motion abnormalities are required. Whereas 
all studies defined DSE positive for significant CAD in case of new or worsening 
wall motion abnormalities during dobutamine infusion (myocardial ischemia), rest 
wall motion abnormalities were interpreted differently. Therefore, we introduced 
three different definitions of positive DSE.
In studies using definition A, DSE was only considered positive in case of new or 
worsening wall motion abnormalities during dobutamine infusion (myocardial isch-
emia). In studies using definition B, DSE was considered positive in case of new or 
worsening wall motion abnormalities or a resting wall motion abnormality without 
improvement during dobutamine infusion (fixed wall motion abnormality). In studies 
using definition C, DSE was considered positive in case of new or worsening wall 
motion abnormalities or a resting wall motion abnormality regardless of change 
during dobutamine infusion.
According to the previously cited review2, we also investigated basic differences 
in research design by using (modified) standards for evaluating DSE (Table I).
Statistical analysis
Statistical tests were performed in a weighted fashion, using the number of dis-
eased patients as the weight for testing of sensitivities and the number of non-
diseased patients for testing of specificities. For calculation of 95% confidence 
intervals, the formula p ± 1.96√pq/n (p = observed index for either sensitivity or 
specificity, q = 1-p, n = number of subjects tested) was used. Comparisons of sen-
sitivity and specificity were performed using the standardized normal distribution 
test. Statistical significance was defined at p < 0.05.
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Reference Year Cases 
(n)
Sub-
Group#
men 
(%)
Sens 
(%)
Spec 
(%)
Test 
protocol*
significant 
CAD (%)
V/Q
Abnormal 
stress 
test 
criterion‡
Cohen3 1991 70 N 100 86 95 III 70 V A
Sawada4 1991 55 Y 62 89 85 I 50 Q A
Epstein5 1992 61 N 70 91 57 II 50 V C
Martin6 1992 40 N 95 76 60 II 50 V A
Salustri7 1992 52 N 73 54 80 II 50 Q A
Marcovitz8 1992 141 N 60 96 66 I 50 Q B
Mazeika9 1992 50 N 88 64 93 I 70 V A
McNeill10 1992 80 N 74 70 88 IV 50 V A
Gunalp11 1993 27 N 85 83 89 I 50 V A
Hoffmann12 1993 60 Y 77 79 83 V 70 Q A
Marwick13 1993 217 N 72 72 83 II 50 Q C
Previtali14 1993 80 N 78 79 83 III 50 V A
Afridi15 1994 45 Y 99 71 86 II 70 Q C
Sahin16 1994 65 N 71 79 87 I 50 V A
Santiago17 1994 77 Y 70 79 67 III 70 V C
Senior18 1994 61 N 72 93 94 III 50 V C
Beleslin19 1994 136 N 85 82 76 II 50 Q A
Daoud20 1995 76 N 58 92 73 I 50 V B
Ho21 1995 54 N 85 93 73 II 50 V A
Sochowski22 1995 46 N 67 68 81 II 50 V A
Dagianti23 1995 60 Y 70 72 97 III 70 Q A
Di Bello24 1996 45 N 73 76 86 V 50 V A
Iwase25 1996 96 N 70 79 88 III 70 V A
Kisacik26 1996 69 N 84 94 86 V 50 V A
San Roman27 1996 102 N 56 78 95 IV 50 Q A
Wu28 1996 30 Y 84 94 92 II 50 Q A
Anthopoulos29 1996 120 N 60 87 84 II 50 V A
Ling30 1996 183 Y 35 95 51 IV 70 V B
Pingitore31 1996 110 Y 83 84 89 IV 50 Q A
Slavich32 1996 46 N 0 59 79 V 50 Q A
Dionisopoulos33 1997 288 N 65 87 89 IV 50 Q C
Hennessy34 1997 317 N 72 86 60 V 50 V B
Ho35 1997 223 Y 81 94 79 IV 50 Q A
Huang36 1997 93 N 77 93 77 IV 50 Q C
Schröder37 1997 99 N 80 89 82 V 50 Q A
Steinberg38 1997 120 N 99 87 91 III 70 V A
Vitarelli39 1997 59 N 64 85 82 III 70 V A
Table II Summary of studies and results of methodological review
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STANDARD
1
A
1
B
2
A
2
B
2
C
2
D
2
E
2
F
3
A
3
B
4
A
4
B
5 6
A
6
B
7
A
7
B
7
C
8
x x x x x x x x
x x x x x x x x x x
x x x x x x x x x x
x x x x x x x x x
x x x x x x x x x
x x x x x x x x -
x x x x x x x x x x x x x
x x x x - x x - x x
x x x x x x x x - x x - x
x x x x x x x x x
x x x x x x x x x x x - x
x x x x x x x x x
x x x x x x x
x x x x x x x x x x
x x x - - -
x x x x x x x - x x x x
x x x x x x x x x x x
x x x x x - -
x - x x x x x - x x x
x x x x x x x x
x x x x x x x x x
x x x x x x x x x x
x x x x x x x x
x x x x x x x x x x x
x x x x x - x x - x x
x x x x x x x x
x x x x - x x x
x x x - x - x x
x x x x - x x x x x
x x x x x x x x - x
x x x x x x x x x x x x
x x x x x x - x x x x
x x x x x x x - x
x x x x x x x x - x x
x x x x x x x - x x
x x x x x x x
x x x x x x - - x
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Results
Overview of studies
In one42 of the 44 articles, three different DSE protocols were compared and imple-
mented as three different studies in this analysis. The clinical characteristics of 
the 46 studies including 5,353 patients are outlined in Table II. In some studies, 
coronary angiography was performed only in a subgroup of patients. In this case, 
only the results from these latter patients were used for calculation of diagnostic 
Reference Year Cases 
(n)
Sub-
Group#
men 
(%)
Sens 
(%)
Spec 
(%)
Test 
protocol*
significant 
CAD (%)
V/Q
Abnormal 
stress 
test 
criterion‡
Elhendy40 1998 295 Y 67 75 87 IV 50 Q A
Santoro41 1998 60 N - 61 96 V 70 Q A
Tackeuchi42 1999 178 N 77 84 89 I 50 Q C
Tackeuchi42 1999 249 N 80 85 83 II 50 Q C
Tackeuchi42 1999 511 N 71 85 82 IV 50 Q C
Lewis43 1999 92 N 0 40 94 IV 50 Q A
Loimaala44 1999 60 N 67 95 63 II 50 V A
Nagel45 1999 172 N 71 74 70 V 50 V A
Smart46 2000 183 N 73 87 91 IV 50 Q C
x standard met by study; - data unavailable; # included patients subgroup of total study population; 
*see table I; † V/Q: visual estimation or quantitative measurement; ‡A: new or worsening wall motion 
abnormalities (=myocardial ischemia); B: myocardial ischemia or a resting wall motion abnormality 
without improvement during dobutamine infusion; C: myocardial ischemia or a resting wall motion 
abnormality regardless of change during dobutamine infusion.
sens = sensitivity; spec = specificity; MI = myocardial infarction; CAD = coronary artery disease
Table III Variation in sensitivity and specificity
Values of sensitivity or specificity 
(%)
Sensitivity (number of studies) Specificity (number of studies)
31-40 1 0
41-50 0 0
51-60 2 4
61-70 4 4
71-80 13 8
81-90 15 21
91-100 11 9
Weighted mean 83% 83%
Boudewijn Krenning BW.indd   120 12-10-2007   15:19:56
Methodological analysis of DSE studies
121
STANDARD
1
A
1
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A
2
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confidence intervals
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accuracy. Baseline patient characteristics were assumed applicable to both the 
total group and this subgroup with the exception of two studies4, 28. In these lat-
ter studies, unfortunately patients with resting wall motion abnormalities were only 
considered to have a positive DSE when dobutamine stress-induced wall motion 
abnormalities outside the infarction area were present. Therefore, we excluded in 
these studies patients with a history of myocardial infarction.
As seen in Table III, the 46 individual studies had wide variations in sensitivity 
and specificity, although clustered around higher values. This can also be appreci-
ated from Figure I, which shows the diagnostic accuracy for each study with 95%-
confidence intervals.
Definition of CAD
Differences in sensitivity and specificity according to two definitions of CAD re-
mained regardless of which definition is used for CAD (Table IV). In 35 studies, 50% 
stenosis as criterion for significant CAD was used with a weighted mean sensitivity 
and specificity of 84% and 82%, respectively. In 11 studies, 70% stenosis was used 
with a weighted mean sensitivity and specificity of 83% and 84%, respectively.
DSE protocol
Table V gives sensitivity and specificity values separated according to different DSE pro-
tocols. Seven studies used a dobutamine dose less then 40 µg/kg/min (protocol I), 12 
used ≥ 40 µg/kg/min dobutamine and continued β-blocker (protocol II), 8 used ≥ 40 µg/
kg/min dobutamine and stopped β-blocker (protocol III), 11 used addition of atropine, 
while continuing β-blocker (protocol IV) and 8 used addition of atropine and stopped 
β-blocker (protocol V). Between individual studies, a wide variation in sensitivity and 
Table IV
Sensitivity and specificity according to differences in angiographic
definition of coronary artery disease.
Values of sensitivity 
or specificity (%)
Sensitivity (number of studies) Specificity (number of studies)
50% R
n=35
70% R
n=11
50% R
n=35
70% R
n=11
31-40 1 0 0 0
41-50 0 0 0 0
51-60 2 0 3 1
61-70 2 2 3 1
71-80 8 5 8 0
81-90 12 3 17 4
91-100 10 1 4 5
Weighted mean 84% 83% 82% 84%
R = reduction in luminal diameter
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specificity can be observed. However, weighted mean sensitivity and specificity were 
not different.
Table V
Sensitivity and specificity according to differences in stress test protocol.
Values of sensitivity 
or specificity (%)
Sensitivity (number of studies) Specificity (number of studies)
I
n=7
II
n=12
III
n=8
IV
n=11
V
n=8
I
n=7
II
n=12
III
n=8
IV
n=11
V
n=8
31-40 0 0 0 1 0 0 0 0 0 0
41-50 0 0 0 0 0 0 0 0 0 0
51-60 0 1 0 0 1 0 2 0 1 1
61-70 1 1 0 1 1 1 1 1 0 1
71-80 1 3 4 2 3 1 4 0 2 1
81-90 3 3 3 4 2 4 4 3 6 4
91-100 2 4 1 3 1 1 1 4 2 1
Weighted mean 87% 81% 83% 84% 82% 83% 80% 88% 84% 76%
I: <40 µg/kg/min,
II: ≥40 µg/kg/min and β-blocker continuation,
III: ≥40 µg/kg/min without β-blocker continuation,
IV: ≥40 µg/kg/min plus atropine addition and β-blocker continuation,
V: ≥40 µg/kg/min plus atropine addition without β-blocker continuation
Table VI
Sensitivity and specificity according to differences in definition of positive DSE.
Values of sensitivity 
or specificity (%)
Sensitivity (number of studies) Specificity (number of studies)
A
n=31
B
n=11
C
n=4
A
n=31
B
n=11
C
n=4
31-40 1 0 0 0 0 0
41-50 0 0 0 0 0 0
51-60 2 0 0 1 1 2
61-70 4 0 0 2 1 1
71-80 10 3 0 6 1 1
81-90 9 5 1 14 7 0
91-100 5 3 3 8 1 0
Weighted mean 81% 84% 91% 85% 84% 60%
A: new or worsening wall motion abnormalities (=myocardial ischemia);
B: myocardial ischemia or a resting wall motion abnormality without improvement during dobutamine 
infusion
C: myocardial ischemia or a resting wall motion abnormality regardless of change during dobutamine 
infusion
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Definition of positive test
Sensitivity and specificity according to three definitions of abnormal DSE described ear-
lier, are presented in Table VI. Criterion A (requiring ischemia) was used in 31 studies, cri-
terion B (requiring ischemia or a fixed wall motion abnormality) in 11 studies and criterion 
C (requiring a wall motion abnormality at any stage) in 4 studies. The weighted means 
for sensitivity and specificity regarding these criteria were 81%, 84%, 91% and 85%, 
84%, 60%, respectively. Significant differences in sensitivity between protocol A and B 
(P < 0.02), protocol A and C (P < 0.0001) and protocol B and C (P < 0.0001) were found. 
Specificity of protocol C versus protocol A and B was significantly different (P<0.0001).
Results for methodological standards
Standard 1: adequate selection and identification of patients
All studies had a reasonably clear description of patient selection, with all but one 
(98%) giving information about age and gender (standard 1A). Also continued beta-
blocker therapy of the population studied may influence the accuracy of the test 
as a lower heart rate increment, caused by β-blockers, may result in an increased 
number of non-diagnostic tests and therefore decrease sensitivity. Standard 1B 
was met by 18 studies (39%), indicating that in these studies β-blocking medication 
was discontinued before DSE.
Standard 2: adequate analysis of disease in individual coronary arteries
As previously noted1, 2, the sensitivity for detection of CAD depends on the extent 
and location of CAD. For example, it is well known that both in patients with single 
vessel CAD and left circumflex lesions, lower sensitivities are found1. Standard 2 
was intended to allow evaluation of the test over the full anatomic spectrum of CAD. 
Almost all studies (98%) described the extent of the coronary lesions in terms of 
1,2 or 3-vessel CAD (72%) or single- versus multi-vessel CAD (26%) (standard 2A). 
Results for the extent of CAD were given in the great majority (87%) of the studies 
(standard 2C). Fourteen studies (30%) gave sensitivity and specificity for single- 
and multi vessel CAD only5, 8, 12, 13, 19, 23-25, 37, 41, 42, 44. Only 15 studies (33%) reported 
the location of the involved vessel (standard 2B). From these 15 studies, 12 (26%) 
met standard 2D by providing DSE results for these individual locations (standard 
2D); 5 only gave sensitivity5, 13, 21, 35, 41 or results for SVD8, 33. Although it is essential to 
differentiate between potential left main or three-vessel CAD versus single-vessel 
CAD48, we only found eight studies to determine the number of patients with multi-
vessel CAD based on multi-region wall motion abnormalities during DSE (standard 
2E). None of the studies mentioned left ventricular cavity dilatation as a marker for 
multi-vessel CAD. As a low ischemic threshold is also a criterion for more severe 
and/or extensive CAD49, we analyzed the number of studies mentioning the dose 
and heart rate at which new wall motion abnormalities appeared on echocardiog-
raphy among various sub-groups with CAD. Few studies3, 14, 23 mentioned ischemic 
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threshold and only one study3 (2%) met standard 2F by giving information on isch-
emic threshold in sub-groups of patients.
Standard 3: adequate analysis for relevant chest pain syndromes
Because both the spectrum of clinical syndromes as well as the anatomical spec-
trum of CAD should be considered, standard 3 intended to ensure that DSE was 
performed in patients with the common chest pain syndromes that usually lead to 
performance of the test. Only 15 studies (33%) provided information on the number 
of patients with typical angina pectoris (standard 3A). There was a wide variation 
(17-87%) in number of patients with typical angina. None of the studies provided 
sensitivity and specificity for chest pain characteristics (standard 3B). Three stud-
ies13, 34, 41 calculated pre-test probability of disease for each patient on the basis of 
age, gender and chest pain characteristics. In only one study34, diagnostic accu-
racy of DSE was assessed according to pre-test probability of disease. In patients 
with higher pre-test probability of disease DSE sensitivity was higher.
Standard 4: avoidance of a limited challenge group
From exercise testing and thallium scintigraphy, it is known that left bundle branch 
block50, 51, left ventricular hypertrophy52, 53 and female gender54 can negatively influ-
ence the diagnostic accuracy of a stress-test. Therefore, analysis of these patients 
should be performed in a separate study or performed as a subgroup within a study. 
Eight studies excluded patients because of left bundle branch block9, 18, 24, 25, 29, 36, 
left ventricular hypertrophy24, 42 or female gender3, and therefore did not meet stan-
dard 4A. The percentage of patients excluded varied from 1% to 14%. One study 
performed DSE in a female population and showed a low sensitivity in single-vessel 
CAD43. In contrast, most investigations were performed in a predominantly male 
population. Also, when patients with poor echocardiographic window are excluded, 
this would reduce the chance of a false-negative result. In 11 studies (24%), infor-
mation was unavailable concerning the inclusion of patients with poor windows and 
22 (48%) excluded patients because of poor basal echocardiographic window. A 
wide range in number of excluded patients was observed (1-14%). Thirteen studies 
(28%) met standard 4B, by not excluding patients with poor echo windows.
Standard 5: avoidance of work-up bias
Studies can be designed prospectively and retrospectively. A retrospective study 
design (in which patients are included who underwent coronary angiography and 
DSE within a certain time period) may suffer from work-up bias. In these studies it 
can be assumed that coronary angiography was guided by (usually positive) DSE 
results. This may obviously increase sensitivity and decrease specificity of DSE. 
However, most prospective study designs are also sub optimal. Patients recruited 
from a coronary angiography waiting list are likely to have undergone some other 
stress test with positive result and thus some sort of work-up bias is still pres-
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ent. Patient prospectively scheduled for coronary angiography and DSE usually do 
not represent the whole spectrum of disease as encountered in clinical practice 
(i.e. consecutive patients with non-anginal chest pain, atypical and typical angina) 
but usually represent the most diseased part of the spectrum. Thirty-six studies 
(78%) had a prospective study-design and thereby fulfilled standard 5, avoidance 
of work-up bias.
Standard 6: avoidance of diagnostic review bias
Interpreting DSE with knowledge of the results of coronary angiography can lead 
to an overestimate of a test’s accuracy, especially because DSE is open to subjec-
tive interpretation. In contrast to previous published reviews on exercise testing2 
and thallium-201 imaging55, 43 studies (93%) met standard 6A by clearly stating 
that DSE scoring was performed blinded. Thirty studies (65%) noted the blinding 
of the readers of the coronary angiogram. Both standard 6A and 6B were met by 
30 studies (65%).
Standard 7: adequate analysis for non-diagnostic DSE tests
If non-diagnostic tests are included as a negative test in the results, sensitivity is 
artificially decreased and specificity increased. The frequency of non-diagnostic 
results in a (new) diagnostic test is important because a test will have a low clinical 
effectiveness if its results cannot be interpreted in a substantial number of patients. 
Common causes for a non-diagnostic DSE are a protocol that is unable to achieve 
target heart rate or side effects resulting in premature termination of the test. Only 
three studies13, 43, 45 (7%) gave explicit information about the number of patients with 
a diagnostic test or this could be deducted from a table with individual patient data 
in two studies7, 9 (4%). In one study45, these patients were excluded and in the other 
four the DSE results were included as normal. Seven studies (15%) mentioned the 
number of patients reaching target heart rate (standard 7B) and 32 studies (70%) 
reported the mean maximum heart rate (standard 7C). However, this can only give 
an indication of stress induced by dobutamine. For instance, in a severely diseased 
study population, the number of patients achieving target heart rate may be limited 
because ischemia was observed prior and mean maximum heart rate is strongly 
dependent on the mean age of the study population.
Standard 8: use of state-of-the-art protocol
The last standard intended to analyze the number of studies using atropine. Several 
reports have shown that addition of atropine to dobutamine is safe56 and beneficial 
in patients who do not reach target heart rate and have no echocardiographic signs 
and symptoms of ischemia10, 30, 31, 37, 47. In our analysis, only 19 studies (41%) used 
a maximum dose of 40 or 50 µg/kg/min of dobutamine and additional atropine if 
necessary, although a clear trend is seen to the use in more recent years.
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Discussion
The main finding of this study is that the diagnostic variability of DSE for the di-
agnosis of CAD is related to the definition of a positive test, and not to the defini-
tion of CAD by coronary angiography nor by the DSE protocol used. However, 
because this cannot sufficiently explain the wide variation in diagnostic accuracy, 
we performed a complete and unbiased evaluation of research design. This meth-
odological analysis showed reasonable compliance with only three of eight stan-
dards. Differences were observed in the selection of the study population (quality 
of echocardiographic window, presence of angina pectoris), handling of confound-
ing factors and analysis of disease in individual coronary arteries. Lack of data 
on analysis of relevant chest pain syndromes and handling of non-diagnostic test 
results hampered further evaluation of these standards. The variations in method-
ology described in this review could produce highly variable results for diagnostic 
accuracy. Many suggestions have already been described to improve study design 
for diagnostic tests2, 55. We can add several recommendations for improving study 
design for DSE.
Recommendations for diagnostic DSE studies.
Study design. DSE studies should be prospectively designed to minimize the 
influence of work-up (post-test) bias. Information on numbers, and reasons, of ex-
cluded patients should be provided. In particular, it should be stated in how many 
patients poor echo window quality precluded DSE analysis. Patients with potential 
false positive or negative test results should not be excluded but analysed sepa-
rately.
Patients. Patient data should preferably be presented in a table with individual 
data on gender, age, risk factors for CAD, clinical history and chest pain type. Such 
a table will make it possible for a reader to assess the pre-test probability of CAD 
for each patient and the study population57.
DSE protocol. Beta-blockers should preferably be stopped before diagnostic 
DSE since these drugs lower peak cardiac work load58 and thus have the potential 
to lower DSE sensitivity. Current state-of-the-art (dobutamine-atropine) protocols, 
including use of the biphasic response, should be used1. Analysis of echo segments 
and correlation with coronary territories should be performed following standard-
ized guidelines59, blinded for clinical and coronary angiographic information. DSE 
should be considered positive in case of stress-induced abnormalities in one or 
more segments60. A possible exception are isolated stress-induced abnormalities in 
basal inferior-posterior segments, because these are well known for their tendency 
toward false positive results61, 62. The stress protocol should probably (more safety 
data are needed) not be terminated because of the induction of minor wall motion 
abnormalities, as the chance to identify multi-vessel CAD increases when maxi-
mal stress testing is pursued. DSE results should be obligatory analysed for the 
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presence of significant CAD (DSE positivity defined as stress-induced wall motion 
abnormality). In patients without a clinical history of myocardial infarction, analysis 
for the presence of CAD (DSE positivity defined as rest and/or stress-induced wall 
motion abnormality) may be reported in addition. Most importantly, all above men-
tioned elements of the protocol should be clearly described.
Coronary angiographic protocol. Coronary angiography should be scored 
blinded for clinical and DSE information. Stenosis should preferably be scored 
quantitatively with 50% diameter stenosis as cut off point for hemodynamic sig-
nificance63.
Description of results. As important as knowledge about the number of pa-
tients excluded because of a poor echo window is the number, and reason, of non-
diagnostic DSE studies. These two sets of data determine, together with diagnostic 
accuracy, the clinical efficacy of DSE in real clinical practice. As with patient data, 
test results should be preferably presented in a table with individual data on peak 
heart rate, test end-point, ischemic threshold, and localisation (coronary territory) 
of ischemia and coronary stenosis. Such a table will make it possible for a reader to 
assess overall diagnostic accuracy and in various subgroups.
Clinical interpretation of results. Clinicians must be aware of differences in 
clinical characteristics between their patient population and the population in which 
a diagnostic test was evaluated. Differences in study groups and work-up bias may 
change diagnostic sensitivity and specificity.
Conclusion
Compared to earlier methodological reviews on exercise electrocardiography2, 64 
and stress thallium scintigraphy55, 65, an increase in conformation to methodologi-
cal standards can be observed. However, a stronger adherence to, and addition of 
important methodological standards can still improve the clinical relevance of DSE 
research.
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Abstract
Aim
Clinical characteristics of patients, angiographic referral bias and several technical 
factors may all affect the reported diagnostic accuracies of tests. This study aims 
to assess their influence on the diagnostic accuracy of dobutamine stress echocar-
diography (DSE).
Methods and results
The medical literature from 1991 to 2006 was searched for diagnostic DSE stud-
ies and meta-analysis was applied to the 62 studies thus retrieved, including 6,881 
patients. These studies were analyzed for year of publication, direct comparison 
with newer technologies, gender and mean age of patients, inclusion of patients 
with prior myocardial infarction, multi-vessel coronary disease, typical angina or 
beta-blocking medication, blinding of tests, definition of angiographic disease, an-
giographic referral bias, addition of atropine, definition of positive DSE and use of 
the biphasic response. DSE sensitivity was significantly related to the inclusion of 
patients with prior myocardial infarction (0.834 vs. 0.740, P <0.0006) and defining 
DSE already positive in case of resting wall motion abnormalities rather than obliga-
tory myocardial ischemia (0.786 vs 0.864, P=0.01). Specificity tended to be lower 
when patients with resting wall motion abnormalities were included in the study 
(0.812% vs. 0.877, P=0.08). The presence of referral bias adversely affected DSE 
specificity (0.771 vs. 0.842, P=0.01).
Conclusion
This analysis suggests that the reported sensitivity of DSE is higher and the specific-
ity lower than that expected in clinical practice because of the inappropriate inclu-
sion of patients with prior myocardial infarction, definition of positive DSE and the 
presence of referral bias.
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Dobutamine stress echocardiography (DSE) has been extensively studied as a di-
agnostic test for the prediction of coronary artery disease (CAD). However, sensi-
tivities and specificities differ greatly from one report to another. In one, often cited, 
review sensitivities ranged from 54% to 96% and specificities ranged from 62% to 
93% 1. Recently, controversy has also arisen regarding the inter-institutional stabil-
ity of sensitivity and specificity and the wisdom of applying DSE results reported 
in the literature to other clinical laboratories 2. Clinical characteristics of patients, 
angiographic referral bias and several technical factors have all been implicated as 
causes of differences in reported diagnostic accuracies for other stress modalities 
such as exercise electrocardiography 3 and thallium scintigraphy 4. Therefore, we 
analyzed which factors influenced the sensitivity and specificity of DSE by applying 
meta-analysis on published diagnostic studies.
Methodology
Literature review
A Medline search for diagnostic DSE studies published up to 2006 using the terms 
“dobutamine stress” and “coronary artery disease” was performed. In addition, we 
reviewed the reference lists of review articles and eligible studies to complete the 
data search. Excluded from this search were reports solely reporting on patients 
with poor echocardiographic windows, left bundle branch block, hypertension and/
or left ventricular hypertrophy or prior myocardial infarction. To avoid duplication of 
data only the largest report from an institution was considered, unless it was clear 
that different patients were included. Occasionally, reports were excluded because 
of clear mistakes in presentation of data5. The remaining 60 reports were retained 
for review 6-65. One of these reports 61 described results of three separate study 
samples that had been based on different DSE protocols and these samples were 
treated as independent observations. For reports describing the value of atropine 
addition to DSE 32,39,45 only the dobutamine-atropine results were considered for 
analysis. For reports describing the value of second harmonic imaging 43,59 only the 
fundamental imaging data were used for analysis.
Statistical analysis
Sensitivity was defined as the number of true-positive tests divided by the total 
number of patients with angiographically significant CAD. Specificity was defined 
as the number of true-negative tests divided by the total number of patients without 
angiographically significant CAD. Sensitivity and specificity were first calculated for 
each study separately. The overall estimate of these test performance characteris-
tics was then determined as the weighed average of the study specific values. The 
weighting factor was the square root of the number of patients on which the study 
specific sensitivity and specificity were based. Differences in the overall sensitivity 
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and specificity between groups of patients according to clinically relevant patient- 
and test characteristics were evaluated by Student’s t-tests. Statistical significance 
for all tests was defined at the P <0.05 level.
 Univariable and multivariable linear meta-regression was applied to identify 
the relation between the variables that are listed in Table 4 and overall sensitivity/
specificity. All variables entered the multivariable stage, irrespective of the results 
in univariable analysis. The final regression model was constructed via a backward 
selection method, and variables with a P-value <0.05 were maintained.
Recording the variables
The values of the variables were noted before recording the reported sensitivity and 
specificity. Two investigators (MLG and BJK) read the reports independently and 
recorded the variables listed in the tables. When a disagreement occurred between 
the two investigators issues were resolved by consensus or a third investigator.
Discrete variables
These included the following: direct comparison with newer technologies (magnetic 
resonance imaging, three-dimensional echocardiography, tissue Doppler imaging, 
myocardial contrast echocardiography, fractional area changes, rapid beta-blocker 
injection, or second harmonic imaging), inclusion of patients with prior myocardial 
infarction, inclusion of patients with beta-blocking medication (for analysis no avail-
able information on beta-blocking medication was interpreted as present), blind 
interpretation of DSE and coronary angiography (for analysis no available informa-
tion regarding blinding was interpreted as not blinded), definition of angiographic 
disease (50% versus 70% reduction in luminal diameter), presence of angiograph-
ic referral bias (DSE results influencing the decision to undergo coronary angio-
graphy), addition of atropine, echocardiographic imaging technique (fundamental 
or second harmonic), definition of positive DSE (dobutamine stress-induced or any 
wall motion abnormality), number of wall motion abnormalities required for a posi-
tive test (one or two segments, for analysis no available information on the number 
of segments or statements like ‘a wall motion abnormality’ were interpreted as one 
segment), and use of the biphasic response (improvement of wall motion at low-
dose followed by worsening of wall motion at high-dose, for analysis no available 
information on use of the biphasic response was interpreted as not used).
Continuous variables
These included the following: year of publication, mean age, percentage of men, 
percentage of patients with prior myocardial infarction, percentage of patients with 
CAD (“a priori CAD probability”), and percentage of patients receiving beta-block-
ing medication.
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Results
Sensitivities and specificities (Table 1) 
For the 62 unique study groups in the 60 reports, 6,881 patients were studied with 
DSE and coronary angiography with sufficient data to record sensitivity and speci-
ficity. Of these, 4,718 had angiographic CAD whereas 2,163 did not. A total of 3,882 
patients had true positive DSE resulting in a sensitivity of 0.812. There were 1,790 
true negatives, allowing for a specificity of 0.822. Sensitivities and specificities for 
each of the 62 study groups are reported in Table 1.
Effect of patient characteristics (Tables 1 and 4)
Extend of CAD. In 48 studies sensitivity for single-vessel and multi-vessel CAD 
could be calculated separately (mean sensitivity and specificity in these 5,581 pa-
tients was 0.814 and 0.836, respectively). In the 1,663 patients with single-vessel 
CAD sensitivity was 0.728. In the 2.156 patients with multi-vessel CAD sensitivity 
was 0.877.
Prior myocardial infarction. The mean reported sensitivity and specificity from the 
45 studies that included patients with prior myocardial infarction were 0.834 and 
0.811, respectively. For the 17 studies that excluded patients with prior myocardial 
infarction sensitivity and specificity were 0.740 (P <0.01) and 0.852, respectively. In 
the 780 myocardial infarction patients whose angiographic disease status and DSE 
result could be inferred from the available data, sensitivity was 0.820 and specific-
ity was 0.745. In the 2,161 non-myocardial infarction patients whose angiographic 
disease status and DSE result could be inferred, sensitivity was 0.756 (P <0.05) and 
specificity was 0.868 (P <0.01). In the 12 studies in which patients with resting wall 
motion abnormalities were excluded, sensitivity tended to be lower compared to 
the 50 studies in which also patients with resting wall motions were included (0.756 
vs. 0.821, P = 0.14) and specificity was higher (0.877 vs. 0.812, P <0.01). Of the 
continuous variables, the a priori CAD probability and the percentage of patients 
with resting wall motion abnormalities showed the highest correlation with DSE 
sensitivity (r = 0.376, P <0.01 and r = 0.254, P <0.01, respectively) and specificity (r 
= -0.352, P <0.01 and r = -0.224, P <0.01, respectively).
Other patient characteristics. Mean age, percentage of men and continuation of 
beta-blocking medication during DSE did not significantly affect DSE sensitivity or 
specificity.
Effect of publication factors (Table 1)
The years that studies were published were not correlated to DSE sensitivity or 
specificity.
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Table 2. Referral bias and other Angiographic Factors.
Author Referral Angiography Angiography Angiography
Bias Blinded CAD% cut off Quantitative
Afridi 6 Yes Yes 70 Yes
Ahmad 7 Yes No 50 No
Anthopoulos 8 No Yes 50 No
Beleslin 9 No Yes 50 Yes
Cain 10 Yes Yes 50 Yes
Carstensen 11 No Yes 50 Yes
Chiou 12 No Yes 50 Yes
Cohen 13 No Yes 70 No
Dagianti 14 No Yes 70 Yes
Daoud 15 Yes No 50 No
Di Bello 16 No Yes 50 No
Dionisopoulos 17 Yes Yes 50 Yes
Elhendy 18 Yes No 50 Yes
Elhendy 19 Yes Yes 50 Yes
Epstein 20 Yes Yes 50 No
Eroglu 21 No No 50 No
Fathi 22 Yes Yes 50 Yes
Gunalp 23 No No 50 No
Hennessy 24 No Yes 50 No
Ho 25 No Yes 50 No
Ho 26 No No 50 Yes
Hoffmann 27 No Yes 70 Yes
Huang 28 No No 50 Yes
Iwase 29 No Yes 70 No
Kisacik 30 No Yes 50 No
Lewis 31 No Yes 50 Yes
Ling 32 Yes No 70 No
Loimaala 33 No No 50 No
Marcovitz 34 Yes No 50 Yes
Martin 35 No Yes 50 No
Marwick 36 No No 50 Yes
Mathias37 Yes Yes 50 Yes
Mazeika 38 No Yes 70 No
McNeill 39 No No 50 No
Mishra 40 Yes Yes 70 No
Nagel 41 No Yes 50 No
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Effect of angiographic referral bias (Tables 2 and 4)
The presence of referral bias, present in 18 studies, negatively affected test speci-
ficity (0.771 vs. 0.842, P <0.01).
Effect of technical angiographic factors (Tables 2 and 4)
Definition of stenosis. There was no difference in sensitivity between the 47 studies 
in which 50% diameter stenosis was used as cut off for significant CAD compared 
to the 15 studies in which 70% diameter stenosis was used as cut off for significant 
CAD.
Blinding of reading. Blinding of the coronary angiogram, present in 41 studies, 
did not significantly affect sensitivity.
Quantitative scoring of stenosis. Quantitative scoring of the coronary angiogram, 
present in 34 studies, did not significantly affect sensitivity and specificity. In the 28 
Nedeljkovic 42 No Yes 50 Yes
Nixdorff 43 No yes 70 Yes
Peteiro 44 No Yes 50 No
Pingitore 45 No Yes 50 Yes
Previtali 46 No Yes 50 No
Rollan 47 No No 70 No
Sahin 48 No Yes 50 No
Salustri 49 No Yes 50 Yes
San Román 50 No No 50 Yes
Santiago 51 No No 70 No
Santoro 52 Yes No 70 Yes
Sawada 53 Yes Yes 50 Yes
Schröder 54 No No 50 Yes
Senior 55 No Yes 50 No
Slavich 56 No No 50 Yes
Smart 57 No Yes 50 Yes
Sochowski 58 No Yes 50 No
Sozzi 59 Yes No 70 Yes
Steinberg 60 No Yes 70 No
Takeuchi 61 No Yes 50 Yes
Takeuchi 61 No Yes 50 Yes
Takeuchi 61 No Yes 50 Yes
Vitarelli 62 Yes No 70 No
Wu 63 No Yes 50 Yes
Xie 64 No No 50 Yes
Yuda 65 Yes Yes 50 Yes
Abbreviation see Table 1.
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Table 3. Stress Echocardiographic Factors.
Author Comparison 
with
Stress 
Echo
Dobu-
tamine
Atropine
Addition
Definition of
Positive
Segments
Required
Biphasic
Response
New 
Technology
Blinded Dose Test
Afridi 6 No Yes 40 No Rest or Stress - No
Ahmad 7 Yes Yes 40 Yes Stress - -
Anthopoulos 8 No Yes 40 No Stress 1 No
Beleslin 9 No Yes 40 No Stress 1 -
Cain 10 Yes Yes 40 Yes Rest or Stress - Yes
Carstensen 11 Yes Yes 40 Yes Stress 1 No
Chiou 12 Yes Yes 40 Yes Stress 2 NA
Cohen 13 No Yes 40 No Stress - No
Dagianti 14 No Yes 40 No Stress 1 NA
Daoud 15 No - 30 No Rest or Stress 1 No
Di Bello 16 No Yes 40 Yes Stress 1 NA
Dionisopoulos 17 No Yes 40 Yes Rest or Stress 2 Yes
Elhendy 18 No Yes 40 Yes Stress 1 Yes
Elhendy19 Yes Yes 50 Yes Stress 2 No
Epstein 20 No Yes 50 No Rest or Stress 1 -
Eroglu 21 Yes Yes 40 Yes Stress 1 Yes
Fathi 22 Yes Yes 40 Yes Stress - Yes
Gunalp 23 No Yes 30 No Stress 1 No
Hennessy 24 No Yes 50 Yes Rest or Stress 2 -
Ho 25 No Yes 40 No Stress 1 No
Ho 26 No Yes 40 Yes Stress 2 No
Hoffmann 27 No Yes 40 Yes Stress - NA
Huang 28 No Yes 40 Yes Rest or Stress - Yes
Iwase 29 No Yes 40 No Stress - No
Kisacik 30 No Yes 40 Yes Stress 1 No
Lewis 31 No Yes 40 Yes Stress 1 Yes
Ling 32 No Yes 40 Yes Rest or Stress 1 -
Loimaala 33 No Yes 40 No Stress 1 -
Marcovitz 34 No Yes 30 No Rest or Stress - No
Martin 35 No Yes 40 No Stress 2 No
Marwick 36 No Yes 40 No Rest or Stress 1 No
Mathias 37 Yes Yes 40 Yes Stress 1 Yes
Mazeika 38 No Yes 20 No Stress 1 No
McNeill 39 No Yes 40 Yes Stress 1 No
Mishra 40 Yes - 40 Yes Stress 1 NA
Nagel 41 Yes Yes 40 Yes Stress 1 Yes
Nedeljkovic 42 No Yes 40 Yes Stress 1 NA
Nixdorff 43 Yes yes 40 yes Stress 2 Yes
Peteiro 44 Yes Yes 40 Yes Rest or Stress - Yes
Pingitore 45 No Yes 40 Yes Stress 1 No
Previtali 46 No Yes 40 No Stress 1 No
Rollan 47 No Yes 40 Yes Stress 1 No
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Sahin 48 No Yes 30 No Stress 1 No
Salustri 49 No Yes 40 No Stress 1 No
San Román 50 No Yes 40 Yes Stress 1 No
Santiago 51 No - 40 No Rest or Stress 1 -
Santoro 52 No Yes 40 Yes Stress - NA
Sawada 53 No Yes 30 No Stress - NA
Schröder 54 No Yes 40 Yes Stress 2 -
Senior 55 No Yes 40 No Rest or Stress - -
Slavich 56 No Yes 40 Yes Stress 1 NA
Smart 57 No Yes 40 Yes Rest or Stress 2 No
Sochowski 58 No Yes 40 No Stress - -
Sozzi 59 Yes Yes 40 Yes Stress 1 -
Steinberg 60 No Yes 40 No Stress 1 No
Takeuchi 61 No Yes 30 No Rest or Stress 1 -
Takeuchi 61 No Yes 40 No Rest or Stress 1 -
Takeuchi 61 No Yes 40 Yes Rest or Stress 1 -
Vitarelli 62 No - 50 No Stress 1 Yes
Wu 63 No Yes 40 No Stress 1 NA
Xie 64 Yes - 40 Yes Stress 1 NA
Yuda 65 No Yes 40 Yes Stress 1 NA
Abbreviation see Table 1. NA = not applicable because no patients with rest wall motion 
abnormalities were included in that studies.
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studies in which reading of the coronary angiogram was not blinded non-quantita-
tive (visual) scoring did also not significantly affect sensitivity and specificity.
Effect of technical stress echocardiographic factors (Tables 3 and 4)
Blinding of reading. Because DSE was in all but five studies blinded the effect of 
blinding could not be established reliably (no effects were seen).
Comparison with newer technologies
In the 14 studies assessing the value of newer technologies in direct comparison 
with DSE, no significant difference in diagnostic accuracy was observed, although in 
particular sensitivity tended to be lower in these studies (0.764 vs. 0.824, P <0.10)
DSE protocol
In the 17 studies in which resting wall motion abnormalities already constituted a 
positive DSE, sensitivity was higher compared to the 45 studies in which a dobu-
Table 4: Sensitivity and specificity according to different variables
Sensitivity Specificity
Variable Yes No P-value Yes No P-value
Categorical variables
History of myocardial infarction 0.834 0.740 <0.01 0.811 0.852 0.17
Rest wall motion abnormalities included 0.821 0.756 0.14 0.812 0.877 <0.10
Referral bias present 0.831 0.804 0.40 0.771 0.842 <0.01
Stenosis cut-off 50% 0.781 0.821 0.28 0.855 0.813 0.19
Blind reading of CAG 0.817 0.804 0.69 0.834 0.797 0.18
Blind reading of DSE 0.816 0.763 0.39 0.824 0.792 0.59
Quantitative scoring of CAG 0.805 0.820 0.62 0.839 0.797 0.13
Comparison with newer technologies 0.764 0.824 <0.10 0.795 0.829 0.30
Ischemia for test positivity needed 0.786 0.864 <0.01 0.838 0.789 <0.10
Use of beta-blocker 0.829 0.791 0.21 0.813 0.841 0.35
Use of atropine 0.803 0.827 0.43 0.823 0.821 0.97
Use of biphasic response 0.816 0.822 0.87 0.832 0.806 0.47
Second harmonic imaging 0.811 0.813 0.97 0.803 0.825 0.57
>1 segments for positive test required 0.840 0.806 0.38 0.800 0.827 0.45
Continuous variables R P-value R P-value
Age, year 0.004 0.20 -0.002 0.47
% Beta-Blocker -0.050 0.46 -0.075 0.27
% Wall motion abnormalities 0.254 <0.01 -0.224 <0.01
% Men 0.079 0.14 -0.025 0.57
A priori CAD probability 0.376 <0.01 -0.352 <0.01
CAG = coronary angiography; DSE = dobutamine stress echocardiography; R = regression coefficient
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tamine stress-induced wall motion abnormality (myocardial ischemia) was neces-
sary to define DSE positive (0.864 vs. 0.786, P <0.01) and specificity tended to be 
lower (0.789 vs. 0.838, P <0.10). Second harmonic imaging, beta-blocker patients’ 
exclusion, addition of atropine, use of the biphasic response and the requirement 
of only one (versus two) ischemic segment for a positive DSE did not increase DSE 
sensitivity. When only the 45 studies that required myocardial ischemia for a posi-
tive DSE were included, atropine did also not increase sensitivity.
Multivariable analysis
In multivariable analysis, the definition of a positive test was the only independent 
factor influencing DSE sensitivity. When dobutamine stress-induced ischemia was 
necessary for a positive test, sensitivity was significantly lower (P = 0.02)
Discussion
This meta-analytical review indicates that patient characteristics, referral bias and 
technical factors (such as the definition of positive DSE) all significantly affect the 
reported sensitivity and specificity of DSE.
The inclusion of patients with prior myocardial infarction significantly increased the 
sensitivity of DSE. This may be the result of more extensive and/or severe CAD or 
the definition of positive DSE (see later). Since the diagnosis of CAD in patients with 
known prior myocardial infarction is nearly certain, the inclusion of such patients in 
investigations purporting to predict CAD seems inappropriate.
Ischemia during DSE is more likely in patients with more extensive CAD. The 
significant relation between the number of diseased vessels and the likelihood of 
dobutamine-stress induced wall motion abnormalities confirmed this. This finding 
confirms earlier reports 1 and support the use of DSE to identify patients at higher 
risk of multi-vessel CAD. The value of other CAD characteristics such as lesion se-
verity 66,67, lesion type 68,69 or the presence of collaterals 68,70 could not be assessed 
because information concerning these variables was lacking in virtually all included 
diagnostic DSE studies.
We had expected that in studies which included patients on beta-blocking medi-
cation DSE sensitivity would be lower because dobutamine effects (predominantly 
mediated by beta-receptors) are obviously limited, resulting in a lesser increase 
in rate-pressure product 71,72. Surprisingly, in these studies peak mean heart rate 
(uncorrected for age) was almost identical to studies that not included patients on 
beta-blocker (122 vs.124 beats per minute) and consequently beta-blocker use 
did not affect DSE sensitivity. This latter finding may also be explained by more 
extensive and/or severe CAD in patients on beta-blockers 73 and the use of atropine 
in most of the studies including patients on beta-blockers 72. However, in studies 
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in which atropine was not used, inclusion of patients on continued beta-blocker 
medication also did not result in a markedly lower peak mean heart rate (108 vs.110 
beats per minute) and consequently did not affect DSE sensitivity.
Unlike exercise electrocardiography 3 and exercise thallium scintigraphy 4, fe-
male gender did not affect DSE sensitivity or specificity. This finding is consistent 
with other publications focusing on the role of DSE in women 74.
Referral bias
Referral bias is present when angiography is guided by results of the stress test 
under investigation. Because patients are predominantly send for coronary angio-
graphy with positive DSE this may increase sensitivity and decrease specificity of 
DSE. Unfortunately, regardless of study design it is almost impossible to complete-
ly avoid referral bias. Clearly, diagnostic DSE studies based on patients who are 
retrospectively selected because they underwent coronary angiography and DSE 
within a certain time frame (usually 6-12 weeks) will suffer severely from referral 
bias. However, prospective studies based on patients recruited from a coronary an-
giography waiting list are also not free from referral bias. These patients are usually 
listed because of some other positive stress test and thus are more likely to have 
a positive DSE. Finally, chest pain patients prospectively scheduled for coronary 
angiography and DSE usually represent those with more serious complaints (typical 
angina rather than non-anginal chest pain) and are therefore not truly representative 
for the whole spectrum of patients encountered at the outpatient clinic. Neverthe-
less these limitations, those studies that attempted to avoid referral bias by not 
allowing the results of DSE to affect the decision to perform coronary angiogram 
had significantly higher specificities than studies that did not. Therefore, specificity 
in normal control patients will be somewhat higher than that obtained in most DSE 
studies.
Publication factors
We expected that technical advances would make sensitivity and specificity in-
crease with time. However, we found no significant increase in test sensitivity be-
tween 1991 and 2006. Also, specificity was unaffected by time although this may 
be caused by the influence of referral bias in more recently published studies.
Stress echocardiographic technical factors
In studies in which rest wall motion abnormalities defined DSE already positive sen-
sitivity was significantly higher. The criterion for a positive DSE was in fact the only 
independent factor related to sensitivity. As mentioned before, since the diagnosis 
of CAD in patients with rest wall motion abnormalities is nearly certain, the inclusion 
of such patients in investigations purporting to predict CAD seems inappropriate.
Previous studies have shown that addition of atropine to dobutamine by increas-
ing heart rate significantly increased DSE sensitivity without a loss in specificity 
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32,39,45. In our analysis, despite a very significant higher peak mean heart rate (131 
vs. 109 beats per minute), the addition of atropine did not affect DSE sensitivity. 
Also, use of the biphasic response did not affect test sensitivity. Previous studies 
have shown that in patients with rest wall motion abnormalities use of the biphasic 
response significantly increased DSE sensitivity 75,76. With respect to the biphasic 
response one problem is to determine exactly in which studies it was used. In 
one third of all studies it was unclear whether or not the biphasic response was 
used (Table 3). We assumed that the biphasic response was only used when it 
was clearly reported or could clearly be deducted. The validity of our conclusion 
that the biphasic response did not affect test sensitivity rests on this assumption. 
Another problem is that in some studies none of the patients had rest wall motion 
abnormalities and that in some studies including patients with rest wall motion ab-
normalities these latter already constituted a positive DSE. However, exclusion of 
these latter studies did not change our analysis.
Also, defining DSE positive in case of dobutamine stress-induced wall motion 
abnormality in one rather than two segments did not increase sensitivity of DSE. 
A previous study has shown that in particular in patients with prior myocardial in-
farction the use of at least two segments reduces sensitivity without a significant 
improvement in specificity 77. Our results may be different by our assumption that 
studies in which the description was unclear, the usual definition of the requirement 
of only one segment for a positive test was used.
Sensitivity and specificity of DSE tended to be lower when the test was directly 
compared in the same patients with newer technologies. It is an intriguing find-
ing that for many stress modalities (i.e. stress radionuclide angiography) initially 
excellent results are reported, whereas in comparisons with newer tests results 
of the previously considered state-of-the-art test are not comparable to the initial 
reported results.
Other technical factors
When the result of one test influences the interpretation of another, a higher concor-
dance between the two is expected. Since DSE reading was not blinded in only five 
studies we could not reliably assess the effect of non-blinding DSE. With respect 
to blinding of the coronary angiogram one problem is to determine exactly in which 
studies authors were blinded. Since the authors never reported the non-blinding of 
test analysis, we therefore assumed that studies used blinded analysis only when it 
was reported as such. In contradiction to reports on exercise thallium scintigraphy 
4, blind reading of the coronary angiogram did not affect DSE sensitivity. Again, the 
validity of our conclusion that blinding does not affect DSE sensitivity significantly 
rests on this assumption.
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Clinical and research applications
Clinicians should be aware of the expected diagnostic sensitivity and specificity of 
DSE. A large amount of data on this topic is available in the medical literature. How-
ever, one should always question whether these diagnostic accuracies obtained in 
top centers by experts in the field can be applied to your own clinical laboratory. 
Moreover, clinical characteristics of the patients studied, referral bias and several 
technical factors may all cause differences in diagnostic accuracies in real life. Our 
results indicate that the reported sensitivity of DSE is higher and the specificity 
lower than that expected in clinical practice because of the inappropriate inclu-
sion of patients with prior myocardial infarction, definition of positive DSE and the 
presence of referral bias, although only the definition of positive DSE independently 
influenced diagnostic sensitivity.
As stated many years ago by Detrano et al. 4 and later by us 78, investigators in 
the field of diagnostic testing should more conform to methodological standards in 
conducting research and reporting their results 4,79-81. Inappropriate patients such 
as those with prior myocardial infarction should be excluded or treated separately. 
Study groups should be explicitly defined; with careful description of patients char-
acteristics and patients should not be excluded because they are expected to give 
false-positive or false-negative results. All tests (DSE and coronary angiography) 
should be analyzed blindly, and referral bias should be avoided. Reviewers should 
use these standards in their criticisms and publication decisions. No report should 
be refused solely because the results are negative or disappointing since this prac-
tice has probably inflated the diagnostic accuracy of many tests.
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Abstract
Two-dimensional stress echocardiography is a non-invasive imaging stress modal-
ity with a continuously evolving spectrum of indications. Although the diagnostic 
and prognostic roles of stress echocardiography are well established, it is widely 
known that stress echocardiography suffers from a number of limitations. Real-time 
three-dimensional echocardiography has been advocated to solve some of these 
problems. The aim of the present state-of-the-art paper is to discuss the benefits 
and current limitations of this new stress methodology.
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Two-dimensional (2D) stress echocardiography is a non-invasive stress modality 
with a continuously evolving spectrum of indications. One of the most important 
indications is the identification of patients with coronary artery disease (CAD)1. For 
this purpose, wall motion of left ventricular (LV) segments is compared between 
rest, low-dose, and peak stress on several standardized LV views. The rationale for 
the use of stress echocardiography is that cardiovascular stress will in the pres-
ence of significant CAD result in myocardial ischemia, manifested as a regional 
wall motion abnormality. Although the diagnostic and prognostic roles of 2D stress 
echocardiography are well established1,2, it is widely known that stress echocar-
diography suffers from a number of limitations. Suboptimal diagnostic accuracy 
may be caused by inadequate image quality, comparisons of non-identical LV wall 
segments at rest, low-dose, and peak stress, and smaller ischemic areas that may 
be missed in the limited available LV cross sections. Also, interpretation of 2D 
stress echocardiography is subjective with different existing definitions of abnor-
mality and considerable inter-observer and inter-institutional diagnostic variability3. 
Stress real-time three-dimensional echocardiography (RT3DE) may be one of the 
ways to shorten acquisition times and/or to improve the suboptimal diagnostic ac-
curacy of stress echocardiography.
Acquisition and analysis of 3D images
From one single apical window the full LV volume data set can be acquired. This 
process may be facilitated by use of two displayed reference 2D images, such 
as an apical four-chamber and an orthogonal view. Full LV volume is acquired by 
scanning 4 to 7 subvolumes during consecutive, electrocardiographically triggered 
beats (Philips iE33, GE Healthcare Vivid 7 Dimension) or 4 subvolumes during 7 
(Philips Sonos) consecutive, electrocardiographically triggered, heartbeats. These 
LV subvolumes are automatically integrated by the system into one pyramidal data 
set of ~80° x 80°, incorporating full LV volume (Figure 1). All desired LV anatomi-
cal images can be cropped out of the pyramidal volumetric data set after which 
regional LV wall motion can be assessed. Analysis of LV wall segments can be 
done according to the 17-segment model recommended by the American Soci-
ety of Echocardiography4, but with 3D more detailed models (incorporating for ex-
ample short axis views) can also be designed. For off-line analysis, the TomTec 4D 
Echo-View system (TomTec GmbH, Unterschleissheim, Germany), the Qlab system 
(Philips Medical Systems, Andover, Massachussets, USA), or the EchoPAC Dimen-
sion Workstation (GE Healthcare, Milwaukee, USA) can be used.
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Benefits of RT3DE imaging
The introduction of new generation RT3DE systems has improved 3D data acquisi-
tion and LV volume analysis to a great extent. Importantly, compared to other 3D 
imaging modalities such as magnetic resonance imaging or computed tomography, 
 
 
 
 
Figure 
11.2 
Figure 
11.3 
Figure 2:
Overview of wall motion 
produced automatically 
from a 3D dataset at 
rest showing apical 
4-chamber view 
(AP4CH, left, top), 
apical 2-chamber 
(AP2CH, right, top), 
cross-sectional short-
axis (left, bottom) and 
reconstructed 3D image 
(right, bottom).
 
 
 
 
Figure 
11.1 
Figure 1:
During 3D data acquisition 
four 20° x 80° sectors are 
scanned during four consecutive 
heartbeats that are integrated 
automatically into a 80° x 80° 
pyramid.
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RT3DE is easy to learn and a less time consuming imaging modality. As pointed 
out on earlier, RT3DE has excellent correlation with cardiac magnetic resonance 
imaging for evaluation of LV volume, mass and ejection fraction with comparable 
reproducibility5-7.
With stress RT3DE, at each stress level only one 3D data acquisition from one 
window is needed instead of multiple 2D data acquisitions from multiple windows. 
This makes a 3D examination faster than conventional 2D stress imaging. This al-
lows for faster acquisition protocols and/or repeated acquisitions to optimize im-
age quality (although this will obviously eliminate the recording speed advantage to 
some extent). Fast image acquisition is very beneficial since stress-induced myo-
cardial ischemia may resolve quickly and the time between peak stress and image 
acquisition influences test sensitivity8. From the acquired 3D volumetric data sets, 
matching views at baseline and at different levels of stress can be selected for a 
precise comparison of identical segments. Importantly, foreshortened acquired LV 
walls can be corrected by rotating the 3D data set. RT3DE allows analysis of simi-
lar segments in more detail from different planes simply by cropping and rotating 
the 3D volumetric data set helping the identification of small ischemic LV regions9 
(Figures 2 and 3). Some investigators have suggested that stress RT3DE identi-
fies more readily wall motion abnormalities in the apical region compared to 2D 
imaging due to non-foreshortened acquisition and analysis resulting in a trend to-
wards better diagnosing myocardial ischemia in the left anterior descending coro-
nary territory9,10. However, this potential benefit becomes only reality after off-line 
adjustments. In this respect it should also be noticed that modern 2D machines, 
but not the RT3DE systems, allow direct comparisons on-line of the 2D images at 
the different stress levels. Thereby, ischemia may be detected (although potentially 
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Figure 3:
Comparison of left ventricular short axis images at the papillary muscle level in a patient who 
underwent stress magnetic resonance imaging (MRI) and stress real-time three-dimensional 
echocardiography (RT3DE). Observe the great similarity in images between RT3DE and MRI.
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inferior) more convenient during 2D stress echocardiography, which could have 
implications for test safety.
In addition, changes in LV volumes during stress have been shown to be helpful 
for the diagnosis of CAD and estimation of prognosis in stress 2D echocardiogra-
phy11. RT3DE also allows a more accurate measurement of LV volumes compared 
to 2D echocardiography12. Another advantage of RT3DE can be that after the iden-
tification of some anatomical landmarks, RT3DE allows automatic calculation of 
regional volumes that can be another indicator for a wall motion abnormality (Figure 
4). Finally, RT3DE allows anyplane evaluation of the LV helping to create short-axis 
views at different LV levels that may be easier to understand by other (non-cardiol-
ogists) physicians.
Current limitations of RT3DE imaging
Notwithstanding its great opportunities, at this moment stress RT3DE has a number 
of technical limitations. In this section, we report on the most important limitations 
that others and us encountered.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 
11.4 
Figure 
11.5 
Figure 4:
Real-time three-dimensional echocardiography allows the analysis of regional (segmental) wall 
motion and calculation of volume/time curve of the left ventricle based on semi-automated contour 
tracings. The volume/time curves of each colour-coded segment in the bull`s eye view (right bottom) 
are represented in the volume/time curve (bottom)
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Spatial volume and spatio-temporal resolution
The primary restriction for RT3DE is the limited spatial volume coverage, or actually 
the trade-off between spatial volume, spatial resolution and temporal resolution 
(3D frame rate). In analogy to 2D echo, there is a trade-off between frame rate, 
image depth and number of beams. This limitation is directly related to a physical 
constant: the speed of sound in human tissue (~1450 m/s). It takes 0.14 msecs to 
transmit an ultrasound pulse and receive its echoes from a depth of 10 cm. There-
fore, only approximately 7500 beams can be acquired per second. With specialized 
beam forming, multiple beams can be acquired simultaneously, but this goes at the 
cost of additional artefacts and is bound to practical limits13. For practical use in 
echocardiography, the temporal and spatial resolution should satisfy certain mini-
mum requirements. This means that the 3D volume imaged within a time frame is 
limited. This is the volume we see in the ‘live 3D’ mode, which is the true real-time 
3D mode of the system.
In real practice, to cover the whole LV, four complete heartbeats containing four 
LV subvolumes have to be recorded. These four LV subvolumes are stitched togeth-
er to form the total pyramidal LV volume (Figure 1). Of note, 3D image acquisition 
with the older Philips Sonos 7500 system takes seven heart cycles to complete, 
because some processing is required before the next beat can be acquired. Slice 
stitching may give rise to discontinuities at the slice edges (Figure 5). 3D image 
slice discontinuities may be aggravated by transducer or patient motion (prominent 
breathing motion at peak stress), variations in heart rate (during stress the latest 
recorded beat may be shorter in duration), arrhythmias and imperfect electrocar-
diographic triggering. Unfortunately, irregular heart rhythms (extra-systolic beats, 
atrial fibrillation) are not seldom encountered during dobutamine stress1.
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Figure 
11.5 
Figure 5:
Slice stitching may give rise to 
discontinuities at the slice edges.
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Poor anterior wall visualization
Visualization of the LV anterior wall can sometimes be difficult even during 2D 
echocardiography. Unfortunately, the anterior wall is inadequately visualized in a 
considerable number of our stress 3D examinations14, although others have re-
ported better results for imaging of the anterior wall10,15, probably related to patient 
selection16. In addition, acquisition of a full-volume dataset in patients with severely 
dilated ventricles can be problematic. As shown in Figure 6, in particular visualiza-
tion problems of the LV anterior wall may be related to the relatively large footprint 
of the RT3DE transducers, in particular the older Philips X4 matrix transducer, com-
pared to a standard transducer (24 x 20 vs. 24 x 15 mm), leading to rib shadowing. 
One could try to make an additional recording from a parasternal window to cover 
the basal and mid anterior wall (distal segments will usually not be visible from 
this window) with even a somewhat higher frame rate (due to less depth), but this 
would eliminate the advantageous short recording time of RT3DE17,18. In addition, 
parasternal-acquired myocardial segments will suffer at some extent from right 
ventricular contrast shielding. Better results may be expected with newer, smaller 
adult transducers such as the Philips X3-1 transducer that has a size comparable 
to a standard transducer or (currently only available in paediatrics) single crystal 
transducers (Philips X7-2 with PureWave crystal technology) with improved electro-
mechanical properties (transducer bandwidth and sensitivity).
Quad-screen display
A practical obstacle for the use of stress RT3DE is the lacking possibility of TomTec 
and Qlab software to display the different stress stages simultaneously in a quad-
screen display. Recently, we developed a simple extension program (Stress4Qlab) 
that allows simultaneous, synchronized viewing of multiple 3D datasets. Informa-
tion on this program is available upon request. It is to be expected that built-in sup-
port for 3D stress echo will be available soon.
Figure 6:
Size of the different Philips transducers, from left to right: 3D-X3-1 (24 x 15 mm), 3D-X4 (24 x 20 mm) 
and 2D-S3 (24 x 15 mm).
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Contrast imaging
It has been demonstrated that echo contrast improves endocardial border visu-
alization during stress 2D echocardiography19. Because of the earlier described 
more problematic spatial resolution of 3D images contrast may be an essential 
part of stress RT3DE18,20 (Figure 7). However, with contrast LV opacification, stitch-
ing artefacts (visible sharp transitions at the slice edges) may become aggravated 
and some additional artefacts may appear21. In particular, during the seven-beat 
acquisition period used in the older Philips Sonos system contrast opacification of 
the LV may decay significantly because of microbubble insonification. This prob-
lem may be less when the contrast agent is continuously infused rather than given 
as repeated boluses or when the acquisition period is shortened to four beats, 
as is possible with the newer Philips iE33 system. Furthermore, the differentiation 
between contrast and tissue is not as good as in standard 2D harmonic imaging, 
because the matrix transducer has a limited relative bandwidth, and is therefore 
less suitable for harmonic imaging.
A minor additional problem with the is the brighter appearance of the first frame 
of a beat compared to the next frames. This is attributable to the fact that there is 
no acquisition at the second, fourth and sixth heartbeat, so the first frame of each 
beat is acquired after a period without insonification. In later frames some contrast 
will be progressively destroyed by the ultrasound pulse and contrast brightness will 
be lower.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 
11.6 
Figure 
11.7 
Figure 7:
Improvement of endocardial delineation by the use of contrast agent (compare unenhanced (left 
side) and contrast-enhanced (right side) left ventricular long-axis planes).
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Clinical 3D stress echocardiography studies
Three-dimensional echocardiography has been available for several years using 
time-consuming reconstruction techniques. However, recent advances in transduc-
er technology and front-end data processing have brought real-time 3D echocar-
diography (RT3DE) into clinical practice. In several studies, resting RT3DE was as 
accurate as magnetic resonance imaging (MRI) in the evaluation of LV morphology 
and function5-7, 22.
At this moment, only a few centers have reported data on the clinical value of 
stress RT3DE (see Table 1). Several general conclusions can be drawn from these 
reports. The percentage of LV segments visible at peak stress ranges in studies 
from approximately 75% to 90% 9, 17, 18, 20. Apart from improvements in transducer 
technology there are two major ways to improve this number. Inclusion of paraster-
Table 1. Real-Time Three-Dimensional Stress Echocardiographic Studies.
Authors Stress RT3DE system Windows
Segments 
visible
at peak stress
(conventional 
imaging)
Segments 
visible
at peak stress
(contrast 
imaging)
Sensitivity 
in detecting 
ischemia  
(3D vs. 2D)
Zwas (17) Treadmill VMI / 2.5 MHz AP + PS 89% (98%*) - -
Ahmad (24) Dob. VMI / 2.5 MHz AP + PS - - 78% vs. 59%#
Matsumura (9) Dob.
Sonos 7500 / 
2-4 MHz
AP 89% - 75% vs. 75%$
Takeuchi (15) Dob.
Sonos 7500 / 
2-4 MHz
AP - 97% -
Pulerwitz (20) Dob.
Sonos 7500 / 
2-4 MHz
AP 75% (87%@) 97% (99%@) -
Nemes (14) Dob.
Sonos 7500 / 
2-4 MHz
AP 76% 90% -
Nemes (25) Dob.
Sonos 7500 / 
2-4 MHz
AP + PS - 91% (96%*) -
Krenning Dob.
Sonos 7500 / 
2-4 MHz or iE33 
/ 1-3 MHz
AP 78% 90% 61% vs. NA
Agelli (10) Dob. iE33 / 1-3 MHz AP - - 84% vs. 72%#
Yang (26) Dob.
Sonos 7500 / 
2-4 MHz or iE33 
/ 1-3 MHz
AP - 100%& -
* including parasternal view analysis. AP = apical. Dop = dobutamine. PS = parasternal. VMI = 
Volumetrics Medical Imaging. Gold standard = # coronary angiography, $ Tl-201 reversible defects, 
@ including short-axes analysis. & Contrast given in patients with >1 segment not adequately 
visualised.
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nal-acquired images into the data set will increase the percentage of visible LV 
segments by approximately 5 to 10%, but at the cost of the advantageous fast re-
cording time of RT3DE17, 20. On the other hand it has been shown by several authors 
that contrast-enhancement can increase the visibility of LV segments with at least 
a similar value, at the cost of a lower frame rate and some artifacts18, 20. Despite 
these limitations, contrast-enhancement has been shown to improve interobserver 
agreement for myocardial ischemia18, and may therefore improve the diagnostic 
accuracy of stress RT3DE.
It has been shown that stress RT3DE requires significant shorter acquisition 
times compared to stress 2D imaging9, 10, 23. In these head-to-head comparative 
studies between stress 2D and 3D, equal9 or at least equal10,23, diagnostic sensitivi-
ties for stress RT3DE were reported, mainly due to the aforementioned more readily 
interpretation of wall motion abnormalities in the apical region with RT3DE imaging 
due to non-foreshortened acquisition and analysis.
Conclusions and future developments
Although stress RT3DE may be well clinical feasible according to some studies9, 17, 
20, 23, in our opinion this imaging modality is currently still hampered by some major 
technical limitations. However, most of these limitations may be handled with or 
may be overcome in the near future. Analysis software will be adapted to support 
stress RT3DE with proper choice of corresponding viewing planes in rest, low-dose 
and stress with simultaneous synchronized viewing. In addition, future transduc-
ers will have larger bandwidth and thus will be more suitable for harmonic imaging 
and contrast and the transducer footprint size will be further reduced. The X3-1 
transducer on the new iE33 system already has a much smaller footprint that may 
circumvent rib shadowing.
Multibeat frame composition and limited spatial resolution actually form the ma-
jor technical limitations18. To overcome this, more ultrasound beams have to be 
processed in parallel. This requires technological innovation, but it will ultimately 
Table 2. Benefits of RT3DE compared to 2D echocardiography
2D echocardiography RT3DE
Wall motion + ++
Contrast ++ +
Volumes + ++
Regional volumes - +
+ means clinically available, - means clinically not available
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result in true RT3DE LV visualization. This will seriously extend the possibilities and 
clinical value of RT3DE, not just for stress RT3DE.
Ultimately, the inherent advantages of stress RT3DE will eliminate some of the 
current limitations of stress 2D echocardiography, and may result in an improved 
diagnostic technique (Table 2). Moreover, with the development of more advanced 
automated border detection software, we can also expect a decrease in inter-ob-
server variability associated with the visual scoring of segmental wall motion. Also 
the learning curve to interpret wall motion analysis may become easier because of 
the 3D nature of the images. If 3D image quality can be brought to a comparable 
level as 2D image quality, stress RT3DE may be more suitable for such automated 
analysis than stress 2D echo because 3D images offer higher information content 
with complete LV visualization. Provided that all these technical improvements will 
occur stress RT3DE may become an important diagnostic test of the future.
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Two-dimensional stress echocardiography is a non-invasive diagnostic and prog-
nostic imaging modality with a wide spectrum of indications 1, 2. Although its clinical 
value is well established, it is recognized that stress echocardiography has a num-
ber of limitations. The method is highly operator dependent, as it requires multiple, 
successive acquisitions. These successive acquisitions at rest, low-dose, and peak 
stress may contain non-identical left ventricular (LV) wall segments that may limit 
optimal comparison of wall motion and diagnostic accuracy. In addition, the limited 
number of cross-sections available for interpretation may limit the identification 
of smaller ischemic areas. Real-time three-dimensional echocardiography (RT3DE) 
has the potential to eliminate these limitations (Table 1). Some critical consider-
ations, however, are appropriate. Good image quality is a prerequisite for stress 
echocardiography but the spatial resolution of RT3DE is still limited. This is likely 
to improve with the evolution of transducer and processing technology. RT3DE 
systems have a number of options for optimization of spatial resolution. Depend-
ing on the size of the LV, the sector angle can be narrowed resulting in a higher line 
density and better image resolution. The Extreme Resolution setting (Xres) is an 
image-processing technique for improved visualization of tissue patterns, but has 
a negative effect on the frame-rate and should therefore not be used for LV function 
analysis.
A high temporal resolution is as important as spatial resolution for the diagnos-
tic accuracy of stress RT3DE. In two-dimensional stress echocardiography lower 
frame rates negatively influence the identification of significant coronary artery dis-
Table 1. Benefits of real-time three-dimensional echocardiography
Rapid image acquisition
Less operator dependent
Reproducible views for analysis
Unlimited number of cross-sections
Absent left ventricular foreshortening
Table 2. Philips iE33 ultrasound system settings for real-time three-dimensional echocardiography at 
a depth of 13 cm influencing frame rate.
Contrast
enhancement
Number of
transmitted 
pulses
Second 
harmonics
Power 
modulation
 Number of 
subvolumes 
for full volume 
reconstruction
Frame-rate
Number of 
volumes per 
cardiac cycle at 
peak stress#
1 X 4 20 Hz 10
1 X 7 35 Hz 18
X 1 X 7 30 Hz 15
X 2 X X 7 14 Hz 7
X 3 X 7 9 Hz 5
# Peak stress defined as 120 beats per minute
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ease3. The number of available frames per heart cycle depends both on the frame-
rate and heart rate of the patient. When the heart rate of the patient increases, 
fewer volumes per heart cycle are available for analysis. The frame-rate is further 
affected by several machine settings (Table 2). The scanning depth should always 
be minimized to a depth that just includes the entire LV. Also, the frame-rate is af-
fected by the number of heart cycles used for full LV volume reconstruction. For 
analysis, a full LV volume is acquired by automated fusion of multiple subvolumes 
during several consecutive electrocardiographically triggered heart cycles. On the 
latest ultrasound systems, it is possible to choose 4 or 7 heart cycles for LV volume 
reconstruction. The latter has the advantage of a higher temporal resolution, but 
with a greater chance of artifacts due to motion, respiration and beat-to-beat vari-
ability.
Contrast enhancement is recommended to improve endocardial border visual-
ization in stress RT3DE 4, 5. Specific imaging functions are used to improve the de-
tection of ultrasound contrast agents, such as pulse inversion (with 2D) and power 
modulation (with RT3DE), which are integrated in preset functions. In pulse inver-
sion imaging, the frame-rate is lowered because a sequence of two ultrasound 
pulses must be transmitted instead of only a single pulse. In power modulation, a 
multi-pulse technique is used whereby the acoustic amplitude of the transmitted 
pulses is changed. Although these methods improve contrast-imaging quality, both 
functions nearly halve the frame rate. It appears that when a heart rate of 120 beats 
per minute is reached during the stress test, the number of volumes per heart cycle 
may be too low for diagnostic testing (Table 2). Therefore, only second harmonic 
imaging should be used during contrast-enhanced stress RT3DE.
In conclusion, several settings are available on current high-end ultrasound sys-
tems that have an important influence on spatial and temporal resolution, and sub-
sequently on diagnostic accuracy of stress RT3DE. Information on these settings 
is currently lacking in the published reports on stress RT3DE. Specific contrast 
imaging methods such as pulse inversion and power modulation seem unsuitable 
for stress RT3DE because of the major limitation on frame-rate. With current tech-
nology, it may therefore be too early to use RT3DE as a reliable diagnostic test as 
the temporal and spatial resolutions are too low. Future studies will have to show 
consistency in the currently available data on diagnostic accuracy6, 7. However, be-
fore any objective comparison can be made, the machine settings should always 
be available in publications in order to compare data between studies.
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Abstract
Dobutamine stress echocardiography is an accepted tool for the diagnosis of coro-
nary artery disease. Some investigators have claimed that three-dimensional imag-
ing improves the diagnostic accuracy of dobutamine stress echocardiography. The 
purpose of the present investigation was to examine the role of echo contrast in 
the improvement of segmental quality and inter-observer agreement during stress 
real-time 3D echocardiography (RT3DE). The study comprised 36 consecutive pa-
tients with stable chest pain referred for routine stress testing. The 3D images were 
acquired with a RT3DE system with X4 matrix array transducer. All available re-
constructed 2D segments were graded as optimal, good, moderate and poor. Wall 
motion was scored as normal, mild hypokinesia, severe hypokinesia, akinesia and 
dyskinesia. At peak stress, 466 of the 612 segments (76%) could be analysed during 
conventional RT3DE. With contrast-enhanced RT3DE, the number of available seg-
ments increased to 553 (90%). The image quality index during conventional RT3DE 
was 2.2, while with contrast-enhanced RT3DE 3.1. With conventional RT3DE, the 
two independent observers agreed on the diagnosis of myocardial ischaemia in 85 
of 108 coronary territories (79%, κ = 0.26). With contrast-enhanced RT3DE, it in-
creased to 95 of 108 coronary territories (88%, κ = 0.59). Study agreement on myo-
cardial ischaemia was present in 26 of 36 studies (72%, κ = 0.43) with conventional 
RT3DE, and in 32 of 36 studies (89%, κ = 0.77) with contrast-enhanced RT3DE. 
In conclusion, during stress RT3DE contrast-enhanced imaging significantly de-
creases the number of poorly visualized myocardial segments and improves inter-
observer agreement for the diagnosis of myocardial ischemia.
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Dobutamine stress echocardiography is an accepted tool for the diagnosis of coro-
nary artery disease 1. The interpretation of the echocardiographic images, however, 
is critically dependent on the quality of the recordings and the experience of the ob-
server 2. Some investigators have claimed that three-dimensional imaging improves 
the diagnostic accuracy of dobutamine stress echocardiography 3-5. However, one 
of the main limitations of three-dimensional imaging is the inherently lower image 
quality compared to two-dimensional imaging. Left ventricular (LV) opacificating 
contrast agents have been successfully applied during 2-dimensional dobutamine 
stress echocardiography to improve endocardial border delineation 6. The use of 
intravenous ultrasound contrast improves endocardial border visualization, leading 
to a more accurate interpretation of wall motion abnormalities 6. The purpose of the 
present investigation was to examine the role of echo contrast in the improvement 
of LV segmental quality and interobserver agreement during stress real-time three-
dimensional echocardiography (RT3DE).
Patients and Methods
Patient population
The study comprised 36 consecutive patients in sinus rhythm with chest pain re-
ferred for stress testing. Baseline clinical characteristics of the patients are pre-
sented in Table 1. Beta-blockers were used in 22 patients (61%). The study was 
approved by the institutional review board and all patients gave informed consent.
Table 1 Clinical and demographic characteristics (n = 36)
Variable Subjects
Age (years) 57 ± 13
Men 24 (67%)
Diabetes mellitus 9 (25%)
Hypertension * 18 (50%)
Hypercholesterolemia † 14 (39%)
Current smoker 4 (11%)
Prior acute myocardial infarction 10 (28%)
Prior coronary bypass surgery 2 (6%)
Prior coronary angioplasty 7 (19%)
* Defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg and/
or the use of antihypertensive medication.
† Defined as total serum cholesterol ≥230 mg/dl and/or serum triglycerides ≥200 mg/dl or the use of 
a lipid-lowering agent.
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Dobutamine-atropine stress protocol
Dobutamine was administered through a peripheral vein by three-minute stages of 
10, 20, 30 and 40 µg/kg/min, respectively. The infusion was stopped when 85% of 
age-predicted heart rate was reached. Otherwise, dobutamine infusion was contin-
ued and supplemented by 0.25 mg doses of atropine (to a maximal dose of 1 mg). 
The stress test was terminated when severe angina, shortness of breath, symp-
tomatic decrease in systolic blood pressure (>40 mm Hg), arterial hypertension (> 
240/120 mm Hg), severe arrhythmias or other serious adverse effects occurred.
The contrast examination
Sonovue (Bracco, Milan, Italy) was used at baseline conditions, low-dose and peak 
stress. The contrast agent was given as a bolus of 0.5 ml with additional boluses of 
0.25 ml when needed. A low mechanical index (0.3) was used. Care was taken to 
record the images at a phase when contrast flow was relatively stable with absent 
or minimal swirling of contrast in the apex.
Real-time three-dimensional dobutamine stress echocardiography
The RT3DE images were acquired from an apical window with a Sonos 7500 echo 
system (Philips Medical Systems, Best, The Netherlands) equipped with a 3D data 
acquisition software package. X4 matrix array transducer was attached to the 
echocardiograph. After visualizing the reference images (the apical four-chamber 
and orthogonal views) a full volume data set of the LV was acquired. With electro-
cardiographic gating four pyramidal subvolumes of ~20x80° were acquired during 
the first, third, fifth, and seventh cardiac cycle. These four conical subvolumes were 
automatically integrated into a pyramidal data set of ~80x80° incorporating full LV 
volume. Regional LV wall motion was evaluated using cropped planes representa-
tive of the 4-chamber, 2-chamber, and 3-chamber view.
Off-line data analysis
The digitally stored RT3DE data set was analysed off-line with assistance of 4D 
TomTec Echo-View 5.3 software (TomTec Inc., Unterschleissheim, Germany). The 
RT3DE data set was judged on the basis of the absence of artefacts throughout 
the cardiac cycle. All at peak stress available reconstructed segments were graded 
as optimal (excellent quality without possibility to improve - 4), good (good quality 
without artefacts - 3), moderate (sufficient quality without artefacts or good qual-
ity with artefact - 2) or poor (poor or moderate quality with artefacts - 1). An image 
quality index was calculated for each segment by summation of all scores in that 
particular segment divided by the number of analysed segments. Wall motion was 
assessed using the standard 17-segment LV model of the 3 reconstructed apical 
views by two independent observers who were blinded to the patient’s clinical data 
7. Wall motion was scored as normal, mild hypokinesia, severe hypokinesia, akine-
sia and dyskinesia. A test was considered positive in case of new or worsening wall 
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motion abnormalities at any stage during stress. Segmental wall motion abnormali-
ties were assigned to coronary artery territories as described before 1.
Statistical analysis
All values were expressed as a mean ± SD. The Student t test was used to compare 
the difference between tests. The kappa (κ) coefficient was calculated to deter-
mine interobserver agreement. A kappa value <0.4 was considered poor, 0.4 to 0.7 
moderate, and >0.7 good. Data were analyzed using standard statistical software 
(SPSS, version 12.0, Chicago, Illinois).
Results
Dobutamine stress data
Heart rate increased from 71 ± 13 to 124 ± 23 bpm and systolic blood pressure 
from 128 ± 21 to 140 ± 29 mm Hg. No significant side effects were encountered 
during the dobutamine stress contrast study.
Myocardial segmental visibility
At peak stress, 466 of the 612 segments (76%) could be analysed during conven-
tional stress RT3DE. With contrast-enhanced stress RT3DE, the number of avail-
able LV segments increased to 553 (90%). Non-visualized LV segment distribution 
during conventional and contrast-enhanced stress RT3DE is depicted in Figure 1.
-studies (agreement 72%, κ = 0.43) with conventional stress RT3DE, and in 32 of 36 
studies (agreement 89%, κ = 0.77) with contrast-enhanced stress RT3DE.
Myocardial segment image quality
The image quality index of the 466 analysable segments during conventional stress 
RT3DE was 2.2. With contrast-enhanced stress RT3DE the image quality index in 
the 553 analysable segments was 3.1. The quality index distribution of the visual-
ized segments during conventional and contrast-enhanced stress RT3DE is de-
picted in Figure 2.
Interobserver agreement for ischaemia
As seen in Figure 3, with conventional stress RT3DE the two observers agreed on 
the diagnosis of myocardial ischaemia in 85 of 108 coronary territories (agreement 
79%, κ = 0.26). With contrast-enhanced stress RT3DE, the two observers agreed 
on the diagnosis of myocardial ischaemia, in 95 of 108 coronary territories (agree-
ment 88%, κ = 0.59). Study agreement on myocardial ischaemia was present in 26 
of 36 studies (agreement 72%, κ = 0.43) with conventional stress RT3DE, and in 32 
of 36 studies (agreement 89%, κ = 0.77) with contrast-enhanced stress RT3DE.
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Discussion
The major findings in this study are: [1] a relatively high number of myocardial seg-
ments are poorly visualized with conventional stress RT3DE, [2] contrast-enhanced 
imaging significantly decreases the number of poorly visualized myocardial seg-
ments and [3] contrast-enhanced imaging improves interobserver agreement for 
diagnosis of myocardial ischemia.
 
Figure 13.1&2 
 
 
 
Figure 2:
Left ventricular 17-segments 
model showing the segmental 
quality index in the visualized 
segments during peak stress 
with conventional (top) and 
contrast-enhanced (bottom) at 
peak stress three-dimensional 
echocardiography.
 
Figure 13.1&2 
 
 
 
Figure 1:
Left ventricular 17-segments model 
showing the percentage of non-
visualized segments during peak stress 
with conventional (top) and contrast-
enhanced (bottom) three-dimensional 
echocardiography.
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Two-dimensional dobutamine stress echocardiography is based on the detec-
tion of stress-induced wall motion abnormalities and is an important clinical tool for 
the detection of coronary artery disease 1. For the detection of wall motion abnor-
malities endocardial border visualization is essential. However, an important num-
ber of patients have suboptimal echo windows 6. Second harmonic imaging 8,9 and 
contrast echocardiography 6,10 are known to enhance LV endocardial visualization 
during 2-dimensional dobutamine stress echocardiography. Because of the trade 
off between frame rate, image depth and number of beams, RT3DE image quality is 
inherently lower compared to two-dimensional imaging. Therefore, contrast imag-
ing may be expected to play a major role in improvement of RT3DE image quality.
Table 2. Segments visible at peak stress with apical real-time three-dimensional stress 
echocardiography.
Authors Patients Stress RT3DE system
Segments visible
 with conventional
imaging
Segments visible
with contrast
imaging
Zwas et al. 5 20 Treadmill Volumetrics MI 89% - 98%* NA
Ahmad et al. 4 253 Dobutamine Volumetrics MI 92%* NA
Matsumura et 
al. 3
56 Dobutamine
Sonos 7500 / X4 
probe
89% NA
Takeuchi et al. 12 78 Dobutamine
Sonos 7500 / X4 
probe
NA 97%
Pulerwitz et al. 11 14 Dobutamine
Sonos 7500 / X4 
probe
75% - 87%# 97% - 99%#
Present study 36 Dobutamine
Sonos 7500 / X4 
probe
76% 90%
* Segment visible when also the parasternal window was used. MI = Medical Imaging. NA = not 
available. # short axis views were used
Figure 3:
Interobserver agreement with 
conventional (left) and contrast-
enhanced (right) three-dimensional stress 
echocardiography for the diagnosis of 
myocardial ischemia for all coronary 
territories (top) and the overall study 
result (bottom).
 
 
Fig 13.3 
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In our non-selected patients 24% of LV wall segments could not be visualized at 
conventional peak stress RT3DE. In particular, anterior wall segments were poorly 
visualized. Obviously, this is an important limitation for conventional stress RT3DE 
because this wall is crucial for the diagnosis of left anterior descending disease. 
Apart from an inherently lower quality of three-dimensional imaging, the large X4 
transducer footprint (24x20 mm) may be responsible for this limitation. As seen in 
Table 2, our results of conventional RT3DE imaging look unfavourable compared 
to other published studies 3-5,11,12. It should, however, be noticed that we studied 
non-selected patients whereas in other studies patients with poor two-dimensional 
image quality were excluded from analysis 4,11.
Contrast stress RT3DE substantially decreased the number of non-visualized LV 
segments and the quality of the visible LV segments was markedly higher. These 
results confirm the value of contrast use for stress RT3DE recently published by 
Pulerwitz et al. in a very small group of 14 patients 11. Importantly, our study is the 
first in which it is shown that the improved visibility of segments at peak RT3DE 
stress improves interobserver agreement for the diagnosis of myocardial isch-
emia in coronary territories with κ-values that improved from poor to moderate 
and for the overall diagnosis of myocardial ischemia with κ-values that improved 
from moderate to good. Notwithstanding our promising results on contrast stress 
RT3DE new, better transducer technology seems necessary to bring stress RT3DE 
into clinical practice.
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Abstract
Real-time three-dimensional echocardiography (RT3DE) allows quick volumetric 
scanning of the left ventricle (LV). We evaluated the diagnostic accuracy of contrast-
enhanced stress RT3DE for the detection of CAD in comparison with coronary arte-
riography as the reference technique. Forty-five consecutive patients (age 59 ± 10, 
31 males) referred for coronary angiography were examined by contrast-enhanced 
RT3DE. Wall motion analysis was performed off-line by dedicated software. New or 
worsening wall motion abnormalities were detected in 17 of 28 patients with signifi-
cant CAD (sensitivity 61%), and in 2 of 17 patients without significant CAD (specific-
ity 88%). The sensitivity for detection of single vessel CAD was 8/15 patients (53%), 
for two-vessel CAD 4/6 (67%) and for three-vessel CAD 5/7 (71%). In 35 patients, 
comparison with conventional RT3DE was available. The image quality index at rest 
improved from 2.5 ± 1.2 to 3.2 ± 1.0 (P<0.001) with contrast and at peak stress 
from 2.3 ± 1.2 to 3.1 ± 1.0 (P<0.001). Interobserver agreement on the diagnosis 
of myocardial ischemia improved from 26 of 35 studies (74%, κ = 0.44) with con-
ventional stress RT3DE to 30 of 35 studies (86%, κ = 0.69) with contrast-enhanced 
stress RT3DE. Sensitivity increased from 50% to 55% and specificity from 69% to 
85% with contrast-enhanced stress RT3DE in these patients. In conclusion, despite 
some important practical and theoretical benefits, contrast-enhanced stress RT3DE 
currently has only moderate diagnostic sensitivity due to several technical limita-
tions as temporal and spatial resolution.
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Introduction
Dobutamine stress echocardiography (DSE) is a well-established method for the 
diagnosis of coronary artery disease (CAD)1. Although standard two-dimensional 
echocardiography (2DE) has acceptable temporal and spatial resolution for assess-
ment of wall motion abnormalities, the technique is limited by the necessity of 
sequentially acquiring 2DE images from multiple precordial windows for analysis. 
This is overcome by real-time three-dimensional echocardiography (RT3DE), by ob-
taining quick volumetric datasets of the left ventricle (LV)2. Previously, we showed 
that the use of ultrasound contrast agent during stress RT3DE improves LV cavity 
border delineation and thus decreases interobserver variability for identifying wall 
motion abnormalities3. The aim of this study was to evaluate the diagnostic accu-
racy of contrast-enhanced stress RT3DE for the detection of CAD in comparison 
with the results of coronary arteriography as the reference method.
Methods
Study patients
We studied 45 consecutive patients in sinus rhythm with suspected CAD referred 
for diagnostic coronary arteriography. No selection based on image quality was 
made. Baseline clinical characteristics of the patients are listed in Table 1. Beta-
blockers were used in 27 patients (60%). The institutional review board approved 
the study and all patients gave informed consent.
Dobutamine–atropine stress protocol
Dobutamine was administered through a peripheral vein in 3-minute stages of 10, 
20, 30, and 40 µg/kg/min. The infusion was aborted when 85% of age-predicted 
heart rate was reached. Otherwise, dobutamine infusion was continued and sup-
plemented by 0.25-mg doses of atropine (to a maximal dose of 1 mg). The infusion 
was stopped when severe angina, shortness of breath, a symptomatic decrease 
in systolic blood pressure (>40 mm Hg), arterial hypertension (>240/120 mmHg), 
severe arrhythmias, or other serious adverse effects occurred 1. 
Table 2. Myocardial image quality at rest and peak stress with and without contrast enhancement.
Rest Peak stress
Contrast - Contrast + Contrast - Contrast +
Number of invisible segments 63 (11%) 55 (9%) 123 (21%) 60 (10%)
Overall visibility index 2.5 ± 1.2 3.2 ± 1.0 2.3 ± 1.2 3.1 ± 1.0
Apical segments 2.7 ± 1.2 3.2 ± 0.9 2.5 ± 1.1 3.2 ±0.9
Mid ventricular segments 2.5 ± 1.2 3.2 ± 1.0 2.3 ± 1.2 3.1 ± 1.0
Basal segments 2.3 ± 1.2 3.1 ± 1.0 2.1 ± 1.2 3.0 ± 1.1
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Contrast examination
SonoVue (Bracco Imaging, Milan, Italy) was used at baseline conditions, low dose, 
and peak stress as a bolus of 0.5 ml with additional boluses of 0.25 ml when need-
ed4. A low mechanical index (0.3) was used. Care was taken to record the images 
at a phase when contrast flow was relatively stable, with absent or minimal swirling 
of contrast in the apex.
Dobutamine stress RT3DE
The RT3DE images were acquired from an apical window with a Sonos 7500 
echocardiographic system (Philips Medical Systems, Best, The Netherlands) with 
a X4 matrix-array transducer (n = 36) or iE33 system with a X3-1 transducer (n = 
9), using second harmonic imaging. After visualizing the reference images (in the 
apical 4-chamber and orthogonal views), a full-volume data set of the LV was ac-
quired. With electrocardiographic gating, 4 (using the X4-transducer) or 7 pyramidal 
subvolumes (using the X3-1 transducer) were acquired which were automatically 
integrated into a pyramidal data set of 80° x 80° incorporating full LV volume.  
Off-line data analysis
The RT3DE datasets were analyzed off-line with the assistance of 4D TomTec Echo-
view 5.3 software (TomTec Inc., Unterschleissheim, Germany). Two-dimensional 
long-axis and short-axis cross-sections were reconstructed for analysis. These im-
ages were judged on the basis of the absence of artifacts throughout the cardiac 
cycle. All at peak stress available reconstructed segments were graded as optimal 
(4 = excellent quality without possibility to improve), good (3 = good quality with-
out artifacts), moderate (2 = sufficient quality without artifacts or good quality with 
artifacts), or poor (1 = poor or moderate quality with artifacts). An image quality 
index was calculated by the summation of all scores of each analyzed segment 
divided by the number of analyzed segments. Wall motion was assessed using the 
standard 17-segment LV model of the 3 reconstructed apical views by 2 indepen-
dent observers who were blinded to the patients’ clinical data5. Wall motion was 
scored as normal, mild hypokinesia, severe hypokinesia, akinesia, or dyskinesia. 
Test results were considered positive in case of new or worsening wall motion ab-
normalities at any stage during stress. Segmental wall motion abnormalities were 
assigned to coronary artery territories as previously described5. Because of the 
known limitations of stress imaging in distinguishing the right coronary artery and 
the left circumflex artery territory, the data were analyzed according to the anterior 
and common posterior circulation1.
Coronary arteriography
Coronary angiography was performed within 2 weeks in all patients. Significant 
coronary artery disease was defined as a diameter stenosis ≥ 50% in a major epi-
cardial artery including major side branches at quantitative angiography.
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Statistical analysis
All values are expressed as mean ± SD. Continuous variables were compared by 
use of the paired Student’s t-test. The β coefficient was calculated to determine in-
terobserver agreement. Sensitivity was defined as the number of true positive tests 
divided by the total number of patients with a positive angiogram. Specificity was 
defined as the number of true negative tests divided by the total number of patients 
with a negative angiogram. Data were analyzed using standard statistical software 
(SPSS version 12.0; SPSS, Inc., Chicago, Illinois).
Results
Coronary angiography
Coronary angiography showed significant CAD in 28 (62%) patients, 15/28 (54%) 
patients had single vessel CAD, 6/28 (21%) two-vessel CAD and 7/28 (25%) three-
vessel CAD. Coronary artery stenoses involved the left anterior descending artery 
in 17 (38%) patients, the right coronary artery in 17 (38%) patients and the left 
circumflex artery in 14 (31%) patients. The posterior circulation was involved in 23 
(51%) patients.
DSE results
DSE increased heart rate (from 73 ± 14 to 130 ± 21 beats per minute, P <0.001) 
and systolic blood pressure (from 125 ± 19 to 143 ± 25 mmHg, P <0.001). Atropine 
was administered in 13 patients (29%) at a mean dose of 0.6 ± 0.2 mg. Chest pain 
occurred in 10 patients (22%) and ST-segment depression (>0.1 mV horizontal or 
down sloping) in 5  (11%) patients. Reasons for termination of the test were target 
heart rate in 34 (76%), maximal dose of dobutamine-atropine in 4 (9%), angina in 5 
(11%), and ST-segment changes in 2 (4%). New or worsening wall motion abnor-
malities during contrast-enhanced RT3DE occurred in 19 (42%) patients.
Diagnostic accuracy of contrast-enhanced RT3DE
New or worsening wall motion abnormalities were detected in 17 of 28 patients 
with significant CAD (sensitivity 61%), and in 2 of 17 patients without significant 
CAD (specificity 88%). The sensitivity for detection of single vessel CAD was 8/15 
patients (53%), for two-vessel CAD 4/6 (67%) and for three-vessel CAD 5/7 (71%). 
The sensitivity and specificity for detection of significant CAD in the anterior circu-
lation was 9/17 (53%) and 26/28 (93%), respectively. The sensitivity for detection 
of significant CAD in the posterior circulation was 10/23 (43%), with a specificity of 
19/22 (86%).
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Comparison between conventional and contrast-enhanced RT3DE
In 35 (78%) patients, a comparison between acquisition using unenhanced sec-
ond harmonic imaging and contrast-enhanced RT3DE was available. During con-
ventional RT3DE, 532 segments (89%) could be analyzed at rest and 472 seg-
ments (78%) at peak stress. With contrast-enhanced stress RT3DE, the number 
of available LV segments at peak stress increased to 535 (90%) (P <0.001). The 
image quality index of the analyzable segments is depicted in Table 2. The global 
LV myocardial segment visibility index at rest improved from 2.5 ± 1.2 to 3.2 ± 1.0 
(P <0.001) with contrast and at peak stress from 2.3 ± 1.2 to 3.1 ± 1.0 (P <0.001). 
There were no regional differences in improvement with contrast. 
As shown in the Figure, the 2 observers agreed on the diagnosis of myocardial 
ischemia in 26 of 35 studies (74%, κ = 0.44) with conventional stress RT3DE and in 
30 of 35 studies (86%, κ = 0.69) with contrast-enhanced stress RT3DE. In these 35 
patients, sensitivity increased from 50% to 55% and specificity from 69% to 85% 
with contrast-enhanced stress RT3DE.
Interobserver agreement with conventional (left) 
and contrast-enhanced (right) 3-dimensional 
stress echocardiography for the diagnosis of 
myocardial ischemia for all territories (top) and 
the overall study result (bottom).
Table 2. Myocardial image quality at rest and peak stress with and without contrast enhancement.
Rest Peak stress
Contrast - Contrast + Contrast - Contrast +
Number of invisible segments 63 (11%) 55 (9%) 123 (21%) 60 (10%)
Overall visibility index 2.5 ± 1.2 3.2 ± 1.0 2.3 ± 1.2 3.1 ± 1.0
Apical segments 2.7 ± 1.2 3.2 ± 0.9 2.5 ± 1.1 3.2 ±0.9
Mid ventricular segments 2.5 ± 1.2 3.2 ± 1.0 2.3 ± 1.2 3.1 ± 1.0
Basal segments 2.3 ± 1.2 3.1 ± 1.0 2.1 ± 1.2 3.0 ± 1.1
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Discussion
Stress RT3DE has the potential to become the new standard in stress echocardiog-
raphy, because of the shorter acquisition time, elimination of off-axis acquisition 
and/or analysis, the ability to obtain multiple cross-sections of any desired LV seg-
ment, and more precise comparison of identical segments. 
In this study we confirm our previous results on image quality improvement in 
regional endocardial wall delineation with contrast-enhanced imaging resulting in 
a better interobserver agreement for the diagnosis of myocardial ischemia3. Con-
trast-enhanced stress RT3DE also increased diagnostic accuracy, although non-
significantly due to the relatively small number of patients. The sensitivity of 61% 
and specificity of 88% for contrast-enhanced stress RT3DE reported in our study is 
in the range of those reported in 2DE stress studies1. However, it should be noted 
that in two earlier stress RT3DE studies higher sensitivities of 78% to 84% were 
reported6, 7.
Several patient and technical characteristics may explain the relatively low diag-
nostic sensitivity found in our study. Most of our patients with CAD had single-vessel 
disease and in particular left circumflex stenosis. Patients with such characteristics 
are very difficult to identify with any stress test1, 8, 9. This is in agreement with the low 
sensitivity (65% and 63%, respectively) for stenosis in the left circumflex territory 
by Aggeli et al.7 and Matsumura et al.10. Also, the vast majority of our patients did 
not have a history of prior myocardial infarction or rest wall motion abnormalities. 
Such characteristics are also known to negatively affect the diagnostic sensitivity 
of DSE11.
Also, several technical issues limit the accuracy of stress RT3DE in its current 
form compared to 2DE. In earlier studies, others and us have shown that in par-
ticular anterior wall segments may be poorly visualized because of ribs interfering 
with the large foot print of the X4 transducer3, 12. Both Aggeli et al. and Matsumura 
et al. suggested that stress RT3DE identifies more readily wall motion abnormalities 
in the apical region compared to 2D imaging due to non-foreshortening acquisition 
and/or analysis7, 10. However, in our study approximately 10% of the distal segments 
could not be visualized due to the earlier described interfering ribs and prominent 
near-field artifacts. It should be noted that all patients in the study of Aggeli et al. 
were studied with the smaller X3-1 transducer, whereas in our study only a minor-
ity were studied with this newer transducer. Moreover, different methods for data 
analysis are used. Aggeli et al. and Matsumura et al. used the integrated software of 
the ultrasound system to analyze cropped planes from apex to base along the long 
axis of the LV. We used TomTec off-line analysis software to visualize identical two-
dimensional cross-sections of the LV at baseline and peak stress. Both methods 
take advantage of the full volumetric dataset, but quantify wall-motion abnormali-
ties only in a limited number of cropped planes. Further investigations are neces-
sary to develop a semi-automated approach to endocardial border delineation and 
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subsequent wall motion analysis. This may result in less observer dependent analy-
sis and more quantitative determination of myocardial ischemia.
Both spatial and temporal resolution are still the Achilles heel of stress RT3DE. 
The spatial resolution of RT3DE is less compared to 2DE, which can partially be 
circumvented by contrast enhancement. Additionally, it is known from 2D stress 
echocardiography that lower frame rates negatively influence the identification of 
significant CAD13. The number of available frames per heart cycle for analysis de-
pends on several machine settings and the heart rate of the patient. When the 
heart rate of the patient increases, fewer volumes per heart cycle are available for 
analysis. Specific imaging methods may be used to improve the detection of ultra-
sound contrast agents, such as power modulation. In this multi-pulse technique, 
the acoustic amplitude of the transmitted pulses is changed. Although this method 
improves contrast-imaging quality, unfortunately, this technique significantly de-
creases frame rate. During a typical full-volume acquisition of the LV with second 
harmonic imaging, frame-rate decreases from 30 to 9 Hz when power modulation 
is activated14. Therefore, an improvement in image quality is followed by a lower 
temporal resolution, as in navigating between ‘Scylla and Charybdis’.  
Conclusions
Despite some important practical and theoretical benefits, contrast-enhanced stress 
RT3DE currently has only moderate diagnostic sensitivity due to several technical 
limitations. Further developments in transducer technology (e.g. with single crystal 
technology15) seem necessary to really profit from these benefits and bring (con-
trast-enhanced) stress RT3DE into clinical practice. Specific imaging functions to 
improve the detection of ultrasound contrast agents, such as power modulation, 
should not be used because of the negative effect on frame-rate. 
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We evaluated the use of three-dimensional echocardiography for quantification of 
left ventricular function. For this purpose, we used different acquisition systems for 
three-dimensional echocardiography in several different patient populations.
In the introduction to this thesis, the methodology and the outline of the thesis 
are brought to attention.
Chapter 2 provides the technical background of the fast rotating ultrasound 
transducer. This transducer has several advantages, such as the capability of using 
standard high-resolution two-dimensional ultrasound techniques, such as second 
harmonic imaging. Also, a high frame rate at a wide sector angle of 90° can be 
chosen, which is necessary to capture the full left ventricle in most patients. The 
validation study (Chapter 3) shows a high diagnostic accuracy for measurement of 
left ventricular function using the fast rotating ultrasound transducer when using 
magnetic resonance imaging as the reference method.
The acute effects of volume changes due to hemodialysis on cardiac function re-
main poorly understood due to conflicting results in earlier studies. These studies, 
mainly using M-mode echocardiography and two-dimensional echocardiography, 
may be hampered by low accuracy of measurements. Previous studies showed 
that smaller changes in volume are more accurately detected by three-dimensional 
echocardiography, and therefore may improve the assessment of the acute effect 
of hemodialysis on left ventricular performance. In chapter four, we show that three-
dimensional echocardiography using the fast-rotating ultrasound transducer is fea-
sible for image acquisition in patients undergoing hemodialysis. Successful image 
acquisition was achieved in 10/12 patients (83%). We found a significant differ-
ence between measurements using two- and three-dimensional echocardiography. 
However, no significant difference in volumes was observed at different time inter-
vals during hemodialysis, probably due to the small number of patients included in 
our study. The correlation between measurements of volume and ejection fraction 
using two- and three-dimensional echocardiography were moderate, but the limits 
of agreement between these methods was poor (for volume measurements larger 
than 30 ml). This study shows that the fast-rotating ultrasound transducer is appli-
cable in a complex patient population for accurate and reproducible measurement 
of left ventricular function.
We used three-dimensional echocardiography using the fast rotating ultrasound 
transducer for diagnosis of left ventricular dyssynchrony in patients with severe 
heart failure. Currently, patients are selected for biventricular pacemaker implanta-
tion based on standard electrocardiographic and echocardiographic criteria, but 
additional selection criteria are needed because 20 to 30% of patients do not re-
spond. Tissue Doppler imaging is mostly used for demonstration of left ventricular 
dyssynchrony and other echocardiographic methods are also explored. We demon-
strated that dyssynchronic segments can be identified and biventricular pacing re-
sulted in reduction of dyssynchrony in seven of eight patients using the fast rotating 
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ultrasound transducer. Thus, this technique could be used as a new approach for 
diagnosis and guidance of pacemaker implantation for achieving optimal results.
In part 2, an overview of studies using three-dimensional echocardiography 
for assessment of left ventricular function in comparison with magnetic reso-
nance imaging is given. We evaluated two different semi-automated border detec-
tion algorithms for assessment of left ventricular function using a novel real-time 
three-dimensional echocardiographic instrument. The older method is limited by 
endocardial contour detection and revision in a limited number of cross-sections 
and subsequent interpolation for left ventricular cavity reconstruction and analysis. 
The most recently developed algorithm, however, takes advantage of the full three-
dimensional dataset for left ventricular volume calculation. The main finding of this 
comparative study is that the new method more accurately estimates left ventricular 
volumes. Bland-Altman analysis showed greater underestimation of end-diastolic 
volume and end-systolic volume by the interpolation algorithm. Larger biases for 
end-diastolic (-24.0 vs. -9.9 ml, respectively) and end-systolic volumes (-11.3 vs. 
-5.0 ml, respectively) were found. It is suggested that a higher accuracy is achieved 
by automated contour detection in the complete three-dimensional dataset, using 
significantly more data for reconstruction of the endocardial contour and avoiding 
errors due to interpolation. Besides less user interaction, this new method is faster 
(6 ± 2 vs. 15 ± 4 min, P <0.01) and has better review options.
The study presented in chapter 8 shows that the use of contrast enhancement 
during real-time three-dimensional echocardiography results in more accurate as-
sessment of left ventricular function, evidenced by a better correlation and smaller 
limits of agreement compared to magnetic resonance imaging, and lower intra- 
and interobserver variability. Interestingly, patients with poor-to-moderate image 
quality showed an improvement in agreement in left ventricular ejection fraction 
measurement after contrast (± 24.4% to ± 12.7%) to the same level as patient with 
moderate-to-good image quality without contrast (± 10.4%).
In the reviews presented in chapters 9 and 10, the factors affecting sensitivity 
and specificity of dobutamine stress echocardiography are described. The analy-
sis shows that methodologic problems may explain the wide range in diagnostic 
variability of dobutamine stress echocardiography. An improvement of clinical rel-
evance of dobutamine stress echocardiography testing is possible by stronger ad-
herence to common and new methodologic standards. Also, the reported sensitiv-
ity of dobutamine stress echocardiography is higher and the specificity lower than 
that expected in clinical practice because of the inappropriate inclusion of patients 
with prior myocardial infarction, definition of positive dobutamine stress echocar-
diography and the presence of referral bias. Chapter 11 provides an overview of the 
current status of real-time three-dimensional stress echocardiography, describing 
its advantages over two-dimensional dobutamine stress echocardiography, such 
as a faster and easier image acquisition, and reconstruction of matching views from 
baseline and different stress levels for a precise comparison of identical segments. 
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However, this imaging method is still hampered by several technical limitations, 
such as multibeat frame composition and limited spatial and temporal resolution. 
Also, several settings are available on current ultrasound systems that have an 
important influence on the spatial and temporal resolution, and subsequently on 
diagnostic accuracy of real-time three-dimensional stress echocardiography. The 
latter is described in further detail in chapter 12. It is expected that most of these 
limitations will be overcome in the near future by new ultrasound transducer tech-
nology and faster processors.
Our results in chapter 13 indicate that an important number of left ventricular seg-
ments are insufficiently visualized during unenhanced real-time three-dimensional 
stress echocardiography. Contrast-enhancement significantly decreases the num-
ber of non-interpretable segments and improves interobserver agreement for the 
diagnosis of myocardial ischemia. Finally, we performed a diagnostic study com-
paring contrast-enhanced real-time three-dimensional stress echocardiography 
with coronary arteriography as the reference standard. We found a sensitivity of 
61% for detection of coronary artery disease, and a specificity of 88%. In a sub-
group of 35 patients, an acquisition using second harmonic imaging and contrast-
enhanced real-time three-dimensional echocardiography was available for compar-
ison. Sensitivity increased from 50% to 55% and specificity from 69% to 85% with 
contrast-enhanced real-time three-dimensional stress echocardiography. Thus, 
despite some important practical and theoretical benefits, contrast-enhanced real-
time three-dimensional stress echocardiography currently has only moderate diag-
nostic sensitivity due to above-mentioned technical limitations.
In conclusion, the fast-rotating ultrasound transducer combines ultrasound imag-
ing properties of a standard phased array transducer with a fast acquisition time 
and is easily integrated into existing ultrasound systems. Together with appropriate 
analytic reconstruction software, it forms an accurate and reproducible method for 
assessment of left ventricular function. For several daily clinical referral questions, 
such as patient follow-up and guidance of resynchronization therapy, this method 
can be used without the need for an expensive high-end ultrasound system or 
magnetic resonance imaging. Despite above-mentioned advantages and favorable 
results, the fast-rotating ultrasound transducer has not been taken into commercial 
production so far. Several ultrasound companies offer products for three-dimen-
sional echocardiography, but most of the current research and development focus 
on (expensive) matrix transducer technology. Despite its cost effectiveness, practi-
cal disadvantages such as maintenance issues and possible defects from moving 
mechanical parts, may be an important drawback for the production of a mechani-
cal transducer.
In general, newer algorithms for automated border detection will decrease analy-
sis time with a higher diagnostic accuracy. In patients with suboptimal image qual-
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ity, the use of ultrasound contrast-enhancement is necessary for accurate assess-
ment of left ventricular volume and function.
 Real-time three-dimensional stress echocardiography has several theoretical 
advantages, such as less operator dependency. However, we found a lower diag-
nostic accuracy compared to two-dimensional echocardiography caused by a low-
er spatial and temporal resolution. Contrast enhanced real-time three-dimensional 
stress echocardiography has shown to improve image quality, but several technical 
limitations remain. Future improvements in transducer technology will likely solve 
these issues and improve its diagnostic accuracy, and make it a practical test to 
detect ischemia .
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Samenvatting en conclusie
Dit proefschrift richt zich op de toepassing van driedimensionale echocardiografie 
voor het kwantificeren van de linker ventrikelfunctie. Hiertoe werden verschillende 
echo systemen toegepast bij diverse patiënten populaties.
In de introductie wordt de methodologie beschreven en een overzicht van dit proef-
schrift weergegeven.
In hoofdstuk twee wordt de technische achtergrond van de snel roterende ultrage-
luidstransducer beschreven. Deze transducer heeft verschillende voordelen, zoals 
toepassing van de tweedimensionale ‘second harmonic imaging’ echocardiografie 
techniek. Voorts wordt gebruik gemaakt van een hoge ‘frame rate’ en brede sector 
hoek van 900, hetgeen bij de meeste patiënten nodig is om de linker ventrikel vol-
ledig te omvatten. De validatie studie (hoofdstuk 3) toont een hoge nauwkeurigheid 
voor metingen van de linker ventrikelfunctie met de snel roterende ultrageluids-
transducer, waarbij MRI werd gebruikt als referentie methode.
De acute effecten van volume veranderingen in het lichaam als gevolg van he-
modialyse op de cardiale functie zijn nog steeds niet volledig bekend. Eerdere on-
derzoeken werden beperkt door een lagere nauwkeurigheid van de metingen door 
het gebruik van M-mode echocardiografie en tweedimensionale echocardiografie. 
Studies hebben uitgewezen dat kleine volume veranderingen nauwkeuriger kun-
nen worden gedetecteerd door driedimensionale echocardiografie. In hoofdstuk 
vier tonen we aan dat driedimensionale echocardiografie met de snel roterende 
transducer geschikt is voor beeldvorming bij patiënten gedurende hemodialyse. Bij 
10/12 patiënten (83%) konden analyseerbare beelden worden verkregen. Er werd 
een significant verschil aangetoond tussen metingen met twee- en driedimensio-
nale echocardiografie. Echter, er kon geen significant verschil met echocardiografie 
worden vastgesteld op verschillende tijdsintervallen gedurende de hemodialyse, 
waarschijnlijk door de kleine studie populatie. De correlaties van volume en ejec-
tie fractie, gemeten met twee- en driedimensionale echocardiografie, waren matig. 
Echter, de mate van overeenstemming (methode van Bland-Altman) was slecht. 
Concluderend toont deze studie toont aan dat de snel roterende ultrageluidstrans-
ducer bruikbaar is bij een complexe patiënten populatie voor nauwkeurige en re-
produceerbare meting van de linker ventrikelfunctie.
Wij gebruikten driedimensionale echocardiografie met gebruikmaking van de 
snel roterende ultrageluidstransducer voor de diagnose van linker ventrikel dis-
synchronie bij patiënten met ernstig hartfalen. Op dit moment worden patiënten 
geselecteerd voor biventriculaire resynchronisatie therapie op basis van standaard 
electrocardiografische criteria. Echter, aanvullende criteria zijn nodig om de 20-
30% van de patiënten te identificeren die niet op deze therapie reageren. Echocar-
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diografische ‘tissue Doppler’ metingen worden frequent gebruikt voor het aantonen 
van linker ventrikel dissynchronie, maar ook andere methoden worden momenteel 
onderzocht. Onze studie met driedimensionale echocardiografie toont aan dat dis-
synchrone segmenten kunnen worden gedetecteerd en biventriculaire stimulatie 
resulteerde in reductie van dissynchronie bij zeven van de acht patiënten. De voor-
spellende waarde van driedimensionale echocardiografie voor resynchronisatie uit-
komst is momenteel een belangrijk onderwerp van onderzoek in ons centrum.
Deel twee van het proefschrift toont een overzicht van studies die gebruik maken 
van driedimensionale echocardiografie voor de bepaling van linker ventrikelfunctie, 
met MRI als referentiemethode. Wij vergeleken twee verschillende deels automa-
tische contour detectie algoritmen voor de bepaling van linker ventrikel volumes. 
De oudere methode wordt beperkt door endocardiale contour detectie en revisie in 
een gelimiteerd aantal doorsneden. Vervolgens vindt interpolatie plaats voor linker 
ventrikel reconstructie en analyse. Het meest recente algoritme gebruikt de vol-
ledige driedimensionale dataset voor linker ventrikel volume calculaties, hetgeen 
resulteerde in nauwkeurigere resultaten. Bland-Altman analyse toonde een grotere 
onderschatting van het eind-diastolisch (-24.0 vs -9.9 ml, respectievelijk) en eind-
systolisch volume ( -11.3 vs. -5.0 ml, respectievelijk) door het interpolatie algoritme. 
Het is aannemelijk dat een hogere nauwkeurigheid wordt verkregen door automati-
sche contourdetectie in de volledige driedimensionale dataset, doordat aanzienlijk 
meer data worden gebruikt voor reconstructie van de endocardiale contour en fou-
ten als gevolg van interpolatie worden vermeden. Voorts is deze nieuwe methode 
sneller (6 ± 2 vs. 15 ± 4 min, P <0.01) en heeft het betere revisie mogelijkheden.
De studie gepresenteerd in hoofdstuk 8 toont aan dat het toepassen van con-
trast gedurende ‘real-time’ driedimensionale echocardiografie resulteert in een 
nauwkeuriger bepaling van linker ventrikel volumes en functie. Interessant is dat bij 
patiënten met een verminderde beeld kwaliteit, het gebruik van contrast bij driedi-
mensionale echocardiografie resulteert in een verbetering in de overeenstemming 
van de gemeten linker ventrikel ejectiefracties ten opzichte van MRI (± 24.4% naar 
± 12.7%) tot hetzelfde niveau als bij patiënten met redelijk tot goede beeldkwaliteit 
zonder contrast (± 10.4%).
In de overzichtartikelen gepresenteerd in hoofdstuk 9 en 10 worden de factoren 
beschreven die de sensitiviteit en specificiteit van dobutamine stress echocardi-
ografie beïnvloeden. Analyse toont aan dat methodologische problemen de grote 
verschillen in de gepubliceerde diagnostische variabiliteit zouden kunnen verkla-
ren. Een verbetering van klinische relevantie van diagnostische dobutamine stress 
echocardiografie studies is mogelijk door gebruikmaking van de huidige en nieuwe 
methodologische standaarden. De gerapporteerde sensitiviteit van dobutamine 
stress echocardiografie is hoger en de specificiteit lager dan verwacht in de klini-
sche praktijk door de onterechte inclusie van patiënten met een myocard infarct in 
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de voorgeschiedenis, verschillende definities van een positieve dobutamine stress 
test en de aanwezigheid van ‘referral bias’.
Hoofdstuk 11 toont een overzicht van de huidige status van ‘real-time’ driedimen-
sionale stress echocardiografie. De voordelen boven tweedimensionale echocardi-
ografie worden belicht, zoals snellere en eenvoudiger acquisitie, en nauwkeuriger 
vergelijking van identieke segmenten van verschillende stadia gedurende de test. Er 
zijn echter nog verschillende technische beperkingen, zoals de beperkte ruimtelijke 
en temporele resolutie. Voorts zijn er diverse instellingen beschikbaar op de huidige 
echocardiografie systemen die een belangrijke invloed hebben op de resolutie en 
derhalve ook op de diagnostische nauwkeurigheid van ‘real-time’ driedimensionale 
stress echocardiografie. Dit laatste wordt in detail beschreven in hoofdstuk 12. Het 
is de verwachting dat de meeste technische beperkingen binnen afzienbare tijd 
door nieuwe transducer technologie en snellere processoren zullen verbeteren.
Onze resultaten in hoofdstuk 13 maken duidelijk dat een belangrijk aantal linker 
ventrikel segmenten onvoldoende wordt gevisualiseerd gedurende ‘real-time’ drie-
dimensionale stress echocardiografie. Toepassing van contrast verlaagt het aantal 
niet-interpreteerbare segmenten significant en verbetert de overeenstemming tus-
sen gebruikers voor de diagnose van myocard ischemie. Ten slotte voerden wij een 
diagnostische studie uit ter vergelijking van ‘real-time’ driedimensionale echocar-
diografie met toepassing van contrast en met coronair angiografie als de referentie 
methode. Wij vonden een sensitiviteit van 61% en een specificiteit van 88% voor de 
detectie van coronairlijden. In een subgroep van 35 patiënten beschikten wij over 
een opname met en zonder toepassing van contrast, waardoor vergelijking mogelijk 
was. In deze groep nam de sensitiviteit toe van 50 naar 55% en de specificiteit van 
69 tot 85% bij gebruik van contrast ‘real-time’ driedimensionale stress echocar-
diografie. Dus, ondanks diverse belangrijke praktische en theoretische voordelen, 
is de huidige diagnostische sensitiviteit van contrast ‘real-time’ driedimensionale 
stress echocardiografie beperkt.
Concluderend combineert de snel roterende ultrageluidstransducer eigenschap-
pen van een standaard ‘phased array’ transducer met een snelle acquisitie tijd 
en is eenvoudig integreerbaar op bestaande ultrageluid systemen. Indien gebruikt 
met geschikte analytische reconstructie software vormt dit een nauwkeurige en 
reproduceerbare methode voor de bepaling van de linker ventrikelfunctie. Voor di-
verse gebruikelijke klinische verwijzingen, zoals vervolgcontroles en resynchroni-
satie therapie, kan deze methode worden gebruikt zonder de noodzaak van een 
duur en geavanceerd echocardiografie systeem of MRI. Ondanks bovenstaande 
voordelen en gunstige resultaten is de snel roterende ultrageluidstransducer tot op 
heden niet in commerciële productie genomen. Diverse bedrijven bieden producten 
voor driedimensionale echocardiografie, maar het meeste onderzoek en ontwikke-
ling richt zich op (dure) matrix technologie. Ondanks de kosteneffectiviteit, zouden 
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praktische nadelen zoals onderhoud en mogelijke defecten van bewegende me-
chanische onderdelen een argument kunnen zijn om af te zien van de productie van 
een mechanische transducer.
In het algemeen zullen nieuwe algoritmes voor automatische endocardiale con-
tour detectie de analyse tijd verminderen met een hoge nauwkeurigheid. Bij patiën-
ten met suboptimale beeldkwaliteit is het gebruik van echografie contrast noodza-
kelijk voor een nauwkeurige bepaling van linker ventrikelvolume en functie.
‘Real-time’ driedimensionale stress echocardiografie heeft diverse theoretische 
voordelen, zoals minder afhankelijkheid van de echografist. Echter, wij vonden een 
lagere diagnostische nauwkeurigheid vergeleken met tweedimensionale echocardi-
ografie door een lagere ruimtelijke en temporele resolutie. Contrast ‘real-time’ drie-
dimensionale stress echocardiografie verhoogt de beeldkwaliteit, maar technische 
beperkingen blijven aanwezig. Het is aannemelijk dat ontwikkelingen op het gebied 
van transducer technologie deze problemen zullen oplossen en de diagnostische 
waarde verbeteren, zodat het een praktische test vormt om ischemie de detecte-
ren.
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mentele echocardiografie met veel enthousiasme verwelkomde. De roterende ul-
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naar de verdere ontwikkeling op dit gebied door de huidige 3D-groep met Marijn 
van Stralen, Gerard van Burken en Esther Leung. Veel dank aan dr. Hans Bosch 
voor de bereidheid om altijd op zeer korte termijn technische aspecten in manus-
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oppakken.
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Zonder het werk van Attila Nemes en Osama Soliman zou het onderzoek met de 
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in het Thoraxcentrum. Dear Attila and Osama, although the analysis time decreases 
with newer 3D reconstruction software, many hours were still necessary to analyze 
the hundreds of datasets. Your help and advice was most valuable. I enjoyed the 
three months of cooperation in the first quarter of this year!
Robert-Jan van Geuns, Sharon Kirschbaum en Timo Baks, ik dank jullie voor de 
vele MRI acquisities bij de studie patiënten. 
Wim Vletter, door jouw jarenlange ervaring en deskundigheid op het gebied van 
echocardiografie konden we gebruik maken van echobeelden van sublieme kwa-
liteit. Ook voor je hulp om die betere beeldkwaliteit te krijgen wanneer mij dat niet 
lukte, ben ik je erg dankbaar. Ook dank aan de overige (oud)medewerkers van de 
echo afdeling, Jacky, Debbie, Marjan, Dieny en Hans. René, bedankt voor de tech-
nische ondersteuning bij de diverse artikelen.
Door de grote gastvrijheid van de maatschap (dr. Leenders, dr. Ilmer en dr. Neu-
mann) en het secretariaat cardiologie van het Havenziekenhuis kon ik ook lang na 
mijn vooropleiding interne geneeskunde op zoek naar patiënten om in een studie te 
includeren. Veel dank hiervoor!
Tot slot gaat mijn grote dank uit naar mijn ouders voor de ondersteuning, vooral 
wanneer de weg wat hobbelig werd. Uiteraard ben ik ook veel dank aan mijn aan-
staande schoon-ouders verschuldigd, met name voor alle goede zorg voor Mijntje 
als het thuis te druk werd. Lieve Annemien, jij wist al dat promoveren tijd kost, maar 
kon dit zelfs combineren met de geboorte van Mijntje. Nu we opnieuw een pro-
motie hebben afgerond rondom de komst van Vittoria, ben ik benieuwd wat onze 
volgende stap zal zijn.......dank je wel voor alle steun!
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